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In recent times there has been an increased urgency to find new anti-microbial compounds as a 
growing number of microorganisms develop resistance to many commonly used anti-microbial 
agents upon exposure to anti-microbials. Infections caused by antibiotic-resistant microorganisms 
complicate conventional treatment, resulting in prolonged illness and greater risk of death (Barza 
and Travers, 2002). 
The problem of microbial resistance to antibiotics appeared as soon as the mass-production of 
penicillin was started in 1945 (Shaughnessy, 2007), and has now become a major concern in 
medicine throughout the world. Bacterial resistance not only can occur to a single class of antibiotic, 
but also to multiple classes of antibiotics. The susceptibility of microorganisms to antibiotics can be 
categorized in two types:  
 innate resistance, which means that some microorganisms are inherently resistant to many 
antibiotics;  
  Acquired resistance, which can arise by a number of diverse mechanisms such as mutation 
and horizontal gene transfer.  
Horizontal gene transfer can occur by several different processes such as bacterial conjugation, 
transfer of genetic material between bacterial cells by direct cell-to-cell contact. Also DNA can be 
transferred from one bacterium to another via a viral vector, or directly taken up from its 
surrounding through the cell membrane (Tenover, 2006). 
One of the most serious cases of multidrug resistance is the resurgence of tuberculosis caused by 
the bacterium Mycobacterium tuberculosis, which results in around 2 million deaths per year. Multi-
drug resistant Mycobacterium strains and the spread of the HIV/AIDS pandemic have contributed to 
this mortality (Amin, 2006). Tuberculosis, combined with other mycobacterium-based infections, has 
killed over 30 million people in the last decade, highlighting the need for new anti-bacterial 
compounds.  
According to an annual World Health Organization (WHO) report (WHO, 2014), half of all 




tetracycline and erithromycine. This left vancomycin as the only effective agent available at the time. 
However, glycopeptide intermediate-resistant S. aureus (GISA) or vancomycin intermediate-resistant 
S. aureus (VISA) strains began to appear in the late 1990s. The first identified case was in Japan in 
1996, and thereafter strains have been found in hospitals in England, France and the US. The first 
documented strain with complete resistance to vancomycin, termed vancomycin-resistant S. aureus 
(VRSA) appeared in the US in 2002.  
Resistance to antibiotics of pathogenic fungi is even a more serious problem, due to the limited 
number of available anti-fungal drugs. Fungi can counteract the fungicidal or fungistatic effects of all 
anti-fungals classes by three major mechanisms, namely: (i) reducing the accumulation of the drug 
within the fungal cell, (ii) decreasing the affinity of the drug for its target, and (iii) modifications of 
metabolism to counterbalance the drug effect (Vandeputte et al., 2012).  
Taken together the increase in (multi) drug resistance of pathogenic microbes and the limited 
amount of antibiotics available for certain classes of microorganisms requires the discovery of new 
methods and drugs to defend humans and animals against infection by the pathogenic organisms. 
Another important reason to discover new classes of antibiotics is the recent recognition that a 
“biofilm” is the most common living environment of microorganisms (including those causing 
diseases) and that in this environment microorganisms are much more resistant against antibiotics. 
Biofilms were actually already discovered in 1650s by Anthonie van Leeuwenhoek when he 
examined the “animalcules” in the dental plaque on his own teeth, however the theory describing 
the biofilm process was not developed until Costerton and colleagues published their study in 1978. 
Costerton’s theory states that the majority of bacteria grow in matrix-enclosed biofilms that adhere 
to biological or non biological surfaces in aqueous environments, and that these sessile bacterial 
cells differ greatly from their planktonic counterparts. Biofilms have been intensively studied in 
recent years due to increased awareness of the impact of biofilms on human health and industrial 
productivity (Costerton et al., 1978; Donlan and Costerton 2002; Hall-Stoodley et al., 2004).  
Biofilms are defined as a community of cells that are attached to a surface, grow on this surface and 
can form structured layers. Within these layers cells develop properties as free living (planktonic) 
cells. One of these traits is the development of an increased antibiotic resistance and the expression 
of pathogenicity properties. Bacterial biofilm formation is likely to involve a cascade of gene 
expression events associating with a crossover of many sensing systems directed against 
environmental changes (Yamanaka et al., 2009). Streptococcus mutans biofilm proved to exhibit a 
different expression of some proteins involved in cell signalling, peptidoglycan biosynthesis, motility, 




Kreikemeyer et al. (2011) concerning biofilm structure, the determinants of 
Streptococcus pathogenicity are related to the discovery of long filamentous structures similar to the 
pilus observed on bacteria surfaces. These structures exhibit adhesive properties and may play a key 
role in adhering to host cells and tissues, as well as in biofilm formation by pathogens of 
the Streptococcus species. Exopolysaccharide (EPS) is one of the main constituents of the biofilm 
extracellular matrix (Flemming et al., 2007), and recent investigations have revealed that each 
biofilm-forming bacterium produces distinctive EPS components e.g. alginate and/or Psl found 
in Pseudomonas aeruginosa (Ryder et al., 2007), and polysaccharide intercellular adhesin (PIA) 
of Staphylococcus (Gotz, 2002). This EPS provides a protection for the biofilm microorganisms from a 
variety of environmental threats, such as UV radiation, pH shifts, osmotic shock, desiccation, and 
toxic compounds, and creates a micro niche favorable for long term survival and functioning of the 
microbial communities (Baumgartner et al., 2008).  Therefore, when microorganisms grow as a 
biofilm they are less susceptible against antibiotics, biocides and other chemical and physical 
challenges (Lewis, 2001). 
It is estimated that at least 65% of all hospital infections involve biofilms, since biofilms are not only 
efficiently formed on human tissues, but also on medical equipment such as catheters and 
biomaterials such as implants (Donlan, 2002). Furthermore, it is shown that biofilms are involved in 
developing resistance of bacterial infections (Furukawa et al., 2006) as biofilms form a very suitable 
environment for the selection and emergence of multi-drug resistant strains.  
Previously, antibiotic discovery and characterization has been studied mostly with free living 
bacteria. Since bacterial cells in a biofilm are physiologically so different, it is clear that specific 
compounds that are able to degrade biofilms still need to be discovered. The anti-biofilm 
compounds are important   tools in the successful treatment of infections and to prevent the 
development of resistance.  
 
Quorum sensing (QS) 
Microorganisms can communicate with one another. One of the communication mechanisms, called 
quorum sensing, has been named so after discovery of the mechanism underlying cell-density-
dependent behavior (Nobile and Mitchell, 2007; Atkinson and Williams, 2009). It has been shown 
that bacteria assess their population density by producing and detecting the concentration of small, 
diffusible cell-to-cell signal molecules (auto-inducer), such as an N-acylhomoserine lactone (AHL), 
that they export into their environment. At high population density, a surplus of signaling molecules 




Losick, 2006; Atkinson and Williams, 2009). When the signal molecules reaches a threshold level 
inside the cell, they activate (or repress) a response regulator. This regulator controls expression of 
quorum-sensing dependent genes such as genes encoding virulence factors or genes encoding 
proteins involved in biofilm formation (Shih and Huang, 2002; Hentzer et al., 2003; Atkinson and 
Williams, 2009), antibiotic production (Liu et al., 2007; Duerkop et al., 2009), pigment production, 
bioluminescence (Fuqua et al., 2001), and surface motility (Rasmussen et al., 2000) as well as gene 
transfer systems (Rodelas et al., 1999; Schaefer et al., 2002). 
 
In Gram-negative bacteria, one of the best studied quorum-sensing systems is the LuxR/I system 
which consists of a four-component circuit: an AHL (N-Acyl homoserine lactones )-signal molecule, a 
LuxI-type signal synthase, a LuxR-type signal receptor, and the target gene(s) The AHL-signal is 
synthesized at a low basal level by the AHL-synthase, the product of the luxI gene. The AHL-signaling 
molecules diffuses out of the cell, and when the cell density is high, AHL diffuses back into the cell 
where it binds to and activates the transcriptional activator LuxR, which then stimulates 
transcription of luxI (Hentzer and Givskov, 2003). 
 
In Gram-positive bacteria, the most common type of signal molecules is oligopeptides that are being 
exported from the bacterium by transporters (Miller and Bassler, 2001). These peptides will interact 
with two-component systems ultimately regulating gene transcription. Interaction with the peptide 
ligand initiates a series of phosphorylation events that culminate in the phosphorylation of a cognate 
response regulator protein. This phosphorylation allows the response regulator to bind to the 
promoter region of the quorum sensing–controlled target gene(s) and to alter in this way their 
transcription (Reading and Sperandio, 2005). 
 
The existence of fungal QS systems was revealed after the discovery that farnesol inhibit biofilm 
formation in the pathogenic polymorphic fungus Candida albicans. In addition to farnesol, the 
aromatic alcohol tyrosol was also found to be a C. albicans QS-molecule (QSM) controlling growth, 
morphogenesis and biofilm formation. In Saccharomyces cerevisiae, two other aromatic alcohols, 
phenylethanol and tryptophol, were found to be QSMs regulating morphogenesis during nitrogen 
starvation conditions. Additionally, population density-dependent behaviors that resemble QS have 
been described in several other fungal species (Albuquerque and Casadevall, 2012). 
 
There is evidence that interspecies communication via QS can occur. This is known as QS cross talk. 




mixed species communities. Among the many virulence factors and phenotypes that are controlled 
by quorum-sensing, there is a clear focus on biofilm formation (Kjelleberg and Molin, 2002). 
 
Biofilm: a novel target 
For decades, microbes are mostly considered as free-floating single-celled (planktonic) organisms 
living an independent lifestyle, rapidly multiplying and described based on their growth 
characteristic in nutritionally rich culture media (Donlan, 2002; Schachter, 2003). But in fact in 
nature, most of microbes live together in large aggregates, are attached to a surface, are growing on 
this surface and often form structured layers. This way of occurance of microbial populations is 
known as a biofilm. A biofilm community can comprises a single kind of microorganism, but in nature 
biofilms almost always consist of mixtures of many species of bacteria, as well as fungi, algae, yeasts, 
protozoa, and other microorganisms, along with non-living debris and corrosion products (Liu et al., 
2000; Sutherland 2001). Biofilms are found in almost every habitat where the combinations of 
moisture, nutrient, and surface are available, such as in pipe-lines of industrial or drinkable water, on 
rocks, at the grime in the toilet bowls and showers or in moss or lichen on tree trunk. Growth as 
biofilms is likely to provide a better opportunity to adapt to changing conditions collectively than as 
single cells. Advantages of microbial life in a biofilm comprise protection from host defense and 
antibiotics, increased availability of nutrients by sequestration to nutrient-rich areas, and 
cooperative benefits of life in a community in general (Leid, 2009). 
 
Biofilms also have an important impact on human health. The National Institutes of Health (NIH) 
estimated that biofilms are involved in at least more than 65% of nosocomial infections and up to 
75% of microbial infections that occur in the human body (Richards et al., 2009). In human tissue for 
instance, biofilms are produced on the surface of teeth as dental plaque, lungs in cystic fibrosis 
patients, and as fungal infection on the woman reproductive system. Biofilms formed on medical 
instruments such as catheters, artificial heart valves, contact lenses, and artificial joints,  putting 
patients at risk for local and systemic infection complications, including local-site infections, 
catheter-related bloodstream infections, and endocarditis (Donlan, 2002; O’grady et al., 2002). The 
establishment of microbial biofilms is often considered a pathogenicity trait during chronic 
infections, and biofilm formation has been recognized as an important virulence mechanism of many 
bacterial pathogens (Donlan and Costerton, 2002). 
 
Biofilm communities can develop within hours. There are five stages of biofilm development, as 




cells, referred as ‘pioneer cells’ to a surface associated with proteins, glycoproteins, humic-like 
substances (HULIS), and other dissolved or colloidal organic matters (the so called "conditioning 
layer"). This conditioning layer is consider to play a vital role in initial microbial attachment as they 
neutralizes excessive surface charge and surface free energy which may prevent a microbial cell 
from approaching near enough to initiate attachment (Schneider and Leis, 2002; Palmer et al., 2007; 
Renner and Weibel, 2011). 
 
 
Fig. 1:  Five stages of biofilm development: 1. Initial attachment of planktonic cells to the surface, 
2. Irreversible (permanent) attachment, 3. Cells proliferation and formation of EPS (maturation I), 
4. Formation of biofilm structure (maturation II), 5. Biofilm spreading (dispersion).  
 
During initial attachment, the ‘pioneer cells’ adhere to the surface initially through weak, reversible 
Van der Waals forces. The bacteria may then form a transient association with the surface, and 
facilitate the arrival of other cells by providing more diverse adhesion sites to yield a basal layer and 
forms a stable association as a member of a microcolony (Watnick and Kolter, 1999).  Afterwards, 
the attachment of the cells becomes irreversible as the microcolonies start joining together above 
the substratum to form a continuous layer of extracellular polymeric substances (EPS) that run into a 
complex, three-dimensional mushroom-like structure stick out from the surface, separated by 
“voids” through which the medium (e.g., water with nutrients) may flow relatively uninhibited.  This 
EPS holds the biofilm together and serves as a barrier to defend the microbial colonies from anti-
microbials. The last stage in the development of biofilms is the detachment of small or large clumps 
of cells, or by a type of "seeding dispersal" from the biofilm that releases individual cells. These cells 
move on to further colonize sites, and repeat the development cycle. Dispersal of cells from the 
biofilm colony is an essential stage of the biofilm lifecycle because it enables biofilms to spread and 





The EPS consists of polysaccharides, proteins, glycoproteins, glycolipids and contribute to biofilm 
integrity. Extracellular DNA (eDNA) has also been found in the EPS and  is considered as a remnant of 
lysed cells (Cheng et al., 2011) All EPS biopolymers are highly hydrated. About 97% of the biofilm 
consists of water and forms a matrix that keeps the biofilm cells together and prevents desiccation 
(Zhang et al, 1998; Shuterland, 2001). It is clear from a number of studies that mutants unable to 
synthesize the EPS are unable to form biofilms although they may still attach to surfaces and form 
micro-colonies to a limited extent (Flemming and Wingender, 2010; Xiao et al., 2012). 
Biofilm communities of bacteria are different from planktonic cells, most importantly being their 
increased resistance to anti-microbial agents. The dense EPS matrix serves as an initial barrier to 
prevent penetration of anti-microbial agents at the full depth of biofilm. As a consequence, cells 
inside the biofilm are about 10 to 1.000 times more resistant to anti-microbial agents than 
planktonic cells. Cells in biofilms are also extraordinarily resistant to phagocytosis, making biofilms 
extremely difficult to eradicate from living host (Stewart et al., 2001). Hentzer, et al. in their 
experiments (2003), showed that classical antibiotics used to treat P. aeruginosa infections, e.g., 
tobramycin and piperacillin are required at concentrations 100-to-1000-fold higher in order to kill 
biofilm bacteria than in order to kill their planktonic counterparts.  
Generally, the most rapid cell growth in a biofilm occurs at the biofilm surface where the oxygen and 
nutrients are plentiful.  Cells that are embedded deep inside the biofilm might grow in a slow or 
starved state due to nutrients and oxygen limitations and accumulation of toxic metabolic product 
(Wimpenny and Kinniment, 1995). Slower growing or non-growing cells are not very susceptible to 
many anti-microbial agents. Penicillin which target cell wall synthesis kills only growing bacteria 
(Tuomanen et al., 1986; Stewart and Costerton, 2001). Also, anti-microbials hardly affect all bacteria 
within the biofilm due to heterogeneity within the biofilm, because unlike the growth of bacteria in 
liquid cultures which produce homogeneous populations of genetically identical cells, growth in 
biofilms generates a large amount of genetic diversity (Stewart, 1998; Costerton et al., 1999). 
Heterogeneity within the biofilm caused by cellular diversity formed by gradients of nutrients, waste 
products and signaling factors which can develop microniches within the biofilm (Mehrotra, 2007).  
 
Biofilms also accommodate heterogeneous populations coming from both epigenetic and genetic 
phenomena. Epigenetic heterogeneity is the production of persister cells as well as in stationary-
phase planktonic culture. Persister cells are cells that neither grow nor die in the presence of 
bactericidal agents (dormant), and tolerant to a lethal stress such as anti-microbial treatment, heat 




1996; Lewis, 2007). The presence of persister cells explains the resistance of biofilms-based infection 
to anti-microbial therapy (Nobile and Mitchell, 2007). 
 
The role of QS in biofilm  
The precise role for QS in biofilm formation and maturataion is not always clear. Multiple reports 
have discussed the involvement of QS in biofilm formation, and conflicting conclusions have been 
drawn regarding the importance of QS in microbial biofilm formation. QS regulatory networks are 
very intricate and may include several genes whose products affect biofilm development at different 
stages (Solano et al., 2014). The effect of AHL QS on P. aeruginosa biofilms appears to depend on 
different growth conditions, such as static or under flow, different growth phases observed, 
different supply of nutrients, or strain differences (Heilmann and Götz, 2010). It was shown that QS 
affected P. aeruginosa biofilms only in the presence of glucose and not citrate (De Kievit et al., 
2001). Schaber et al., (2007) found that biofilms formed by P. aeruginosa in acute burn wound 
infections in mice to be unaffected by mutation of the lasI and rhlI QS genes, despite the fact that 
the mutant strains were significantly less virulent than their wild-type counterpart.  
 
In Listeria monocytogenes, the effect of the agr (accessory gene regulation) system is to induce the 
cells to bind to a surface (Rieu et al., 2008). A mutation in the agrD gene reduced its ability to attach 
to a PVC surface, thus makes it difficult to form biofilm. Similarly in Enterococcus faecalis, the fsr 
peptide base QS system has also been shown to positively influence biofilm formation (Hancock and 
Perego, 2004; Nakayama et al., 2006).In Aeromonas hydrophila, the deletion of the AHL synthase 
gene ahyI responsible for the synthesis of both C4 and C6 HSL results in the reduction of biofilm 
differentiation and the failure of the bacteria to form microcolonies (Lynch et al., 2002).  
 
In several cases, such as in P. aeruginosa and a common co-habitat of Cystic Fibrosis (CF) patient 
lung infections, Burkholderia cenocepacia, QS does not appear to affect the initial attachment of 
cells to a surface, but rather the maturation of biofilm structure. Mutations in the QS systems of 
these bacteria result in the formation of flat, undifferentiated biofilms (Huber et al., 2001). In 
Serratia liquefaciens and S. marcescens, QS system regulates the maturation stages of biofilm 
formation. A mutation in the AHL synthase gene swrI results in biofilm development which is 
apparently halted after 24 hours, forming a flat and thinner biofilm, with more homogenous cells 
which are poorly attached and less cellular aggregation. This is in contrast to the wild type, which 




Staphylococcus uses the agr system to regulate biofilm formation. The agr system downregulates 
the expression of genes encoding colonization factors, such as the microbial surface components 
recognizing adhesive matrix molecules (MCSRAMMS) and other adhesin that promote attachment 
and biofilm accumulation, or to induce the dispersal cells from a biofilm by initiate secretion of a 
variery of toxins (α-toxins, δ-toxins, and toxic shock syndrome toxins-1), and ezymes (such as 
proteases, lipases, hyaluronidase, and nuclease) that are involved in tissue destruction and/or 
biofilm detachment probably requires for dissemination of the infection and colonization of new 
sites (Heilmann and Götz, 2010).  
 
However, not all microorganisms positively regulate biofilm formation using QS. High cells densities 
of Vibrio cholerae are known to inhibit biofilm formation (Karatan and Watnick, 2009), whilst studies 
have shown that V. cholera “locked” in a low-cell density mode, produce more pronounced biofilms 
(Teschler et al., 2015).  
 
Model organism: P. aeruginosa 
P. aeruginosa (figure 2), is a Gram-negative bacteria rod-shaped, about 1-5 µm in length and about 
0.5-1.0 µm in breadth (Prescott et al., 2009). This bacteria is an obligate aerobe, however P. 
aeruginosa is considered by many as a facultative anaerobe, as it is well adapted to proliferate in 
conditions of partial or total oxygen depletion (Kelli et al., 2007; Prescott, et al., 2005).  
 
P. aeruginosa produces two types of water-soluble pigments: pyocyanin, a blue-green, water- and 
chloroform-soluble, non-fluorescent pigment, and pyoverdine, a yellow-green, water-soluble, 
fluorescent pigment which are released in the medium resulting yellow-green iridescent colonies on 
plate agar. Pyocyanin (from "pyocyaneus") refers to "blue pus", which is a characteristic of 
suppurative infections caused by P. aeruginosa. Pyoverdin is most often produced by P. 
aeruginosa and other Pseudomonads commonly isolated from humans.  In contrast, P. aeruginosa is 
the only Pseudomonas spp. known to produce pyocyanin, a pigment that diffuses into the 
surrounding medium. Definitive clinical identification of P. aeruginosa often includes identifying the 
production of pyocyanin and pyoverdine, as well as its ability to grow at 42°C (Forbes et al., 2007; 
Todar, 2011; Tamang, 2014).  
 
P. aeruginosa has an outer membrane which contains Protein F (OprF) OprF functions as a porin that 
enable certain molecules and ions to come into the cells. OprF also act as a structural protein to 




motile by single polar flagellum. The flagellum is very important during the early stages of infection, 
as it is required for the attachment and invasion of the tissues of the hosts. This bacterium also has 
N-methyl-phenyl-alanine (NMePhe) or type IV pili which contribute greatly to its ability to adhere to 
mucosal surfaces and epithelial cells (Mattick, 2002; Klaussen et al., 2003).  
  
 
Fig. 2: Multiple views of Pseudomonas aeruginosa. (a) Gram stain of P. aeruginosa, (b) scanning 
electron micrograph (SEM) of P. aeruginosa, (c), colonies of S. aureus on blood agar plates 
showing hemolysis (Kaiser, 2009; Carr, 2006). 
 
 
Under oxidative-stress conditions, P. aeruginosa synthesizes Fe- or Mn-containing superoxide 
dismutase (SOD) enzymes, which catalyze the very reactive O- to H2O2 and O2. P. aeruginosa also 
produces several catalases that detoxify H2O2, leaving oxygen and water (Hassett et al., 1993; Elkins 
et al., 1999).  
 
P. aeruginosa virulence factors and disease association 
P. aeruginosa is an opportunistic human pathogen that is commonly found in the environment e.g. 
soil, water and other moist locations. It is the most common Gram-negative bacterium found in 
nosocomial infections. For most healthy people, this bacterium seldom poses a problem. P. 
aeruginosa causes urinary tract infections, respiratory system infections, dermatitis, soft tissue 
infections, bacteremia, bone and joint infections, gastrointestinal infections, and a variety of 
systemic infections, particularly in patients with severe burns and in cancer or AIDS patients who are 
immunosuppressed.  In the expanding AIDS population, P. aeruginosa bacteremia is associated with 
50% of deaths. CF patients are characteristically susceptible to chronic infection by P. aeruginosa, 





Fig. 3: Various sites of P. aeruginosa infection (Iglewski, 1996). 
The capability of P. aeruginosa to produce infections is due to several extracellular and cell-
associated virulence factors, (e.g, adhesins, invasins, toxins, antiphagocitic surface properties, 
defense against serum bactericidal reactions, and defense against immune responses) which play 
major roles in the toxicity and aggressivity of the bacteria. The bacterial capsule or alginate slime 
layer that forms matrix of the Pseudomonas biofilm effectively protects the bacteria from the 
opsonization by antibodies, complement deposition, and phagocyte engulfment (Todar, 2011). 
Elastase and alkaline protease, are two extracellular proteases which have been associated with 
virulence that during the invasive stage. Elastase cleaves collagen, IgGs, IgAs, elements of the 
complement system. It also lyses fibronectin to expose receptors for bacterial attachment on the 
mucosa of the lung.  Elastase activity also disrupts the respiratory epithelium and interferes with 
ciliary function. Alkaline protease interferes with fibrin formation and will lyse fibrin. It destroys the 
ground substance of the cornea and other supporting structures composed of fibrin (Todar, 2011). 
P. aeruginosa secretes a number of toxins into the extracellular environment, but one set of toxins is 
injected directly into host cells. This occurs through a macromolecular syringe consisting of a type III 




to disruption of Ras- and Rho-mediated signal transduction pathways, collapse of the actin 
cytoskeleton, and cell death (Frank, 1997; Engel and Balachandran, 2009).  
Exotoxin A is the most potent toxic factor which is responsible for local tissue damage, bacterial 
invasion and immunosuppression. Exotoxin A catalyzes ADP-ribosylation and inactivation of 
elongation factor 2, an essential component of the protein synthesis machinery which leads to 
inhibition of protein biosynthesis and cell death (Todar, 2011).   
About 60% of people with cystic fibrosis have a chronic respiratory infection caused by P. aeruginosa 
biofilm-growing mucoid (alginate-producing) strains that settle into the thick mucus trapped in the 
respiratory passages. P. aeruginosa mucoid biofilms allow bacterial cells to escape from the innate 
and adaptive defense mechanisms of the lungs, and intense antibiotic therapy (Høiby et al., 2010).  
 
P. aeruginosa QS and biofilm formation 
There are two QS systems in P. aeruginosa, which have been extensively studied. The las system 
consists of the LasR transcriptional regulator and the LasI synthase protein. LasI is essential for the 
production of the AHL signal molecule N-(3-oxododecanoyl)-L-homoserine lactone (3O-C12-HSL). 
LasR requires 3O-C12-HSL in order to become an active transcription factor. A second QS system in P. 
aeruginosa consists of the RhlI and RhlR proteins. The RhlI synthase produces the AHL N-butyryl-L-
homoserine lactone (C4-HSL), and RhlR is the transcriptional regulator. Only when RhlR is complexed 
with C4-HSL it is activated. Both 3O-C12-HSL and C4-HSL have been shown to freely diffuse out of 
bacterial cells; however, 3O-C12-HSL diffusion is significantly slower than that of C4-HSL. Recently, a 
third LuxR homologue termed QscR was identified, which has been shown to regulate the 
transcription of both lasI and rhlI. Although QscR exhibits significant homology to LasR and RhlR, it is 
currently unknown whether an AHL or similar molecule is needed to stimulate QscR function. Data 
indicate that qscR is important in regulating the production of several virulence factors but whether 
this regulation occurs through controlled expression of both the las and the rhl systems is currently 
unknown (Smith and Iglewski, 2003; Bjarnsholt, 2010).  
 
At least three exo-polysaccharides, Psl, Pel, and alginate contribute to biofilm formation in P. 
aeruginosa that responsible to protect bacteria from environmental stressed and is required for 
bacterial cells to adhere to a substratum and maintaining biofilm structure (Matsukawa and 
Greenberg, 2004; Ryder et al., 2007). The Psl (polysaccharide synthesis locus) containing the pslA-O 
genes, is responsible for mannose and galactose rich EPS, whereas pel (referring to pellicle, a biofilm 
formed at the air-medium interface), containing the genes pelA-G, is responsible for synthesis of a 





The dispersal mechanism for bacterial cells to escape the biofim is induced by unfavorable 
conditions and important to spawn new communities of bacterial cells at new locations.  It involves a 
reduction mechanism of bacterial adhesiveness, and a breakdown of the biofilm matrix (Harmsen et 
al., 2010; Gjermansen et al., 2005). Davies and Marques (2009) found that the compound cis-2-
decenoic acid (CDA), an unsaturated fatty acid produced by P. aeruginosa is capable of inducing the 
dispersal of established biofilms and of inhibiting biofilm development. The authors suggested that 
this molecule is produced continuously by P. aeruginosa during growth in biofilms and that small 
microcolonies do not disperse because CAD is removed through diffusive and advective transport; 
However dispersal from larger microcolonies occurs because the rate of production of this molecule 
exceeds the rate of diffusion. 
 
Model organism: S. aureus 
S. aureus, means the “golden cluster seed” is a Gram-positive coccus, non-motile, non-spore forming 
bacteria, facultative anaerobic, with the diameter of 0.5-0.15 μm, that usually occur single, in pairs, 
tetrads, short chains (three or four cells) or irregular grape-like clusters. Typical colonies are yellow 
to golden-yellow in color, smooth, entire, slightly raised, often with hemolysis when grown on blood 
agar plates (figure 4). S. aureus is able to produce enzyme catalase (catalase positive) and able to 
convert hydrogen peroxidase (H2O2) to water and oxygen. The catalase test is useful to distinguish 
Staphylococci from Enterococci and Streptococci. The ability of S. aureus to clot blood plasma by the 
presence of enzyme coagulase is the main criteria to identify this bacterial, separating the virulent 
pathogen of S. aureus from the less virulent coagulase-negative Staphylococci species (Prescott et 
al., 2005). 
 
Resistance of Staphylococcus to many commonly used antibiotics started as soon as the first 
antibiotic, penicillin, was introduced in 1943. By 1950, 40% of hospital S. aureus isolates were 
penicillin-resistant (Chambers, 2001). The resistance is mediated by penicillinase, an enzyme that 
breaks-down the β-lactam ring of the penicillin molecule. β-Lactamase-resistant penicillins such as 
methicillin, oxacillin, cloxacillin, and fluconacillin that are able to resist degradation by 
staphylococcal penicillinase were developed to treat penicillin-resistant S. aureus.  Methicillin was 
the first antibiotic in this class to be used in 1959, but only two years later, the first case of 






Fig. 4: Multiple views of Staphylococcus aureus. (a) Gram stain of S. aureus, (b). scanning electron 
micrograph (SEM) of S. aureus, (c) colonies of S. aureus on blood agar plates showing hemolysis 
(Tambe, 2005a; Carr, 2007; Buxton, 2013). 
 
 
First line treatments for infections caused by MRSA are currently glycopeptide antibiotics 
(vancomycin and teicoplanin). Most of S. aureus isolates are susceptible to vancomycin. 
Staphylococcus bacteria are classified as vancomycin intermediate resistant S. aureus (VISA) if the 
MIC for vancomycin is between 4-8 µg/mL, and classified as vancomycin resistant S. aureus (VRSA) if 
the vancomycin MIC is ≥16µg/ml (Walters et al., 2015). The first case of vancomycin-intermediate S. 
aureus (VISA) was reported in Japan in 1996 (Hiramatsu et al., 1997), and the first case of S. aureus 
resistant to glycopeptide antibiotics was only reported in 2002 (Chang et al., 2003). Surveillance data 
shows VISA and VRSA infections are uncommon, and only seen in people with significant underlying 
health conditions. However, the prevalence has been gradually rising and reports of cases have 
spread throughout the United States. Due to the high rates of vancomycin clinical treatment failure 
and associated morbidity and mortality rates of 60%–70%, these VISA and VRSA strains deserve 
serious attention (Walters et al., 2015).  
 
Virulence factors and disease association 
S. aureus is one of the most common causes of nosocomial infection. S. aureus infections are often 
acute and pyogenic and, if untretated, may spread to surroundings tissue or, via bacteremia, to 
metastasic sites (involving organs) such as skin which is the cause Staphylococcal scalded skin 
syndrome (SSSS) in infants. Infection from Staphylococci can also cause life-threatening diseases 
such as pneumonia, meningitis, endocarditis, bacteremia, septicemia, cervicitis, and toxic shock 
syndrome (TSS) (Prescott et al., 2005).  
 
The diverse range of S. aureus diseases has been attributed to its ability to produce an array of 
virulence factors. S. aureus expresses many potential virulence factors, such as surface proteins that 




hyaluronidase); surface factors that inhibit phagocytic engulfment (capsule, Protein A); biochemical 
properties that enhance their survival in phagocytes (i.e. catalase production); immunological 
disguises (Protein A, coagulase); membrane-damaging toxins that lyse eucaryotic cell membranes 
(hemolysins, leukotoxin, leukocidin); exotoxins that damage host tissues or otherwise provoke 
symptoms of disease: Staphylococcus enterotoxins (SEs), TSST, exfoliative toxins (ET); and inherent 
and acquired resistance to anti-microbial agents (Todar, 2011; Cheung et al., 2004).  
 
Bacterial surface protein adhesins, known as MSCRAMMs (microbial surface components 
recognizing adhesive matrix molecules) mediates S. aureus adherence to extracellular matrix (ECM) 
components to initiate colonization to the host colonize and resist physical removal (Foster and 
Höök, 1998). Certain MSCRAMMs acting as invasins, an adhesin (a surface protein in the cell wall of 
bacteria) molecule, can facilitate bacterial entry into the cell by phagocytosis, and place the bacteria 
in a vacuole. By entering the cytoplasm of the host cell, it has a ready supply of nutrients and is 
protected from complement, antibodies, and certain other body defenses. Once the bacterium 
escapes from the vacuole and is able to replicate in the cytoplasm of the host cell (Prescott et al., 
2005). This interaction is critical for infection and virulence and also permits internalization of 
pathogens into non-phagocytic host cells (Cambronne et al., 2005; Niemann et al., 2004).  
 
S. aureus is a clinically important capsule-forming bacterium, i.e., they produce uronic acid-
containing, extracellular polysaccharides, which enhance microbial virulence by rendering the 
bacterium resistant to phagocytosis. The capsular polysaccharide (CPs) production appears to be an 
important virulence determinant, and occurs as different chemical structures depending on the 
serotype of the organism (Cook, et al., 2009). This CPs are found in 90% of the clinical strains. Eleven 
serotypes have been described, type 5 and 8 are the most common among human isolates (80%) 
(Poutrel et al., 1988). 
Some pathogens can hide their unique antigenic surface components from the immunological 
system. S. aureus produces cell-bound coagulase and clumping factor that cause fibrin to clot and to 
deposit on the cell surface. It is possible that this disguises the bacteria immunologically so that they 
are not readily identified as antigens and targets for an immunological response (Todar, 2011).  
According to the presence of enzyme coagulase, the virulence-pathogen S. aureus can be separated 
from the less virulent coagulase-negative Staphylococci species. There are three coagulase-positive 
Staphylococci species: S. aureus in humans and mammals, and S. intermedius and S. hyicus in 




not produce coagulase, are nonpigmented, and are generally less invasive but have increasingly 
been associated as opportunistic pathogens with serious nosocomial infections (Prescott et al., 
2005). 
 
Two different forms of coagulase can be produced, free and bound. While free coagulase is an 
extracellular enzyme that is secreted extracellularly, bound coagulase is part of the larger family of  
MSCRAMMs. Bound coagulase, also known as clumping factor, reacts with fibrinogen to cause 
organisms to aggregate. Another factor, extracellular staphylocoagulase, reacts with prothrombin to 
form staphylothrombin, which can convert fibrinogen to fibrin. This results in clotting of the blood. 
Approximately 97% of human S. aureus isolates possess both of free and bound forms of coagulase. 
There are two different tests that can be performed to detect the presence of coagulase: a tube test 
to detect the presence of free coagulase, and a slide test to detect bound coagulase. Isolates that do 
not produce clumping factor must be tested for the ability to produce extracellular coagulase (free 
coagulase). Another way of S. aureus to hide its unique antigens from opsonizing antibodies or 
complement is by producing Protein A which is located on cell wall. Protein A is an IgG-binding 
protein which binds to the Fc end of an antibody, thus coating the bacteria with antibodies that 
helps inhibit phagocytic engulfment and acts as an immunological disguise (Todar, 2011).  
 
Depending on the strain, S. aureus is capable of secreting several toxins that can be categorized into 
three groups: Pyrogenic toxin superantigens (PTSAgs), Exfoliative toxins (ET), and other toxins. Toxic 
shock syndrome (TSS) is associated with strains that produce and secrete exotoxin toxic shock 
syndrome toxin 1 (TSST-1), a member of PTSAgs family that has the ability to stimulate T-cells. 
Although first described in children, it was most frequently associated with women using tampons 
during menstruation. The staphylococcal enterotoxins which cause food poisoning also belong to 
PTSAgs family. These enterotoxins are divided into 6 types of heat-stable toxins, i.e. A, B, C1, C2, D, 
E, responsible for the gastrointestinal upset typical of food poisoning (Prescott et al., 2005). 
Exfoliative toxins are implicated in the disease staphylococcal scalded-skin syndrome (SSSS), also 
known as Ritter disease, which occurs most commonly in infants and young children. The protease 
activity of exfoliative toxins causes peeling of the skin observed with SSSS (Bukowski et al., 2010). 
 
Other Staphylococcal toxins that act on cell membranes include alpha hemolysin-toxin, beta 
hemolysin-toxin, delta hemolysin-toxin, and gamma hemolysin-toxin which are destroy erythrocytes, 
and several bicomponent toxins such as toxin Panton-Valentine Leukocidin (PVL), a pore forming 






S. aureus is normal inhabitants of the upper respiratory tract, skin, intestine, and vagina, and known 
as the most important human staphylococcal pathogen. This bacterium, altogether with 
pneumococci and streptococci, is member of a group of invasive Gram-positive bacteria known as 
the pyogenic (or pus-producing) cocci, causing various supurative, or pus-forming diseases (e.g., 
boils, carbuncles, folliculitis, impetigo contagiosa, scalded-skin syndrome) in humans. S. aureus also 
cause medical device-related infections such as intravascular line sepsis and prosthetic joint 
infections (Prescott et al., 2005). 
 
 




S. aureus QS and biofilm 
The S. aureus quorum-sensing system is encoded by the accessory gene regulator (agr) locus, which 
consists of two divergent transcripts, RNAII and RNAIII, driven by the P2 and P3 promoters (Yarwood 
et al., 2004). RNAII contains four open reading frames designated agrA to agrD, that encode factors 
required to synthesize auto-inducing peptide (AIP).  The current working model suggests that the 
autoinducer peptide is generated from agrD and then processed, post-translationally modified, and 
secreted by a membrane-bound protein bearing an ABC-type transporter system known as AgrB. The 




quantities of the appropriate AIP ligand have accumulated, AgrC phosphorylates AgrA. which then 
binds to the RNAIII transcript that encodes a small RNA that functions to modulate gene expression 
of S. aureus gene (Figure 6) (Chegelski et al., 2008). 
 
A second quorum-sensing cascade, RNAIII activating protein (RAP) and the target of RNAIII activating 
protein (TRAP), is thought to serve as a precursor to the Agr system (Balaban and Novick, 1995). The 
RAP is secreted and accumulates outside the cell, and at a threshold concentration, RAP triggers the 
phosphorylation of the cytoplasmic protein TRAP, which induces expression of the RNAII transcript 
(Gov et al., 2004). Interestingly, a linear heptapeptide called RIP is known to block the activity of 




Fig. 6. Schematic diagram of quorum-sensing systems of S. aureus. The gene locus for the agr system 
contains two divergent transcripts, RNAII and RNAIII, driven by the P2 and P3 promoters. The RNAII 
transcript encodes the agrBDCA operon, which encodes the signal, processing and detection 
components for quorum-sensing in S. aureus. The RNAIII transcript is a regulatory RNA that up-
regulates and down-regulates all genes related to quorum-sensing. Agr, accessory gene regulator; 
AIP, autoinducer peptide; P, promoter site; P*, phosphorylated protein; RAP, RNAIII-activating 






The capability of S. aureus to form biofilms is one of the defense mechanisms that makes this 
bacterium difficult to eradicate with standard antibiotic treatment and makes it inherently resistant 
to host immune responses. The biofilm formation then consequently impedes the treatment of 
many chronic S. aureus biofilm related infections, including endocarditis, osteomyelitis and 
indwelling medical device infections (Costerton et al., 1999). 
 
As well as P. aeruginosa biofilm, the development of a biofilm in S. aureus involves an initial 
attachment, maturation and detachment phase. Initial attachment can occur on tissues or after 
covering of an abiotic surface by host matrix proteins in the human body (specific, protein-protein 
interaction) or directly to an abiotic surface (nonspecific interaction) by surface hydrophobicity. 
MSCRAMMMs expressed by S. aureus have the capacity to bind to human matrix proteins such as 
fibrinogen or fibronectin (Patti et al., 1994; Otto, 2008). 
 
The major functional component responsible for intercellular adhesion essential for formation of 
multilayered S. aureus biofilm is the polysaccharide intercellular adhesin (PIA) which is also called 
poly-N-acetylglucosamine (PNAG). Together with other polymers such as teichoic acids (TA) and 
proteins, PIA forms the major part of slime, the extracellular matrix of biofilm-forming staphylococci 
(Otto, 2008). In S. aureus isolates from animals suffering from mastitis, a cell wall-bound surface 
protein named biofilm-associated protein, Bap, is involved in adherence to a polystyrene surface, 
intercellular adhesion, and biofilm formation (Cucarella et al., 2001). 
 
Biofilm detachment which may occur by the detachment of single cells or larger cell clusters is 
crucial for the dissemination of bacteria to other colonization sites. Some factors such as mechanical 
forces (e.g. blood vessel flow), cessation of the production biofilm building material such as exo-
polysaccharide, and detachment factors such as enzymes that destroys the matrix, or surfactants-
like molecules (e.g. δ-toxin or quorum-sensing-controlled surfactant peptides known as Phenol-
soluble-modulins (PSMs)) contributing to the detachment of biofilm (Boles and Horswill, 2008; Otto, 
2008).  
 
PSMs is a novel class of small peptides with an amphipathic α-helical structure and strong surfactant-
like properties, are produced by most staphylococci, especially pathogenic S. aureus and S. 
epidermidis.  PSMs can induce the production of proinflammatory cytokines; recruit, activate and 
lyse neutrophils to help staphylococci evade immune damage; lyse erythrocytes, and are associated 




staphylococcal biofilms and disseminate biofilm-associated infection; and kill competing microbes 
and act as weapons in interbacterial warfare. Therefore, PSMs are considered to be critical 
virulence-associated factors and to play important roles in the pathogenesis of staphylococci. PSMs 
can be subdivided in two classes: an alpha-type that is 20 amino acids in length and a beta-type that 
is approximately 40-45 amino acids in length. Under biofilm conditions, PSM expression is shifted to 
the beta-type of PSM peptides, which are encoded in an operon (Yao et al., 2005). After attachment 
to a surface and actively expressing PSM beta-type peptides, some cell clusters discontinue 
expressing PSM beta-type for yet unknown reasons, possibly due to limited oxygen concentration. 
Cell clusters with active PSM beta expression detach, leaving gaps in the biofilm, which ultimately 
leads to the typical structure of a biofilm with mushroom-likes structure and fluid-filled channels 
that are believed to have a vital function in delivering nutrients to cells in deeper biofilm layers 
(Costerton et al., 1995; Otto, 2008). 
 
An anti-biofilm drug in staphylococci that would inactive a factor required for biofilm formation that 
appears to be involved in biofilm-associated infection such as polysaccharide intercellular adhesin 
(PIA), is worth considering. Actinobacillus actinomycetemcommitans produces PIAse, named 
dispersin B which is a potential anti-biofilm drug (Kaplan et al., 2003). Lysostaphin, a peptidoglycan-
degrading enzyme, although not biofilm-specific, is being evaluated for therapeutic use against 
staphylococci biofilm (Wu et al., 2003; Otto, 2008). 
 
Model organism: C. albicans 
C. albicans belongs to the Ascomycota class of fungi and the family Saccharomycetaceae. C. albicans 
is a diploid fungus that can exist in two morphological states (dimorphism): as unicellular yeast 
(blastopores and chlamydospores), as well as in filamentous forms: hyphae, or pseudohyphae, a 
chain of distinct cells formed by the failure of mother and daughter to separate after each cell 
division. This dimorphism is depending upon environmental factors such as nutrients, CO2, neutral 
pH, high temperature (37⁰C), and cell population density (Kohler and Fink, 1996; Brown and Gow, 
1999; Romano, 2008). C. albicans switched to the chlamydospore morphology when cultured under 
certain nutrient-poor media (Staib and Morschhäuser, 2007). Among Candida species, C. 
albicans has the strongest tendency to form hyphae, which parallels its role as the most 
virulent Candida species. C. albicansmutants defective in hyphal formation have almost completely 
lost their virulence (Sonneborn et al., 1999)  Strains of C. albicans which are ‘locked’ into either yeast 





C. albicans is also well known for its capability to undergo a process called phenotypic switching, 
which is superficially resembles dimorphism, and is thought to be important for Candida’s virulence 
(Thompson et al., 2011). Switching usually is generated spontaneously and discriminated by colony 
morphology and in some cases by the phenotype of cells in the budding phase. For example C. 
albicans strains WO-1 produces two different colonies: one that grows as round cells in smooth 
white colonies and one that is rod-like and grows as flat gray colonies. The switching is reversible, 
and colony type can be inherited from one generation to another (Tao et al., 2014).  
 
The capability of C. albicans to change its morphological pattern from the yeast (Y) form to the mold 
or mycelial (M) form in the external environment (YM shift) is important in pathogenesis of 
candidiasis. In the yeast state, Candida is a non-invasive, sugar-fermenting organism, while in 
mycelia state it is invasive and can produce rhizoids, a filament used to anchor the fungus down. 
Rhizoids can penetrate mucosa or intestinal walls, leaving microscopic holes and allowing toxins, 
undigested food particles, bacteria, and yeast to enter the bloodstream (Ryan and Ray, 2004).  
 
 
Fig. 7. Multiple views of C. albicans. (a)  SABHI agar plate culture of the fungus C. albicans grown at 
20°C, (b) Microscopic image (200-fold magnification) of C. albicans ATCC 10231, grown on cornmeal 
agar medium with 1% Tween80 : 1. Pseudohypha, 2. Chlamydospore, 3. Blastospore, 4. Yeast-like 
cells (Tambe, 2005b; Kaplan, 2009).  
 
C. albicans virulence factors and disease association 
Candida is the most common cause of fungal disease of mammals. Mycoses range from the common 
mild cutaneous or subcutaneous skin infections, to the potentially lethal acute or chronic infection of 
deep tissue. Of the Candida species afflicting humans, C. albicans is the most abundant and 




in humans (Siqueira and Sen, 2004). This fungus has been claimed to be the fourth most common 
cause of hospital-acquired infectious disease in the United States (Miller et al., 2001). 
 
One of the major reasons for C. albicans to be such an effective opportunist is that the organism has 
at its disposal an arsenal of virulence traits to cause a persistent infection in susceptible individuals. 
These traits include production of secreted aspartyl proteases and phospholipases, host recognition 
biomolecules (adhesins), phenotypic switching and the ability to undergo morphogenic shift from 
yeast-to-hyphae (Navarro-Garcia et al., 2001; Si et al., 2013). The transition from unicellular yeast 
form to filamentous form (pseudohyphae or hyphae) is strongly required for C. albicans 
pathogenesis. Yeast forms are more suited for dissemination in tissues and to other hosts, whereas 
hyphal forms are required for tissue damage and invasion. Yeast cells, when phagocytosed by 
macrophages, produce hyphae and secrete hyphae-associated proteinases that kill macrophages. 
These factors prevent hyphal cells from being killed by neutrophils. In addition, hyphal cells have 
been shown to induce epithelial cell endocytosis. C. albicans cells induce epithelial cells to produce 
pseudopods that surround them, and pull them into the cell, helping Candida cells to invade 
epithelial cells (Gow et al., 2012).  The ability of Candida to form biofilms on catheters, endotracheal 
tubes, pace-makers, and other prosthetic devices has contributed to its predominant prevalence in 
nosocomial infections. Dental plaque is a well-known example of biofilm formation from Candida 
cells, and is responsible for oral candidiasis. Biofilm formation on such tissues is favored by a high 
concentration of glucose, serum, and other proteins (Calderone and Fonzi, 2001). 
 
Normal amounts of Candida live in the mouth, stomach, and vagina, and do not cause infections. 
Candidiasis (Candida infections) can occur in the mouth, vagina, skin, stomach, and urinary tract 
when there is an overgrowth of Candida. Causes may include taking certain drugs (especially 
antibiotics, corticosteroids, and some birth control pills), pregnancy, being overweight, having a 
bacterial infection, or several different health conditions (for example, a weakened immune system, 
diabetes, and psoriasis).  About 75% of women will get a vaginal yeast infection during their lifetime, 
and 90% of all people with HIV/AIDS develop Candida infections. Oral infections, called oral thrush, 
are most common in infants, elderly people, and those with a weakened immune system (Calderone 
and Fonzi, 2001).  
 
Candida  QS and biofilm 
QS has a contribution to morphogenic control in C. albicans. The yeast-to-hyphal shift in vitro is 
dependence on cell density, a phenomenon called the inoculum size effect. The inoculum effect is 




conditions which affect the cells to germinate into the hyphal form (pH 7.5, 37⁰C). Inoculation of the 
cells at higher concentration will maintain the cells in yeast morphology (Kruppa, 2008).  
 
The basis for this cell-density-dependent control of morphogenesis is similar to that which is seen 
with bacterial cells regulating their activities via QS. The QS molecule in C. albicans is farnesol 
[(2E,6E)-3,7,11-trimathyldodeca-2,6,10-trien-1-ol], farnesoic acid [(2E,6E)-3,7,11-trimethyldodeca-
2,6,10-trienoic acid], and tyrosol [4-(2-hydroxyethyl)phenol]. Farnesol was shown to prevent the 
germination of yeast cells into mycelia, a phenomenon that may be pertinent to C. albicans biofilm 
formation. Farnesoic acid, like farnesol, acts to block the yeast to filament transition, but it is far less 
active than farnesol and produced by only one known strain of C. albicans 10231, while tyrosol is a 
promoter of hyphal development, shortens the lag-time for cells to begin germinating when present 
under hyphal-inducing conditions (Oh et al., 2001; Hornby et al., 2001; Alem et al., 2006).  
 
The capacity of C. albicans to cause disease is closely associated with their ability to grown as biofilm 
communities, in contrast to planktonic growth. The biofilm of C. albicans formed in almost any 
medical devices including catheters, joint prostheses, cardiac valves, artificial bypass devices, 
pacemakers, contact lens, dentures, and intrauterine devices (IUDs). Candidiasis associated with 
indwelling devices can result in serious medical complications, expensive care and limiting the 
prolonged use of the devices, since removal of the device is nearly always necessary to cure the 
infections (Nett and Andes, 2006; Lal et al., 2008).  
 
Candida biofilm formation occurs in three developmental phases over a period of 24-72 hours. The 
initial phase (0-11 h) begins with the adherence of yeast cells to the substrate. The intermediate 
phase (12-30 h) involves the attached cells proliferations to form microcolonies and producing 
carbohydrate-rich extracellular matrix. The maturation phase (31-72 h) occurs when adherent cells 
are achieved with a biofilm consisting of interspersed yeast/hyphae cells encased in the thick 
extracellular matrix. Finally, newly formed yeasts on the surface of biofilm are released from the 
biofilm which allows further dissemination of the organism (Blankenship and Mitchell, 2006). 
 
Biofilm-associated fungal cells are much more resistant to the traditional anti-fungal agents.  
Resistance of biofilm cells can be up to 1000-fold greater than that of planktonic cells and can also 
resist host immune factors (Hawser and Douglas, 1995). Several factors have been proposed for the 
increased anti-fungal resistance of C. albicans biofilms. These include altered growth ⁄ metabolic rate 




microbial agent, expression of resistance genes and presence of persister (drug tolerant) cells 
(Tobudic et al., 2011). A biofilm consists of a heterogeneous population of cells with different growth 
rates; therefore, a subpopulation of cells could also confer anti-fungal resistance because of their 
slower growth rate (Kumamoto, 2002). Extracellular matrix can act as a physical barrier that 
prevents the access of anti-microbials to cells embedded in the biofilm community. This barrier is 
depends on both, amount and nature of the extracellular matrix, as well as the physicochemical 
properties of the drug (Tobudic et al., 2011).  
 
 
Fig. 8: C. albicans biofilm structure in vitro and in vivo. A) Scanning electron micrograph (SEM) of 
an in vitro biofilm. The biofilm sample was sliced to reveal three layers in a cross-sectional view. 
The basal layer includes primarily yeast cells, as evident in the lower enlarged inset. The central 
layer is mainly hyphae. The upper layer has yeast cells budding from the hyphae. The upper 
enlarged inset shows extracellular matrix material, which appears fibrous in this preparation. B) 
SEM of an in vivo biofilm from the rat catheter model. Yeast cells, hyphae, and some 
pseudohyphal cells are evident, along with extracellular matrix material (Finkel and Mitchell, 
2011). 
 
The involvement of two different types of membrane-localised efflux pumps, adenosine 
triphosphate-binding cassette transporters encoded by the Candida drug resistance (CDR) genes and 
major facilitators encoded by the multi-drug resistance (MDR) genes increased azole anti-fungal 
resistance in planktonically grown of C. albicans. The expression of MDR and CDR genes in biofilms is 
phase-specific, contributing to azole resistance only during the early phases of biofilm growth. 
Moreover, changes in the membrane sterol composition also contribute to azole resistance in the 





Drug discovery from natural sources 
Natural products are products from natural origin, including an entire organisms (plants, animals, or 
microbes) that have not been subjected to any kind of processing or treatment other than a simple 
process of preservation (e.g., drying); part of an organism (e.g., leaves or flowers of a plant, an 
isolated animal organ);  an extract of an organism or part of an organism, exudates, and pure 
compounds (e.g., alkaloids, coumarins, flavonoids, glycosides, lignans, steroids, sugars, terpenoids, 
etc.) isolated from plants, animals, or microorganisms (Sarker et al., 2006).  
 
Traditional medicinal use of natural products plays a major role since in ancient civilizations and in 
many parts of the world.  The importance of natural products as a source of medicines is 
acknowledged by the World Health Organization (WHO). There are many example of drugs derived 
from natural product, such as compounds from plants: artemisinin from Artemisia annua (Weathers 
et al., 2011), Taxol from Taxus baccata (Malik et al., 2011); compounds from microbes: 
menisporopsin B from Menisporopsis theobromae (Chinworrungsee et al., 2006), hirsutellide A from 
Hirsutella kobayasii (Vongvanich et al., 2002); and compounds from animals (Trabectedin from 
Ecteinascidia turbinata (Monk et al., 2012), and Ziconotide from Conus magus (McGivern, 2007).  
 
Natural products remain to play an important role in the discovery of new drugs in the coming years 
as a rich source of novel chemotypes. It is because of plants and other organisms produce many 
biologically active compounds for defense and other purposes that are often very complex and offer 
incomparable structural diversity. Synthetically prepared drugs can never compete with the natural 
variation therefore the screening and isolation from natural sources is the only feasible way to 
access them. Natural products have also been an invaluable source to synthesize novel drug 
candidates. There are three roles of natural products to the development of new drugs; by acting as 
new drugs to be used directly for the treatment of disease; by indicating new modes of 
pharmacological action which allow complete synthesis of novel analogs (e.g. synthesis analogs of 
penicillin from Penicillium notatum); and by providing natural blueprint used for the synthesized of 
more complex molecules (e.g. diosgenin from Dioscorea floribunda for the commercial synthesis of 
cortisone, pregnenolone, progesterone, and other steroid products) (Sarker et al., 1999; Li and 
Vederas, 2009). The structural analysis of natural compounds and the ability to synthesize them 
allowed chemist to modify them in order to suppress or enhance certain characteristics such as 






Plants as anti-microbial therapies 
The search for pharmaceutically active compounds to combat new and existing diseases is ongoing, 
and higher plants have often been targeted as part of this search because they contain an 
abundance of potentially active secondary metabolites. It is estimated that there are 250.000 to 
500.000 species of plants on Earth (Boris, 1996). About 155.000 seed plants occur in the tropics, with 
about 120.000 in the tropical moist forest alone (only 7-8% of the land surface on earth). This is due 
to the high humidity, elevated temperature, species density and a continuous growing season. The 
result is an enormous diversity of chemical structures, including secondary metabolites involved in 
many biological processes and interactions, e.g., as attractants of pollinators, signal products, 
defensive substances against predators and parasites, or in resistance against pests and diseases. 
Since only 5-15% of the higher plants have been systemically investigated for the presence of the 
bioactive compounds, nature’s biodiversity remains largely unexplored (Cragg et al., 1997; McGee, 
2006).  
 
Plants have always played a central role in the prevention and treatment of disease since the ancient 
time. Many modern medicines are derived from traditional medicinal plants. The illnesses treated by 
medicinal plants cover an incredibly broad range, from minor ailments such as cuts and skin 
infections, to more severe diseases including typhoid fever, diabetes, and cancer-like conditions 
(Clardy and Walsh, 2004). The goals of using plants as sources of therapeutic agents are: to isolate 
bioactive compounds for direct use as drug, e.g., atropine, scopolamine, digoxin, digitoxin, 
morphine, reserpine, taxol, vinblastine, vincristine;  to produce bioactive compounds from novel or 
known structures, using them as lead compounds for (semi)synthesis of novel patentable entities 
with better activity and/or lower toxicity, e.g., metformin, nabilone, oxycodone, taxotere, 
taniposide, terapamil, podophyllotoxin; to use natural product as pharmacological tools, e.g., 
lysergic acid diethylamide, mescaline, strychnine, yohimbine; and to use the whole plant or part of it 
as a herbal remedy, e.g., cranberry (Vaccinium macrocarpon), Echinacea, feverfew (Tanacetum 
parthenium), garlic (Allium sativum), Ginkgo (Ginkgo biloba), St. John’s wort (Hypericum 
perforatum), and saw palmetto (Serenoa repens).  There are four standard approaches available for 
selecting plants for medicinal purposes: random selection followed by chemical screening, random 
selection followed by anti-microbial assay, follow-up of anti-microbial assay reports, and follow-up 
of ethnomedical or traditional uses of plants against infectious diseases (Fabricant and Farnsworth, 
2001). 
 




expressed by a high number of indigenous medicinal plants. As an archipelagic state with thousands 
of islands, Indonesia is endowed with a rich and unique biodiversity. The area of Indonesian tropical 
forests covers about 143 million hectares and is inhabited by about 80% of the world’s medicinal 
plants. It is estimated that the Indonesian tropical forests inhabit 28,000 plant species. There are 
various reports concerning the inventory of higher plant in Indonesia. The Indonesian Country Study 
on Biodiversity (ICSBD 1993) puts the number of flowering plants species in Indonesia between 
25,000 and 30,000. Some 40 million Indonesians depend directly on the country’s biodiversity, and 
the Indonesian community makes use of around 6,000 plant species. Data of the number of 
medicinal plants also vary. Zuhud et al. (2001) identified 1,845 species with medicinal potential in 
the forests of Indonesia. These numbers are potentially to be updated due to the continuing 
inventory and investigation of yet unidentified species (Damayanti et al., 2011). 
 
A large number of anti-microbial agents derived from traditional medicinal plants are available for 
treating various diseases caused by microorganisms. There are vast amount of published scientific 
information from around the globe describing the anti-microbial activities of plant extracts against a 
range of bacteria, or fungi. The anti-bacterial activity also could be due to various chemical 
components. The useful major groups of anti-microbial phytochemicals can be divided into several 
categories that include alkaloids, flavones (flavonoids, flavonols, quinones), essential oils, lectins, 
polypeptides, phenolics, polyphenols, tannins and terpenoids (Samy and Gopalakrishnakone, 2008). 
 
The use of medicinal plants in Indonesia has always been a part of culture that has been passed 
down from generation to generation. Throughout the centuries, Indonesia’s indigenous people 
developed traditional medicines from plants identified by their forefathers for curing illness and 
keeping their health (Bermawie, 2004).  By trial-and-error the country’s early inhabitants learns how 
to distinguish useful plants with beneficial effects from those that were either toxic or non-active. 
They picked, kept and used medicinal plants to satisfy their basic needs and even experimented on 
combinations of plants or processing methods to gain optimal results. The abundantly available 
medicinal plants in Indonesia might be the great potential source for the isolation of novel, naturally-
occuring anti-microbial active compounds with high activity against microbial biofilms.  
 
Main hypotheses and aims of this thesis 
Hypothesis: Some traditionally used Indonesian medicinal plants have anti-infective properties 
which may affect biofilm formation of human pathogenic microorganisms such as P. aeruginosa, S. 





Specifically this research will investigate of the presence of anti-microbial and anti-biofilm activity of 
Indonesian medicinal plants against P. aeruginosa, S. aureus and C. albicans planktonic growth and 
biofilm. The construction of extract libraries of plant material will provide the source for screening 
and elucidation of anti-microbial (anti-biofilm) compounds. The capability of these plants in 
inhibiting QS systems also will be determined. Purification and characterization together with 
determination of the mode of action of the active compound(s) from these plants species is 
important in order to obtain compound(s) that may be used for drug candidate against biofilm 
infection and will be powerful tools in the successful treatment of microbial infections.  
 
Aim and Thesis Outline 
Microbial biofilms are responsible for several chronic diseases that are difficult to treat. Biofilm 
protects the microbial from killing by antibiotics. Even sensitive microbials that do not have a known 
genetic basis for resistance can have profoundly reduced susceptibility when they form a biofilm. In 
biofilms, poor antibiotic penetration, nutrient limitation and slow growth, adaptive stress responses, 
and formation of persister cells are hypothesized to constitute a multi-layered defense. Disabling 
biofilm resistance may enhance the ability of existing antibiotics to clear infections involving biofilms 
(Stewart and Costerton, 2001; Stewart, 2002). This thesis aims to discover new anti-microbials from 
medicinal plants with a high activity against microbial biofilms and to analyze if such compounds will 
exhibit a synergistic effect with other known antibiotics. 
 
Chapter 1 reviews the discovery of drugs from natural sources, the use of plants as anti-microbial 
therapies, the quorum sensing mechanism in microbial related to biofilm formation, biofilm involved 
infections, antibiotic resistance of biofilm cells and emergence of multi-resistant microbial 
pathogens and strategies to discover anti-biofilm therapeutics.  
 
Chapter 2 describes the screening for anti-microbial compounds on microbial biofilms. Compounds 
are isolated from Indonesian medicinal plants by ethanol extraction to discove new candidate 
antibiotics to be used against microbial biofilms.  
 
Chapter 3 and 4 are focused on the discovery of novel essential oils as anti-microbials from 
Indonesian medicinal plants. The effect of the plant essential oils on bacterial cells and microbial 
biofilms is studies using viability staining, fluorescence microscopy analysis and colony forming unit 





Chapter 5 focuses on the screening of the Indonesian medicinal plants ethanol extract and essential 
oils for their capability to inhibit the quorum sensing mechanisms. 
 
The purification and structural identification of the most potential compounds to obtain a novel anti-
biofilm compound along with the analysis of a synergistic effect of novel anti-biofilm activities 
isolated from medicinal plants in combination with known antibiotic used to treat biofilms is 
described in Chapter 6. 
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The increasing rates of antibiotic-resistant microbial infections requiring continuous development of 
new anti-microbial agents. Moreover, microbial biofilms are exhibits elevated resistance to both 
most anti-microbial drugs and the host defense systems, which often results in persistent and 
difficult-to-treat infections.  The discovery of anti-infective agents which are active towards 
planktonic and biofilm microbial are consequently required to deal with these biofilm-mediated 
infections. The aim of this study is to evaluate the activity of Indonesian medicinal plants extracts on 
planktonic growth and biofilm of Pseudomonas aeruginosa PAO1 and Staphylococcus aureus Cowan 
I. Fifty four (54) ethanol extracts were obtained from a variety of known Indonesian medicinal 
plants. The growth inhibitory concentration (PMIC), effects on biofilm formation and biofilm 
breakdown, and biofilm architecture in the absence and presence of the extracts by confocal laser-
scanning microscopy along with LIVE/DEAD staining were performed. The extracts showed an 
inhibitory effect on planktonic growth of these bacteria and also on their biofilm formation. At a 
concentration as low as 0.12 mg/mL, biofilm formation of P. aeruginosa PAO1 and S. aureus Cowan I 
is inhibited by 5 plant ethanol extracts : Kaempferia rotunda L., Caesalpinia sappan L., Cinnamomum 
burmannii Nees ex Bl., C. sintoc and Nymphaea nouchali Burm.f. Limited bacteriostatic activity was 
evident. The results obtained clearly indicate the extracts obtained are interesting sources of 
putative anti-biofilm agents. This research can contribute to the development of new strategies to 
prevent and treat biofilm infections. 
 
 












In the past, it was thought that microorganisms are free-floating single-celled (planktonic) 
organisms. They rapidly multiply and are living an individualistic lifestyle in nutrient rich media. 
However, in nature most microorganisms mostly live together in large numbers, attached to a 
surface, forming structured layers. This feature is known as a biofilm. A biofilm community can be 
formed by a single kind of microorganism, but in nature biofilms can also consist of mixtures of many 
species of bacteria, as well as fungi, algae, yeasts, and protozoa (Hall-Stoodley et al., 2004; Jones, 
2007).  
Biofilms of infectious microorganisms play an important role in human health (Jefferson, 2004) and 
because of their resistance to detergents and anti-microbial agents they are difficult to treat. The 
National Institute of Health (NIH) estimates that biofilms are involved in at least more than 65% of 
nosocomial infections and up to 75% of microbial infections occurring in the human body (Richards 
and Melander, 2009).  Biofilms of infectious microorganisms are also formed on medical instruments 
and implants such as catheters, artificial heart valves, contact lenses, and artificial joints, putting 
patients at risk for local and systemic infectious (Donlan and Costerton, 2002; O’grady et al., 2002). 
In addition, the prevalence of microbial resistance to many commonly used antibiotics tends to 
increase. These findings enlarge the need for new anti-microbial compounds.  
Since ancient times, man has used plants for healing, although incapable to find a rational 
explanation for their curing effects. According to the World Health Organization, the use of 
traditional medicine (TM) continues to play an important role in health care. In many parts of the 
world, it is the preferred form of health care. About 80% of people in developing countries, 
especially in rural areas, use TM as the primary source of medicine (Kim, 2005). There are 
approximately 500.000 plant species occurring worldwide, and less than 1% has been screened for 
biologically active compounds (Palombo, 2006). The Indonesian Country Study on Biodiversity 
(ICSBD, 1993) places the number of species of flowering plants in Indonesia between 25.000 and 
30.000. Of the total flora of Indonesia, 10% is expected to have pharmaceutical potential. There is a 
large variety of plants that are used as medicine (Sunesi and Wiryono, 2007).  
Previously, antibiotic discovery and characterization has been performed mostly with planktonic 
bacteria. Therefore, it can be predicted that compounds that are suitable to inhibit biofilm formation 
still need to be discovered. Up to now, only a few compounds, isolated from natural products with 
activity against microbial biofilm formation have been reported (Hentzer et al., 2003). Eugenol 




He et al., 2007). Aeromonas hydrophylla biofilm formation is inhibited by vanillin (Ponnusamy et al., 
2009). Usnic acid, a secondary lichen metabolite, is also capable to inhibit Pseudomonas aeruginosa 
biofilm formation (Francolini et al., 2004). In this study, we screened extracts of Indonesian 
medicinal plants with respect to their capacity to inhibit biofilm formation and or to breakdown the 
biofilms of two known human opportunistic pathogens, the Gram negative strain P. aeruginosa 
PAO1 and the Gram positive strain Staphylococcus aureus Cowan I. P. aeruginosa and S. aureus are 
bacteria that cause nosocomial infections worldwide and can form biofilms which play an important 
role in various acute infections. 
 
The plants investigated in this paper were those predicted and known to have anti-microbial 
properties based on the studies and local uses of the plants (Nawawi et al., 1999; Sangat and 
Larashati, 2002; Batugal et al., 2004; Elfahmi et al., 2014). However, very few studies have 
investigated Indonesian medicinal plants for their anti-biofilm activities. This study focused 
particularly on the idea that Indonesian medicinal plants might be the source of new anti-biofilm 
compounds. Therefore, specific focus was given to the screening programs for anti-microbial and 
anti-biofilm activity, which may yield candidate compounds for developing new anti-biofilm 
compounds that may provide a powerful tool in the discovery of a successful treatment for biofilm 
infections.  
 
Our result demonstrated the effectiveness of Kaempferia rotunda L., Caesalpinia sappan L., 
Cinnamomum burmannii Nees ex Bl., C. sintoc L., and Nymphaea nouchali Burm.f extract towards P. 
aeruginosa PAO1 and S. aureus Cowan I biofilm. This property can be applied clinically to treat 
infectious biofilm along with conventional antibiotics, or applied industrially as to remove biofilm 
from water pipes. 
 
 
MATERIALS AND METHODS 
 
Plant material and extraction 
Indonesian medicinal plants were collected from Yogyakarta, Indonesia and its surroundings on the 
basis of ethnopharmacological information during January – May 2009. The plant materials were 
identified, authenticated and preserved at Department of Pharmaceutical Biology, Faculty of 




Plants samples were washed, cut into small pieces and oven dried at 40⁰C for 48-72 hours (Salie et 
al., 1996; Zakaria et al., 2007; Farooq et al., 2014). The drying process prevents degradation through 
metabolic process, and prevents microbial development. The drying temperature may vary from 
35⁰C to 70⁰C depending on the part of the plant and sensitivity of the active principles. For the 
leaves, a temperature range of 20⁰C – 40⁰C is recommended. Drying plant material in oven with low 
drying temperatures between 30⁰C and 50°C is faster than exposure plant materials to fresh air 
(shaded from direct sunlight), and still capable to protect sensitive active ingredients (Cechinel-Filfo, 
2002). The dried plant materials were ground into a fine powder. The pulverized materials were 
extracted by maceration using Petroleum Ether (PE) in a ratio of 1 g (plant material) : 10 mL PE to 
remove the lipids. The plant material of which lipids have previously been removed were again 
extracted with 70% ethanol (EtOH) using a ratio of 1 g (plant material) : 10 mL (EtOH) to obtain crude 
ethanol extract. Furthermore, extracts were dried and concentrated under reduced pressure using a 
rotary evaporator. Stock solutions (100 mg/mL) of crude ethanol extract in dimethyl sulfoxide 
(DMSO) were prepared, filter-sterilized (0.2 µm) and stored at 4oC.  
 
Determination of planktonic growth inhibitory concentration (PMIC) 
Preparation of the inoculums used for inoculums standard and the growth phase of the microbial 
tested at the time of testing are important factors that needs to be carefully controlled. P. 
aeruginosa PAO1 and S. aureus Cowan I was grown on LB agar plates at 28oC and 37oC, respectively. 
A single colony was inoculated in 5 mL LB broth. After overnight growth, the OD600 was set to a 0.5 
McFarland standards, i.e. optical density 600 nm 0.01 equal to 107 CFU/mL. Cells were incubated for 
2 hours and the final OD600 was diluted to 10
5 CFU/mL.  
Inhibiting concentration of extracts was determined by the microtiter broth method in sterile flat-
bottom 96-well polystyrene plates using Mueller-Hinton broth medium (Difco). Experiments were 
perfomed according to the Clinical and Laboratory Standards Institute (CLSI) guidelines (CLSI, 2007), 
with concentration ranging from 0.06 to 1 mg/mL. Controls were: media control, and infected 
untreated control (100% growth). DMSO used as vehicle control, and streptomycin concentration of 
1024 µg/mL was used as positive control. All tests were performed in triplicate. Culture plates were 
incubated overnight at 37 °C for S. aureus Cowan I and 28 °C for P. aeruginosa PAO1. Optical density 
readings were obtained using microplate reader (Bio-Rad 680 XR) at 595 nm.  
 
Growth reduction was calculated as % of inhibition by using the formula mentioned below. The % of 




Concentration (PMIC) values. The concentration at which the extract depleted the growth of 






ODt24 = optical density (595 nm) of the test well at 24 h post-inoculation; ODt0: optical density (595 
nm) of the test well at 0 hour post-inoculation; ODgc24: optical density (595 nm) of the growth 
control well at 24 hours post-inoculation; ODgc0: optical density (595 nm) of the growth control well 
at 0 hour post-inoculation (Quave et al., 2008). The OD time zero was used to account for the effect 
of plant extract color on the OD595 nm reading. 
 
Effect on biofilm formation and biofilm breakdown 
To test for the inhibition activity of plant extract on biofilm formation, a PVC (polyvinyl chloride) 
flexible U bottom 96 wells plates were used (Falcon 3911, Becton Dickinson, Franklin Lakes, NY). To 
determine biofilm formation inhibition and biofilm breakdown activity, extracts at sub inhibitory 
concentration (concentration under PMIC50) ranging from 0.03-0.5 mg/mL were used to ensure a 
concentration that is not affecting the microbial growth. Negative controls (cells + media: TSB for S. 
aureus Cowan I and M63 supplemented with 20% casamino acid, 20% glucose and 1mM MgSO4 for 
P. aeruginosa PAO1), positive control (cells + media + streptomycin), vehicle controls (cells + media 
+DMSO), and media controls were included. For the positive controls concentrations of 1024 µg/mL 
streptomycin were used, prepared by serial dilution techniques. Blanks undergo the same treatment 
as samples, but without incubation. All tests were performed in triplicate.  
Plates were incubated for 24 h at 28⁰C for P. aeruginosa and 48h at 37 ⁰C for S. aureus. After 24-48 h 
incubation, the content of the well was aspired, rinsed 3 times with distilled water, and dried at 
room temperature for 10 min. Then, 125 µL of 1% crystal violet stain was added to the wells for 
staining for 15 min. The excess stain was rinsed off with tap water and 200µL methanol was added 
to the wells, and transferred to a flat-bottom 96-well plates. Optical density readings were obtained 
by a plate reader at 595 nm. Biofilm formation inhibition was calculated as % of inhibition by using 
the formula mentioned below. The % of inhibition of replicate tests was used to determine the final 






minimum biofilm inhibitory concentration (MBIC) values. The concentration at which the extract 





ODt= optical density (595 nm) of the test well; ODmc: optical density (595 nm) of the media control 
well; ODvc: optical density (595 nm) of the vehicle control well (Quave et al., 2008; Sandasi et al., 
2009). 
 
The efficacy of plant extract on established biofilm (biofilm breakdown) was also studied, as 
described by Nostro et al. (2007) with some modifications. Biofilms were grown on 96-well plates for 
24-48 h. At post-inoculation time, planktonic cells and media were removed, and fresh media was 
added together with the test extract. Plates were placed back into the incubator for another 24-48 h. 
The staining methods have been described above. Percentage of inhibition was calculated, as 
described before, to determine the final minimum biofilm eradication concentration (MBEC) values. 
The concentration at which the plant extract capables to breakdown the bacterial established 
biofilm by at least 50% was labeled as the MBEC50. 
 
Biofilm architecture 
Confocal laser-scanning microscopy (CLSM) was used to study the structure of the P. aeruginosa 
PAO1 and S. aureus Cowan I biofilms (Jin et al., 2005). Bacterial biofilms were grown under static 
conditions on glass slides in sterile tubes. To examine effect of extract on inhibiting biofilm 
formation, fifteen mL of LB media in a sterile tube with or without plant ethanol extract was 
inoculated with the different bacteria to an OD600 of 0.1 from overnight grown LB cultures. Glass 
slides were submerged in this suspension and tubes were incubated for 24h or 48h at 28 °C or 37 °C. 
For analysis the effect of extract in breaking down the biofilm, bacterial biofilm were grown under 
static conditions on glass slides in sterile tubes for 24h or 48h at 28 °C or 37 °C. Following the 
incubation period, the suspensions of bacteria were removed and glass slides were rinsed with 0.15 
M phosphate-buffered saline (PBS, pH 7.0) to remove unattached cells. Fifteen mL of LB media with 
or without plant ethanol extract were poured into the tubes, and the tubes then incubated for 
another 24h or 48h at 28 °C or 37 °C.  







Prior to CLSM analysis, glass slides were rinsed with 0.15 M phosphate-buffered saline (PBS, pH 7.0) 
to remove unattached cells. After a washing with PBS, the bacterial biofilm on the cover-glass slide 
was incubated for 15 min with 1.5 µL of 3.34 mM SYTO9 in anhydrous DMSO to stain the living 
organisms, and with 1.5 µL of 20mM Propidium Iodide (PI) in anhydrous DMSO to stain the dead 
organisms. SYTO9 penetrates intact bacterial membranes (life) and stains the cells green; while PI 
penetrates only cells with damaged membranes (dead) and stains the cells red. The life organisms, 
freshly cultured and subsequently harvested, were used for staining control. Cells killed by heating in 
100 ⁰C were used for PI staining control. Stained biofilms were observed with a Carl Zeiss LSM 5 
Exciter Laser Scanning Confocal Microscope (Leica Microsystems, Germany). A 40× oil immersion 
objective was used with 488 nm Ar laser excitation and 500–640 nm band pass emission setting. The 
images were subsequently analysed using the freely available image processing software imageJ 
version 1.46 (Rasband, National Institutes of Health (NIH), Bethesda, Maryland, USA: 
http://rsb.info.nih.gov/ij/) including the LSM reader plugin to open LSM5 formatted image stack 
created by the microscope software. The images' scale bar used to calibrate the ImageJ area 
measurement algorithm. The observations were made in triplicates and representative images are 
presented here (Dusane et al., 2012).  
 
The image obtained has 2 channels (red and green) and converted into a composite image with: 
Image>Color>Make composite. By default, it will assign red to channel  
#1, green to #2. Brightness and contrast levels were then adjusted to give the best differentiation 
between the live (green) and dead (red) areas. The scale bar was determined with: Analyze > Tools > 
Scale bar. Estimated 3D surface plot was obtained using: Plugins > 3D > Interactive 3D Surface Plot. 
Data containing arrays of the type (x, y, z) where x and y are the coordinates of the pixel positioning 




For statistic analysis, all data were initially analyzed by a normal distribution using the one-sample 
Kolmogorov-Smirnov test. Following the confirmation of normal distribution, differences for 
individual parameters between treated group and control were tested by one way ANOVA, followed 





RESULT AND DISCUSSION 
Preparation of ethanol extract from 54 Indonesian plants 
During this study, fifty four plants (Table 1) were collected from Yogyakarta, Indonesia and its 
surroundings. The ethanol extracts of these plants were obtained as described in Material and 
Methods. Briefly, plant materials of which lipids were previously been removed were macerated in 
an ethanol solution (70%). Crude ethanol extracts were obtained after filtration and the evaporation 
of this solution (Zhang et al., 2004; Kosar et al., 2007).   
 
Table 1: Indonesian medicinal plants tested for anti-biofilm activity 
Voucher 
Number 
Plant name Part used 
STP001 Curcuma xanthorrhiza Roxb. Rhizome 
STP002 C. heyneana Val. & v.Zijp Rhizome 
STP003 C. aeruginosa Roxb. Rhizome 
STP006 Zingiber officinale Roxb. Rhizome 
STP007 Zingiber officinale Roscoe (var. rubrum Theilade) Rhizome 
STP004 C. domestica L. Rhizome 
STP011 Kaempferia galanga  L. Rhizome 
STP013 Boesenbergia pandurata (Roxb.) Schlecht. Rhizome 
STP005 C. mangga Val. & v.Zijp Rhizome 
STP012 Kaempferia rotunda L. Rhizome 
STP014 Languas galanga (L.) Stuntz. Rhizome 
STP008 Z. aromaticum Val. Rhizome 
STP009 Z. zerumbet (L.)J.E. Smith Rhizome 
STP015 Elettaria cardamomum (L.) Maton Fruit 
STP018  Cosmos caudatus H.B.K. Leaves 
STP016 Sonchus arvensis L. Leaves 
STP019 Pluchea indica (L.) Less. Leaves 
STP017 Elephantophus scaber L. Leaves 
STP020 Blumea balsamifera (L.) DC. Leaves 
STP021 Psidium guajava L. Leaves 
STP022 Syzygium aromaticum (Linn.) Merr. Flower 
STP024 Apium graveolens L. Leaves 
STP026 Foeniculum vulgare Mill. Fruit 
STP027 Piper betle L. Leaves 
STP029 P. retrofractum Vahl. Fruit 
STP040 Terminalia catappa L. Leaves 
STP041 Azadirachta indica A.Juss Leaves 




STP031 Citrus aurantifolia Swingle Leaves 
STP032 Tamarindus indica L. Leaves 
STP034 Caesalpinia sappan L. Bark 
STP042 Sesbania grandiflora L.PERS var. Rubra Leaves 
STP033 Andropogon citratus (DC.) Stapf. Leaves 
STP044 Clerodendron serratum (L.) Spreng. Leaves 
STP043 Sauropus androgynus (L.) Merr. Leaves 
STP045 Andrographis paniculata (Burm.f) Nees Leaves 
STP035 Myristica fragrans Houtt. Seeds 
STP036 Guazuma ulmifolia Lmk. Leaves 
STP046 Ocimum basilicum L. Leaves 
STP047 Orthosiphon stamineus Benth. Leaves 
STP048 Coleus scutellaroides (L.) Benth. Leaves 
STP038 Anredera scandens (L.) Moq. Leaves 
STP037 Phaleria macrocarpa (Scheff.) Boerl. Leaves 
STP050 Litsea cubeba(Lours.) Pers. Bark 
STP051 Cinnamomum burmannii Nees ex Bl. Bark 
STP052 C. sintoc Bl. Bark 
STP049 Tinospora tuberculata Beumee. Leaves 
STP054 Paederia foetida L. Leaves 
STP055 Melastoma polyanthum Bl. Leaves 
STP056 Stelechocarpus burahol (Blume) Hook F. & Thomson Leaves 
STP058 Stachytarpheta mutabilis (Jacq.) Vahl. Leaves 
STP059 Alyxia stellate Roem & Schult. Bark 
STP060 Parameria laevigata (A.Juss.) Moldenke Bark 




Effects of ethanol extracts on planktonic growth, biofilm formation and biofilm breakdown of P. 
aeruginosa PAO1 and S. aureus Cowan I 
 
Plant extracts assayed in this research were selected based on their anti-bacterial activity that was 
reported in the literature. The maximum concentration of 1 mg/mL  of plant ethanol extracts for 
testing was chosen based on the previous study by Rios and Recio (2005) who reported that extracts 
should be avoided exhibiting minimum inhibitory concentration (MIC) values higher than 1 mg/mL or 
isolated compounds exhibiting MIC values higher than 0.1 mg/mL. The inoculums concentration 
used in this study is 105 CFU/mL. According to Clinical and Laboratory Standards Institute (CLSI) 
guidelines (CLSI, 2007) and protocols for broth microdilution minimum inhibitory concentration 
(MIC) testing (Rankin, 2005), a 5x105 CFU/mL inoculum provides an acceptable challenge dose for 
assessing the biological activity of anti-microbial agents, and is large enough to provide statistically 




demonstrated by Barry et al. (1983), the growth phase may not have significant effect on MIC 
determination assay, however, it does critical in the MBC assay because if a stationary phase of 
inoculums is used, the number of surviving cells tends to increase after 24 hours incubation and 
makes the MBC result artificially high.  
 
The percentage of planktonic growth inhibition was measured from the reduction in absorbance 
level of the treatments wells which is indirectly measure the bacterial cells biomass, compare to 
negative control well (without the presence of the test compounds). The negative control was 
assumed to have 0% activity compare to the compounds tested. The PMIC50 concentration was 
calculated using probit analysis. Based on the probit analysis data, extract concentration around 
PMIC50 and below (sub-PMIC) were used for anti-biofilm assay, to ensure a concentration that is not 
affecting the microbial growth. 
As shown in Table 2, most of the crude extracts used in this study have limited anti-bacterial activity 
against planktonic growth of P. aeruginosa PAO1 and S. aureus Cowan I.  As much as 20 out of 54 
plant extracts tested failed to give inhibition on planktonic and biofilm growth of bacteria tested. 
The lowest concentration of plant ethanol extract to inhibit growth of the bacteria tested shown by 
C. xanthorrhiza and M. fragrans which give 50% growth inhibition of P. aeruginosa PAO1 at 
concentration of 0.25 mg/mL, whereas C. xanthorrhiza and M. fragrans ethanol extract showed a 
PMIC50 against the growth of S. aureus Cowan I at concentration of 0.12 mg/mL. In addition to 
testing of the plant extracts for inhibition of planktonic growth we also have investigated their effect 
on biofilm formation and biofilm breakdown. Crystal violet staining has been widely adopted by 
microbiologist to investigate biofilm formation and attachment of microorganisms to diverse 
surfaces. This staining method is inexpensive, relatively quick, and adaptable for use in high-
throughput screening with microtiter plates (Niu and Gilbert, 2004). 
 
Using the crystal violet method, we have found that the inhibition of biofilm formation and biofilm 
breakdown by plant ethanol extract was dose dependent (Figure 1 and 2) in both P. aeruginosa 
PAO1 and S. aureus Cowan I. Plant ethanol extract concentration of 0.12 mg/mL is the lowest 
concentration which shows 50% inhibition on P. aeruginosa biofilm formation (Table 2). Only five of 
the 54 extracts tested inhibit ≥ 50% of P. aeruginosa PAO1 biofilm formation at that concentration 
(Figure 1). Ethanol extract of N. nouchali at concentration of 0.12 mg/mL inhibit P. aeruginosa 
biofilm formation as much as 54.7±0.3 % (**P<0.01). As much as 51.1±0.6 % and 53.4±0.5 % 
(**P<0.01) inhibition of P. aeruginosa biofilm formation were obtained by ethanol extract of C. 




respectively (**P<0.01). In addition, 4 of 54 extracts show 50% inhibition on P. aeruginosa biofilm 
formation at an extract concentration of 0.25 mg/mL and 6 extracts at an extract concentration of 
0.5 mg/mL (Table 2). 
 
The lowest concentration which shows 50% of biofilm breakdown of P. aeruginosa (Table 2) is 0.5 
mg/mL and only three of extracts tested shows that activity. N. nouchali extract at a concentration 
of 0.5 mg/mL shows as much as 52.8±0.3 % (**P<0.01) degradation of the P. aeruginosa PAO1 
preformed biofilm, and ethanol extracts of C. sappan and K. rotunda shows 52.2±0.6 % and 50.6±0.5 
% degradation respectively (**P<0.01) (Figure 3A).  
 
The lowest concentration of ethanol extracts which causes 50% inhibition on S. aureus Cowan I 
biofilm formation was also 0.12 mg/mL. As much as 51.29±0.61% inhibition of S. aureus biofilm 
formation was observed by incubation of S. aureus with K. rotunda ethanol extract at concentration 
of 0.12 mg/mL (**P<0.01). At the same concentration, N. nouchali, C. sappan, C. burmannii and C. 
sintoc cause 53.4±0.6 %, 52.5±0.32 %, 51.4±0.6 % and 50.6±0.5 % inhibitions of S. aureus biofilm 
formation (**P<0.01) (Figure 2). In addition, 4 of the 54 extracts show 50% inhibitions on P. 
aeruginosa biofilm formation at an extract concentration of 0.25 mg/mL and 10 extracts at an 
extract concentration of 0.5 mg/mL (Table 2).  
 
Similar as for breakdown of preformed P. aeruginosa biofilm, only 5 of the 54 ethanol extracts 
caused 50% breakdown of preformed biofilm of S. aureus Cowan I at an extract concentration of 0.5 
mg/mL. In the presence of the ethanol extract of C. sappan at a concentration of 0.5 mg/ml, 
preformed biofilm of S. aureus was decreased as much as 53.8±0.4 % (**P<0.01). At the same 
concentration, C. burmannii, K. rotunda and N. nouchali show the capability to degrade S. aureus 
biofilm as much as 50.0±0.3 %, 50.2±1.0 % and 52.9±0.3 % (**P<0.01), respectively (Figure 3B).  
 
Qualitative analysis of P. aeruginosa and S. aureus biofilm 
The activity of the extracts on the biofilm formation inhibition and biofilm breakdown was analysed 
by confocal laser scanning microscope (CLSM), along with LIVE/DEAD staining as described in 
Material and Methods. Examples of estimated 3D surface plot of the biofilm are shown in Figures 4-
7. Qualitative analysis of biofilm structure by CLSM indicated an evident disruption of the biofilm 
structure resulting from exposure to plant extract. Viability staining using LIVE/DEAD staining 
showed that both life and dead cells were present in the analyzed biofilms. The control cells 
fluorescened green indicating that the cells were alive, embedded in a polysaccharide matrix that 






















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Ethanol extracts from K. rotunda, C. sappan , C. burmannii, C. sintoc, and N. nouchali at concentration of 
0.12 mg/mL significantly reduced P. aeruginosa PAO1 and S. aureus Cowan I initial biofilm formation 
compared to the negative control (biofilm cells without addition of plant extract) which is densely 
packed. The initial biofilm formation inhibition by plant ethanol extracts was found to be concentration 
dependent. The presence of 0.25 mg/mL extract resulted in loss of aggregates structures. The cells were 
found scattered individually along the substratum (Fig 4-5).  
 
At concentration of 0.5 mg/mL, the ethanol extracts from C. sappan, K. rotunda and N. nouchali showed 
capability in breaking down preformed biofilm of both bacterial tested even more than at a 
concentration of 0.25 mg/mL (Fig 6-7). The biofilm exposed to the plant extracts were disrupted, leaving 
small aggregates which are remained attached to the substrate compare to the densely packed cells in 
untreated biofilm control (without the presence of extract) (Fig 6-7).  
 
CLSM images showed that plant ethanol extracts tested significantly prevent the formation of biofilm at 
concentration of 0.12 mg/mL. Compared to the cells in the control that formed cells clusters and 
attached to the substratum, the amount of cells in the clusters, embedded in the EPS matrix was 
diminished with the presence of plant extract. It seems that bacterial growth was inhibited before the 
cells were able to promote attachment on the surface. However, the result showed that activity on 
biofilm breakdown was more difficult to achieve than inhibition in cell attachment. The concentration of 
plant extract needed to disrupt preformed biofilm was higher (0.5 mg/mL) than the concentration 
needed to inhibit the initial attachment. It is evident that cells in a biofilm are more resistant to anti-
microbial agents compare to free floating cells (Stewart, 2002). 
 
The cell attachment is the initial stage in biofilm formation following formation of film consists of 
nutrients, organic and inorganic molecules adsorbed on a surface (surface conditioning). The surface 
conditioning is important for the growth of cells and often creates a favorable environment for bacterial 
attachment, which in turn promotes cell adhesion to surfaces which subsequently leads to infections 
(Sandasi et al., 2009). It can therefore be postulated that the presence of plant extracts in growth media 
produced an unfavorable condition that could inhibit cell attachment or reduce the surface adhesion 





The reduced susceptibility of bacteria in a biofilm is thought to be due to a combination of several 
factors. The presence of extracellular polymer substances (EPS) containing mainly polysaccharides, 
proteins and nucleic acids and other compounds  that surrounds biofilm cells contribute to the anti-
microbial resistance properties of biofilms by impeding the mass transport of antibiotics through the 
biofilm (Donlan and Costerton, 2002). The anti-microbial agent is adsorbed onto the EPS and effectively 
diluted before it reaches the individual bacterial cells in the biofilm (Dibdin et al., 1996). Killing by many 
anti-microbial agents is growth dependent by targeting macromolecular synthesis. Reduction in oxygen 
and nutrients availability in biofilm leads to cell growth limitation and bacterial macromolecular 
synthesis is arrested. This among others makes the bacterial cells in the biofilm less susceptible to anti-
microbial agents (Stewart, 2002; Lewis, 2001). Our study suggests that the inhibition activity of the plant 
ethanol extract of bacterial biofilm formation and the disperse existing of biofilms appears to be coupled 
with biocidal/biostatic activity. These results are helpful for designing novel biofilm inhibitors and 
developing more effective therapeutic methods. 
 
The activity of K. rotunda, C. burmannii, C. sappan, C. sintoc and N. nouchali ethanol extracts to inhibit P. 
aeruginosa PAO1 and S. aureus Cowan I initial biofilm formation and degradation of formed biofilm has 
not been reported previously. It has been reported that K. rotunda contains flavonoids, crotepoxide, 
chalcones, quercetin, flavonols, β-sitosterol, stigmasterol, benzoic acid, syringic acid, protocatechuic 
acid and some hydrocarbons such as camphor. The abundant presence of flavonoids in this plant has 
interpreted as the involvement in antioxidant mechanisms as a prime role (Mohanty et al., 2008). 
Resins, tannin and essential oils which contain cinnamaldehyde, cinnamyl acetate, eugenol and anethole 
are present in C. burmannii bark. Other chemical components of the essential oil include ethyl 
cinnamate, beta-caryophyllene, linalool, and methyl chavicol. Eugenol oil that can be used as an 
ingredient in cosmetics is also present in C. sintoc bark (Sangat and Larashati, 2002; Jantan et al., 2005). 
Especially cinnamaldehyde and eugenol are proved to be active against many pathogenic bacteria and 
fungi (Ooi et al., 2006; Shan et al., 2007; Gende et al., 2008). Nuryastuti et al., (2009) reported the 
potency of C. burmannii oil to combat both planktonic and biofilm cultures of clinical Streptococcus 
epidermidis strains, with MICs ranging from 0.5 to 1%, and 1 to 2%, respectively. A study based on cell 
permeability assay and electron microscopy observation on cinnamaldehyde revealed  that anti-
bacterial mechanism of cinnamaldehyde are possibly due on its interaction with cell membrane causes 
disruption on membrane permeability, and the leakage of intracellular constituents (Gill and Holley, 































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Phytochemical investigations on heartwood and other parts of C. sappan  (sappan wood), have 
resulted in reports of various compounds including triterpenoids, lipids, amino acids,  flavonoids, 
and phenolic compounds such as 4-O-methylsappanol,  protosappanin A, protosappanin B, 
protosappanin E, brazilin, brazilein, caesalpin J, brazilide A, neosappanone A,  caesalpin P, 
sappanchalcone, 3-deoxysappanone, 7,3′,4′-trihydroxy-3-benzyl-2H-chromene (Nagai et al., 1986; 
Namikoshi and Saitoh, 1987). Brazilin is known to have anti-bacterial activity. It has also the potency 
to be developed into an antibiotic.  A study from Xu and Lee (2004) suggested that the antibacterial 
activity of brazilin could be attributes to its capability on inhibit bacterial DNA and protein synthesis. 
However, the exact anti-bacterial mechanism of action of brazilin remains unknown at this time. 
The chemical constituents of N. nouchali (red and blue water lily), synonym N. stellata Willd flowers, 
contain quercetin, luteolin, isoquercitrin, kaempferol, galuteolin, and alkaloids. The seeds are rich in 
starch, and also contain raffinose, proteins, fats, carbohydrates, calcium, phosphorus, iron, 
nuciferine, oxoushinsunine, N-norarmepavine. The rhizome contains starch, protein, asparagine, and 
vitamin C. It also contains catechol, d-gallocatechol, neochlorogenic acid, leucocyanidin, 
leucodelphinidin, and peroxidase. The roots contain tannic and asparagine. The leaves of this plant 
contain roemerine, nuciferine, nornuciferine, armepavine, pronuciferine, N-nornuciferine, DN-
methylcoclaurine, anonaine, liriodenine, quercetin, isoquercitrin, nelumboside, citric acid, tartaric 
acid, malic acid, gluconic acid, oxalic acid, succinic acid, and tannin. Oxoushinsunine, found on the 
seed coat, suppress the development of throat cancer while the seeds and stalks have efficacy as 
anti-hypertension (ICSBD, 1993; Nagavani and Rao, 2010).  Studies found that quercetin, a flavonoid 
compound, has anti-bacterial properties which, possibly due to the DNA gyrase inhibition that is 
required for DNA synthesis (ICSBD, 1993; Cushnie and Lamb, 2010).   
Biofilm formation can be controlled by quorum sensing, a bacterial communication system which 
causes a rapidly and coordinately change of expression pattern in the bacterial population in 
response to population density. The fact that in sub-PMIC concentration, the K. rotunda, C. sappan, 
C. burmannii, C. sintoc and N. nouchali ethanol extracts are capable of disturbing biofilm formation 
and biofilm breakdown suggests that this disturbance may have been caused by the presence of  
compounds inhibiting quorum sensing. Similarly, Rasmussen et al. (2005) reported that carrot, garlic, 
habanero (chili), and water lily produce compounds that interfere with bacterial quorum sensing. 
Halogenated furanone compounds isolated from marine algae Delisea pulchra inhibit biofilm 
formation influence microbial biofilm formation by interfering with bacterial quorum sensing 
(Manefield et al., 1999). Other plant’s compounds could attenuate biofilm development by inhibit 
bacteria’s peptidoglycan synthesis (Ogunlana et al., 1987), disrupt the permeability barrier of 
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microbial membrane structures, causing the cell to leak out (Cox et al., 2000), modify bacterial 
membrane structure hydrophobicity (Turi et al., 1997; Das, 2014), disturbing the extracellular 
polymeric matrix in the biofilm to release biofilm from the surface of the solid substratum (Traba 
and Liang, 2011). Further studies need to be performed to confirm the actual mode of action of anti-
biofilm activity from these extracts.  
Assignment of the active compound to one of these groups is often the first step in determining the 
identity of the compound. Therefore, characterization of the active anti-biofilm compound(s) is 
needed to gain a deeper understanding of the active compounds that affect the biofilm formation of 




The results obtained in this study have made the extract of K. rotunda, C. sappan, C. burmannii, C. 
sintoc and N. nouchali an interesting source for anti-biofilm agents in the development of new 
strategies to treat infections caused by P. aeruginosa, and S. aureus biofilm. The future scope of this 
work is to isolate the biologically active compounds responsible for anti-biofilm activity from K. 
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Biofilms are communities of microorganisms that can be found in almost every habitat. They are 
attached to a surface and embedded in an extracellular matrix of biomolecules that substantially 
protect microorganisms and make them more resistant to anti-microbials and to the defense 
mechanism of the host than single cell planktonic microorganism, which makes them a progressive 
source of infections. The discovery of anti-biofilm agents is required to deal with these biofilm-
mediated infections. This study aimed to explore the potency of essential oils from various selected 
Indonesian medicinal plants against planktonic growth and biofilm of, two opportunistic pathogens, 
Pseudomonas aeruginosa PAO1 and Staphylococcus aureus Cowan I. Anti-biofilm activity was 
studied using microtiter broth dilution method. Confocal laser-scanning microscopy (CLSM) with 
Live/Dead staining was used to observe the ultrastructure of the P. aeruginosa PAO1 and S. aureus 
Cowan I biofilms. Major compounds in Cinnamomum burmanniii and Massoia aromatica oils were 
identified by gas chromatography-mass spectrometry (GC-MS). Essential oil from C. burmannii and 
M. aromatica showed a 50% growth inhibition of P. aeruginosa and S. aureus I at a concentration of 
0.12 % v/v.  The result also demonstrated an evident activity of those oils  in preventing and 
breaking down biofilm formation of P.aeruginosa PAO1 and S.aureus Cowan I at sub-PMIC 
concentration (0.03 % v/v). The analysis by GC-MS showed cinnamic aldehyde (92.0 %) to be the 
major component of C. burmannii oil, whereas Massoialactone (92.1 %) was the main constituent of 
M. aromatica oil. The results obtained clearly indicate that C. burmannii and M. aromatica oil  
represents an interesting source for anti-biofilm agents in the development of new strategies to 
treat and  prevent biofilm associated infections. 
 
 
Keywords : Biofilms, Cinnamomum burmannii Nees ex Bl., Massoia aromatica Becc., Pseudomonas 








Biofilms are communities of microorganisms that attached to a surface and are protected by an 
extracellular matrix of biomolecules (O’Toole et al., 2000). Because of the matrix-enclosed mode of 
growth among others, a biofilm has a high resistance against antibiotics which makes them hard to 
treat. Treatment of biofilm infections with antibiotics is often not sufficient. The demand for new 
and effective anti-microbial agents is increasing considerably (Harrison et al., 2005).  
 
In recent years there has been a growing interest in discovery of GRAS (generally regarded as safe) 
compounds from natural substances to combat new and existing diseases. Higher plants are 
attractive species for this discovery because they contain an abundance of potentially active 
secondary metabolites (Clardy and Walsh, 2004). Extracts of these plants, like e.g. essential oils, are 
generally assumed to be more acceptable and less hazardous than synthetic compounds. Moreover, 
essential oils that are registered as food grade material, could even form a better alternative source 
for anti-fungal and anti-bacterial compounds. Therefore essential oils have been extensively studied 
for its anti-microbial and anti-fungal activities (Reichling et al., 2009; Bagamboula et al., 2004; 
Hadizadeh et al., 2009).  
Essential oils consist of many chemical constituents and the makeup of the oil quite often varies 
between species. It is difficult to correlate the activity to single or classes of compounds, and it 
seems that the anti-fungal and anti-bacterial effects are often the result of many compounds acting 
synergistically. This means that the individual components by themselves are not always sufficiently 
effective (Hadizadeh et al., 2009). Because of a negligible chance for fungi and bacteria to of develop 
a  resistance towards these oils, makes essential oil one of the most promising candidate groups of 
natural compounds for the development of safer and active anti-microbial agents (Nadoushani et al., 
2010). 
 
In this study we examined the anti-microbial and anti-biofilm activities of several essential oils, 
isolated from Indonesian medicinal plants towards Pseudomonas aeruginosa PAO1 and 
Staphylococcus aureus Cowan I, as well as their chemical compositions.  The purpose of this research 








MATERIALS AND METHODS 
 
Plant Material  
Indonesian medicinal plants were collected from Yogyakarta, Central Java and its surroundings, and 
the bark of Massoia aromatica Becc. was collected from Nabire district, West Papua, Indonesia, on 
the basis of ethnopharmacological information. The species were identified, authenticated, and the 
voucher specimens were preserved in Department of Pharmaceutical Biology, Faculty of Pharmacy, 
Gadjah Mada University, Yogyakarta, Indonesia for further reference (Table 1). 
 
Isolation of the essential oils 
Plant materials were triturated and steam hydrodistilled for 6 hours to obtain volatile oils. The 
essential oils yielded were sealed and kept in a dark glass vial for further analysis. Stock solutions of 
50% plant essential oil in 90% methanol (MeOH) was made to enhance the solubility of essential oil 
in suspension and used for the following dilution to obtain an essential oil concentration ranging 
from 1 to 0.01 % v/v.  
 
Bacterial strains and culture conditions 
P. aeruginosa PAO1 and S. aureus Cowan I were inoculated in Luria Bertani (LB) media and incubated 
in a shaking incubator at 28 ⁰C for P. aeruginosa PAO1 and 37 ⁰C for S. aureus Cowan I overnight. 
Cultures were then diluted 100 fold into LB media and allowed to grow to an OD600 of 0.1 
(approximately 1 · 108 CFU/mL) for the different assays described below. 
 
Anti-microbial susceptibility testing  
Anti-microbial susceptibitily test for essential oils was performed according to Clinical and 
Laboratory Standards Institute (CSLI) guidelines (2007). A culture of S. aureus and P. aeruginosa (5 
mL) in LB broth was grown overnight at 37 °C for S. aureus and at 28 °C  for P. aeruginosa, and 
diluted to an OD600 of 0.01 (10
7 CFU mL-1). The cultures were incubated for an additional 2 h and 
finally the OD600 was diluted to 10
5 CFU/mL. Inhibitory concentrations of essential oils were 
determined by microdilution method in sterile flat-blottom 96-well polystyrene using Mueller Hinton 
(MH) broth medium. Concentrations of essential oils used for the test are ranging from 1 to 0.06 % 
v/v. Negative controls (cells + media), positive controls (cells + media + antibiotic: streptomycin), 
vehicle controls (cells + media + MeOH), and media controls were included. Streptomycin sulphate 
was obtained from Duchefa Biochemie, Netherlands. All tests were performed in triplicate. Culture 
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plates were incubated overnight at 37 °C for S. aureus and 28 °C for P. aeruginosa, and optical 
density readings were taken using plate reader at 595 nm. The % of inhibition of replicate tests was 
used to determine the final MIC50 values. Since the oils obtained has a clear/transparent 
appearance, the formula from Pirbalouti et al. (2010) instead of formula from Quave et al., (2008) 
where the OD time zero was measured (Chapter 2, this thesis), was used to determine the 
planktonic minimum inhibitory concentration (PMIC) of the EOs: 
 
Inhibition % = [(ODc –OD t) / ODc] ×100 
 
Where ODc is the OD595 for the negative control (containing no essential oil) at 24 h post-inoculation 
and Odt is the OD595 for the anti-microbial compounds tested at 24 h post-inoculation. The 
concentration at which the essential oils depleted the growth of bacteria by at least 50% was labeled 
as the PMIC50.  
 
Effect on biofilm formation and established biofilm 
Biofilm inhibition was studied using a sterile flat-bottom 96-well polystyrene plate. In order to 
determine the activity of biofilm inhibition and biofilm breakdown, essential oils at subinhibitory 
concentration (below PMIC50 concentration) were used to ensure a non-toxic concentration (Quave 
et al., 2008). A 5 µL culture of 107 CFU/mL of S. aureus I or P. aeruginosa was dispensed into each 
well of 96-well polystyrene flat-bottomed microtitre plates containing medium in the presence of 
100 µL subinhibitory concentrations (0.01 – 0.5 % v/v) of essential oils. For negative controls, as 
much as 100 µL TSB medium for S. aureus and M63 medium supplemented with 20% casamino acid, 
20% glucose and 1mM MgSO4 for P. aeruginosa were used. A medium with streptomycin 
concentration of 1024 µg/mL used as positive control. All tests were performed in triplicate. As a 
measure of efficacy, OD595 of the negative control was subtracted from corresponding absorbance 
reading and compared to that of positive control and multiplied by 100. The concentration at which 
the essential oil depleted the biofilm biomass by at least 50% was labeled as the minimum biofilm 
inhibition concentration 50 (MBIC50).  
 
Plates were incubated overnight at 28⁰C for P. aeruginosa and 48 hours at 37 ⁰C for S. aureus. 
Following the incubation, the contents of the wells were removed, rinsed 3 times with distilled 
water, and air dried at room temperature for 10 min. Then, 125 µL of 1% crystal violet was added to 
the wells to stain for 15 min. The excess stain was rinsed off with tap water and 200 µL ethanol 
(EtOH) was added to the wells, and transfer to flat-bottom 96-well plates. Optical density was 
determined at 595 nm. The % inhibition of replicate tests was used to determine the final MBIC50 
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values. Comparing the average of OD of the growth control wells with that of the sample wells, the 
inhibition percentages for each concentration of the oil was defined by the following formula: 
 
[(ODgrowth control – Odsample) / ODgrowth control] x 100 
 
The efficacy of plant essential oils on established biofilm was also studied, as described by Nostro et 
al. (2007) with some modifications. Biofilms were grown on 96-well plates for 24 for P. aeruginosa 
and 48 h for S. aureus. At post-inoculation, planktonic cells and media were removed and fresh 
media was added together with the test essential oils. Plates were placed back into the incubator for 
24 h. The staining methods are described above. Percentage of minimum biofilm eradication 
(breakdown) concentration (MBEC) was calculated, as described before. 
 
Qualitative analyses: Microscopic and image acquisition 
Confocal laser-scanning microscopy (CLSM) (Jin et al., 2005) was used to observe the ultrastructure 
of the P. aeruginosa and S. aureus biofilms. Bacterial biofilms were grown under static condition on 
glass slides. Twenty millilitres media in a sterile tube with or without essential oil was inoculated to 
an OD600 of 0·1 from overnight cultures grown in LB. Glass slides were submerged and the cultures 
were incubated for 24 h at 28 °C or for 48 h at 37 °C. Prior to CLSM analysis, glass slides were rinsed 
with 0.15 M phosphate-buffered saline (PBS, pH 7.0) to remove unadsorbed cells. After washing with 
PBS, the bacterial biofilm on the cover-glass was stained for 15 min with 1.5 µL of 3.34 mM SYTO9 in 
dimethylsulfoxide (DMSO) for the live organisms, and with 1.5 µL of 20mM Propidium Iodide (PI) in 
DMSO for the dead organisms. SYTO9 penetrates all bacterial membranes and stains the cells green, 
while PI penetrates only cells with damaged membranes and stains the cells red. The live organisms, 
freshly cultured and subsequently harvested, were used for control staining. The dead organisms, 
killed by heating in 100 ⁰C were also used for control staining. Stained biofilms were observed with 
with a Carl Zeiss LSM 5 Exciter Laser Scanning Confocal Microscope (Leica Microsystems, Germany), 
using high magnification: 40x - oil immersion microscopy. The images were processed for display 
using freely available image processing software imageJ version 1.46 (Rasband, National Institutes of 
Health (NIH), Bethesda, Maryland, USA: http://rsb.info.nih.gov/ij/) including the LSM reader plugin 
to open LSM5 formatted image stack created by the microscope software. The images' scale bar 




The image obtained has 2 channels (red and green) and was converted into a composite image with:  
Image > Color > Make composite. By default, it will assign red to channel  
#1, green to #2. Brightness and contrast levels were then adjusted to give the best differentiation 
between the live (green) and dead (red) areas. The scale bar was determined with: Analyze > Tools > 
Scale bar. Estimated 3D surface plot was obtained using: Plugins > 3D > Interactive 3D Surface Plot, 
whereas estimated 3D view was obtained using: Plugins > 3D > 3D viewer. Data containing arrays of 
the type (x, y, z) where x and y are the coordinates of the pixel positioning and the luminance of an 




Gas chromatography mass spectrometry (GC-MS) is a useful tool for quantitative and qualitative 
analysis of a wide range of relatively volatile compounds, and the technique has been widely applied 
in medical, biological, and food research. Essential oil extracts were analysed by GC-MS according to 
the method of Wu et al. (2008) on a GC-2010 gas chromatography (Shimadzu, Japan) equipped with 
a GC-MS-QP2010 Plus mass spectrometer (Shimadzu, Japan). An Rxi-5MS capillary column (30 m 
length, 0.25 mm diameter, 0.25 µm film thickness, Shimadzu, Japan) was used for separation. A split 
injector was used and diluted samples (1/100 in ethyl acetate, v/v) of 1.0 mL were injected by an 
autosampler in the split mode (1/153). The oven temperature was programmed from 60⁰C to 290⁰C 
at a rate of 10⁰C ml-1. Helium was used as the carrier gas. Identification of compounds was based on 
comparisons of their mass spectra with those recorded in the National Institute of Standards and 
Technology (NIST) database. Quantitative analysis of each essential oil component (expressed as 
area percentage) was carried out by peak area normalization measurement. For dead-time and 
Kovats Retention Index determination were conducted under isothermal condition (70⁰C). 
 
Kovats Retention Index Determination 
The accurate determination method of dead-time is very crucial role in calculating other retention 
parameters such as, the adjusted retention time (tr’), retention factor (k’), Retention Index (RI) and 
Separation Factor (α). Kovats retention index (shorter Kovats index, retention index; plural retention 
indices) is a concept firstly used in gas chromatography system by Ervin Kovats in year 1968 (Kovats, 
1968) to quantify the retention of an analyte by comparing it with a pair of n-alkane adjacent 
chromatograms. This index is claimed independent of column packing, temperature, or any other 
chromatographic conditions. In an extensive study for determining chromatographic dead time, 
some researchers (Smith et al., 1985; Idroes & Oesman, 2011) concluded that iteration method 
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established by Guardino et al., (1976) not only the fastest but also the most accurate compared to 
the other methods. The iterative method in this research developed based on the flow chart that has 
been given by Guardino et al., and the written source code by Furr (1989). 
 
Statistical analysis 
The data were initially analyzed by a normal distribution using the one-sample Kolmogorov-Smirnov 
test. The differences for individual parameters between treated group and control were tested 
using one way ANOVA, followed by Dunnett’s test. The bars in all of the graphs indicate the standard 
deviation of the mean. A P value of 0.05 or less was considered to be statistically significant. 
 
RESULT  
Essential oil yields 
As much as 29 Indonesian medicinal plants were collected and screened for inhibition of biofilm 
formation and biofilm breakdown. Plant essential oils assayed in this research were selected based 
on their ethnopharmacological application. Also their abundant availability in Indonesia was 
considered. The scientific, family, and local names of the samples as well as their common usage are 
presented in Table 1. The yield of the plant samples oils is presented in Table 1. Most plants had oil 
yield around 0.25-2.5 % v/w, and largest quantities of oil were obtained from the leaves part of 
Litsea cubeba (6 % v/w). 
 
Screening and determination of MIC plant oils for P. aeruginosa and S. aureus planktonic growth 
The values of growth inhibition of bacterial strains by essential oils are shown in Figure 1 and Table 
2. The essential oils used in this study showed anti-bacterial activity against P. aeruginosa PAO1 and 
S. aureus Cowan I, at concentrations ranging from 0.12 to 1 % v/v.  
 
Bacterial planktonic growth inhibition by essential oils was measured from the reduction in 
absorbance level of the wells which consist of essential oil tested compare to the negative control 
wells. The negative control was assumed to have 0% activity compare to the compounds tested. The 
PMIC50 concentration was calculated using probit analysis. To ensure a concentration that is not 





















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Effect of plant essential oils on C. albicans biofilm formation and established biofilm 
Against bacterial biofilms, both essential oils showed 50% inhibition on biofilm formation at 
concentration of 0.03 % v/v against P. aeruginosa PAO1, whereas higher concentration (0.06 % v/v) 
needed by Massoia oil to give 50% inhibition of S. aureus Cowan I biofilm formation (Figure 1). The 
biofilm formation of P. aeruginosa was partially reduced (50.2± 0.5 %) (**P<0.01) in the presence of 
C. burmannii oil at concentration of 0.03 % v/v, whereas as much as 51.3±0.8 % (**P<0.01) reduction 
in biofilm was shown by the M. aromatica oil at concentration of 0.03 % v/v. Similar result was 
shown against S. aureus biofilm formation. At concentration of 0.03 % v/v, C. burmannii oil reduced 
the formation of S. aureus biofilm as much as 51.7±0.9 % (**P<0.01), whereas at the same 
concentration, massoia oil capable to give 45.3±0.4 % (**P<0.01) reduction of S. aureus biofilm 
development.  
 
Both C. burmannii and M. aromatica oil needs higher concentrations (0.12 % v/v) in order to be able 
to break the biofilm of the bacteria tested (Figure 2). MBEC50 of both oils against P. aeruginosa, as 
well as against S. aureus was at concentration of 0.12 % v/v. As much as 49.5±0.6 % (**P<0.01)  of P. 
aeruginosa biofilm was degraded in the presence of C. burmannii oil (concentration of 0.12 % v/v), 
whereas 49.7±0.5 % (**P<0.01) breakdown of P. aeruginosa biofilm was given by concentration of 
0.12 % v/v massoia oil. The activity in breakdown established biofilm were shown by both oils 
against S. aureus established biofilm. At concentration of 0.12 % v/v, C. burmannii oil gave 52.5±0.8 
% (**P<0.01) breakdown, while at the same concentration, massoia oil capable to disrupt S. aureus 
settled biofilm as much as 50.1±0.5 % (**P<0.01), accordingly. 
 
Qualitative analyses 
The inhibition of biofilm formation and biofilm breakdown of C. burmannii and M. aromatica 
essential oils was confirmed by confocal laser scanning microscope (CLSM) analysis, along with 
LIVE/DEAD staining for monitoring live/dead cells. From CLSM observations, we observed an 
inhibition of biofilm formation and a breakdown of an established biofilm for both bacteria when 




















































































































































































































































































































































































































































































































Fig. 3: Representative confocal scanning micrograph images of Pseudomonas aeruginosa PAO1 
initial biofilm formation grown in the presence or absence of Massoia aromatica (a & b), and 
Cinnamomum burmannii (c & d) essential oil at concentration of 0.12 – 0.01 % v/v. Streptomycin 
(positive control) at concentration of 1024 µg mL-1; (a & c): projected upper view of the biofilm, (b 
& d): estimated three-dimensional surface plot of the biofilm refers to the total area in the x-y-z 
dimension, where x and y are the coordinates of the pixel positioning and z is the intensity 
collected using ImageJ. The cells in biofilms were stained with SYTO9 (green), and PI (red). Live 






Fig. 4: Representative confocal scanning micrograph images of Staphylococcus aureus Cowan I 
initial biofilm formation grown in the presence or absence of M. aromatica (a & b), and 
Cinnamomum burmannii (c & d) essential oil at concentration of 0.12 – 0.01 % v/v. Streptomycin 
(positive control) at concentration of 1024 µg mL-1; (a & c): projected upper view of the biofilm, (b 
& d): estimated three-dimensional surface plot of the biofilm refers to the total area in the x-y-z 
dimension, where x and y are the coordinates of the pixel positioning, and z is the intensity 








Fig. 5: Representative confocal scanning micrograph images of biofilm breakdown activity of 
Massoia aromatica (a & b), and Cinnamomum burmannii (c & d) essential oil at concentration of 
0.12 – 0.01 % v/v against P. aeruginosa PAO1. Streptomycin (positive control) at concentration of 
1024 µg mL-1 ; (a & c): projected upper view of the biofilm, (b & d): estimated three-dimensional 
view of the biofilm refers to the total area in the x-y-z dimension, where x and y are the 
coordinates of the pixel positioning, and z is the intensity collected using ImageJ. Live cells are 







Fig. 6: Representative confocal scanning micrograph images of biofilm breakdown activity of 
Massoia aromatica (a & b), and Cinnamomum burmannii (c & d) essential oil at concentration of 
0.12 – 0.01 % v/v against S. aureus Cowan I. Streptomycin (positive control) at concentration of 
1024 µg mL-1 ; (a & c): projected upper view of the biofilm, (b & d): estimated three-dimensional 
view of the biofilm refers to the total area in the x-y-z dimension, where x and y are the 
coordinates of the pixel positioning, and z is the intensity collected using ImageJ. Live cells are 
labeled in green (SYT09), and dead cells are labeled in red (propidium iodide).  
 
At the highest concentration tested (0.12 % v/v), a clear inhibitory effect was observed for the 
essential oil tested against both P. aeruginosa and S. aureus biofilm compared to the untreated 
control (figure 3 and figure 4). The biofilm formed in the presence of 0.12 % v/v oil was less dense 
and consisted of scattered cell clusters compared to the normal biofilm without the presence of oil. 
At the lowest concentration tested (0.01 % v/v), both oils of M. aromatica and C. burmannii failed to 
inhibit the biofilm. From CLSM studies, in the presence of sub-PMIC concentration (0.01 % v/v) oils 
these biofilms showed dense microcolonies intersected by irregular channels. When we tested the 
oil at concentration higher than sub-PMIC (0.25 – 0.5 % v/v) no biofilm was formed and the few 
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planktonic cells were dead (data not shown). This is probably related to the anti-bacterial activity of 
the oils, which provide no growth of the bacteria tested in the presence of the oils, therefore the 
biofilm could not be established.  
 
The similar characteristic was also observed when the oil activity was tested for disruption of 
preformed biofilms (Figure 5 & 6). At concentrations higher than subMIC (0.25 – 0.5 % v/v), the 
biofilms largely disappeared and a few dead cell clusters were evident (data not shown). At lower 
concentrations (0.12 % v/v), the oils have less capability in disrupting the preformed biofilm as 
shown by surviving cell clusters and dispersion on the glass slide surface. The oils were least effective 
at concentration of 0.01 % v/v against the adherent cells. In the presence of oil at concentration of 
0.01 % v/v the microcolonies within the biofilm are more compact and formed layers which increase 
the thickness of the biofilm developed on the glass side surface. 
 
GC-MS analysis 
The principal components of the oils of M. aromatica and C. burmannii  were determined using gas 
chromatography and identified by comparing the mass spectra of chemical compounds in essential 
oils with library mass spectra from NIST02  (www.nist.gov/index.html). In this study, the analysis by 
GC-MS showed cinnamic aldehyde (92.0 %) to be the major component of C. burmannii essential oil, 
whereas massoialactone (92.1 %) was the main constituent of M. aromatica essential oil. The 
chemical composition of the volatile oils from C. burmannii and M. aromatica obtained from GC-MS 
were described in Table 3; Figure 7 & 8.  
 
The identification of the essential oils chemical constituents was assigned on the basis of comparison 
of their retention indices mass spectra with data published in the literature. Kovats retention Index 
of C. burmannii and M. aromatica oil by isothermal GC were shown at Table 4.  The dead-time was 
estimated 1.82 minutes with a very good of coefficient correlation 0.9992. These calculations 
particularly involved approximately 25 iterations. N-alkanes homologous series was used not only as 
standards described by Kovats but also for estimating dead-time simultaneously. The obtaines 





Fig. 7: GC-MS profile of Cinnamomum burmannii oil. The indicated compounds in the 
chromatograms were shown in Table 3. 
 
 
Fig. 8: GC-MS profile of Massoia aromatica oil. The indicated compounds in the chromatograms 








































































































































































































































































































































































































































































































































Table 4:  Kovats retention Index of C. burmannii and M. aromatica oil by isothermal GC on an 
AGILENT J&W DB-1 GC column. 
 
Estimation of Coloumn Dead-time (to) 
Estimated dead time                               : 1.81510 
Estimated Coef Corr Semi-log plot        :  0.99915 
Calculated Slope Semi-log plot              : 0.00658 










Hexane 6 2.381 0.558 0.311 
Heptane 7 2.850 1.077 0.570 
Oktane 8 3.899 2.080 1.148 
Nonane 9 6.098 4.018 2.359 
Decane 10 9.281 7.758 4.113 
     






k' Retention Index 
C. burmannii 19.296 17.480 09.630 1123.459 





The result obtained from this study showed that the anti-bacterial and anti-biofilm activity of plant 
essential oils varied for the studied microorganisms. It is very likely that different compounds within 
the essential oils are responsible for the inhibitory effect on biofilm formation and biofilm 
breakdown activity. Many plant essential oils, which are mixtures of numerous organic chemicals, 
contain compounds that inhibit microbial growth. Some anti-microbial agents at sub-inhibitory 
concentrations could influence bacterial virulence factors, such as adherence, cell surface 
hydrophobicity, biofilm formation, sensitivity to oxidative stress and motility (Cowan, 1999; 
Nadoushani et al., 2010).  
 
Essential oils, which are mixtures of numerous organic chemicals, are biosynthesized by plants and 
their anti-microbial properties, their constituents and their mechanism of action have been 
extensively studied (Bagamboula et al., 2004). Phenolic compounds such as eugenol and 
cinnamaldehyde are present in essential oils of many plants and are proved to be active against 
many pathogenic bacteria and fungi (Suresh et al., 1992; Pacheco et al., 1993; Ooi et al., 2006; Chami 
et al., 2004; Bennis et al. 2004).  
 
From this study we found out that cinnamon and massoia oils possess the anti-bacterial and anti-
biofilm activity against the studied microorganisms. It is very likely that different compounds within 
the essential oils are responsible for the inhibitory effect on biofilm formation and biofilm 
breakdown activity. Many plant essential oils, which are mixtures of numerous organic chemicals, 
contain compounds that inhibit microbial growth. Some anti-microbial agents at sub-inhibitory 
concentrations could influence bacterial virulence factors, such as adherence, cell surface 
hydrophobicity, biofilm formation, sensitivity to oxidative stress and motility (Cowan et al., 1999; 
Bennis et al., 2004). 
 
C. burmannii and M. aromatica are a rare plant species that grow in Indonesia. Massoia plants 
grown in Indonesia, especially in Maluku and Papua. Wood and bark of Massoia contains oil which 
has a distinctive sweet coconut fragrance that has been traded for centuries. M. aromatica has a 
long history to be used as a traditional medicine (Rali et al., 2007).  Canoes made from this tree resist 
insect and fungal predation that might be due to its anti-fungal properties (Suresh et al., 1992).  
Massoia lactone, the major compound in Massoia oil, is a rare essential oil component in nature 
that was first characterized by Abe in 1937 (Pacheco et al., 1993). Widely used as a 
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natural coconut flavouring, natural massoia lactone has been largely superseded by a synthetic 
alternative because the extraction process is expensive and the tree is killed during the process of 
removing the bark (Ooi et al., 2006). 
 
C. burmannii also known as Indonesian cinnamon, is distributed in Southeast Asia and is cultivated in 
parts of Indonesia and Philippines. The dried bark of the plant is found in the market in the form of 
rolls and quills, which is used for cooking and flavoring. The dried inner bark of the plant is used as 
flavoring agent in foods, beverages, chewing gums, etc. The distilled bark oil and the oleoresin of the 
bark of the plant are used in soap and perfume manufacturing. The powdered bark is also used in 
traditional medicine (Nadoushani et al., 2010; Suresh et al., 1992; Chami et al., 2004). 
 
Up to now, there is no information in the literature regarding the influence of sub-PMIC essential oils 
of M. aromatica Becc. on inhibition and breakdown of P. aeruginosa PAO1 and S. aureus Cowan I 
biofilm. However, a study has been conducted on activity of cinnamaldehyde, the main compound of 
C. burmannii Nees ex Bl. essential oil, against S. aureus biofilm (Jia et al., 2011).  
 
Jia et al. (2011) showed that cinnamaldehyde was able to kill S. aureus and detach existing biofilms. 
Also it was found that the expression of sarA, encoding a staphylococcal accessory regulator which is  
a central regulatory element that controls the production of virulence factors and is essential for 
biofilm development of S. aureus, was decreased upon exposure to sub-PMICs of cinnamaldehyde. 
 
In the quantification measurement of (static) biofilms, crystal violet (CV) staining has been widely 
used as a indirect methods with 96-well microtiter plates (Burt, 2004; Mastelic et al., 2005).  The 
major disadvantage is that CV, a basic dye which binds to negatively charged surface molecules and 
polysaccharides in the extracellular matrix, stains both living and dead cells. Therefore it is difficult 
to evaluate killing of biofilm cells (Burton et al., 2007).  
 
In order to gain a clear view about the effect of essential oils on P. aeruginosa and S. aureus biofilm, 
the Live/Dead staining was performed and viewed using CLSM. Examining the permeability of a 
compound through biofilms using CLSM and Live/Dead staining capable to show the dead organisms 
which are differentiated from the live ones with the respective labeling of SYTO9 and propidium 




We observed inhibiting activity on biofilm formation when we inoculate the biofilm together with 
the essential oils using concentration lower than concentration for 50% inhibition of planktonic 
growth (0.01 - 0.12 % v/v). We found that the essential oil activity against the biofilm formation was 
concentration dependent. In the presence of the oil, biofilms of both bacterial tested was poorly 
developed and most of the cells were eventually killed (Table 4).  
 
The concentration of plant essential oils needed to degrade preformed biofilms was higher than the 
one needed to inhibit the initial attachment. The reduced susceptibility of bacteria in biofilms is 
thought to be due to a combination of several factors such as the presence of extracellular polymer 
substances (EPS) surrounding the biofilm cells. The anti-microbial agents is absorbed onto the EPS 
and effectively diluted in its concentration before it reaches the individual cells in the biofilm 
(Peeters et al., 2008; Takenaka et al., 2001). 
 
The cinnamaldehyde and eugenol in the C. burnamii essential oil has been proven to have anti-
bacterial and anti-fungal activity (Ooi et al., 2006).  These two compounds and massoia lactone as 
the main compound of M. aromatica essential oil might have an influence in inhibiting biofilm 




According to the findings of this study, the essential oils of M. aromatica and C. burmannii have anti-
biofilm formation and biofilm breakdown activity against P. aeruginosa PAO1 and S. aureus Cowan I. 
The present study suggests that the essential oils of these plants are a potential source of natural 
anti-biofilm agents. After this screening process, further work on phytochemical characterization will 
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The emerging resistance to anti-fungal agents encourage the exploration of new and effective 
natural product showing anti-fungal activity to significantly impact the treatment and the 
management of biofilm associated fungal infections. Essential oils which are mixture of multiple 
heterogenous compounds can exhibit anticandida activity because many essential oils are capable to 
disrupt fungal cell membranes with their lipophilic compounds. The aim of this study is to find a 
possible source of new anti-fungal for the treatment of C. albicans biofilms from Indonesian 
medicinal and spices plant essential oils. Essential oils from collected plants were obtained by water-
steam distillation process. The susceptibility of the oils against C. albicans planktonic cells were 
determined using microdilution method. Microtiter plates method was used to test for the anti-
biofilm activity. Effect of essential oil on C. albicans biofilm architecture was assessed using Confocal 
Laser Scanning Microscopy (CLSM) along with LIVE/DEAD staining. ANOVA and Dunnett’s test using 
SPSS19 is used for statistical analysis. Differences were considered significant with P-values of 0.05 
or less. Our study revealed that the essential oil from Cinnamum burmannii, Massoia aromatica, 
Ocimum basilicum and oil from the seeds part of Litsea cubeba showed an evident anti-fungal 
activity against planktonic growth of C. albicans, inhibited the formation of C. albicans biofilm and 
demonstrated the efficacy in disrupting C. albicans established biofilm at a sub-PMIC concentration. 
We conclude that the oils from C. burmannii, M. aromatica, O. basilicum and the seeds of L. cubeba  
are an interesting sources of innovative plant derived anti-fungal agents, thus can be used in the 
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Candida is a common commensal fungus of humans and has been shown to be the third most 
commonly isolated bloodstream pathogen from US hospitals, now surpassing gram-negative rods in 
frequency (Ramage et al., 2001). They can convert to an opportunistic pathogen causing superficial 
infections through the invasion of oral and vaginal epithelial surfaces. Candida also causing lethal 
systemic infections in susceptible host including neonates, individual who are immunocompromised 
or otherwise compromised by severe underlying disease, surgery or hospitalization, through 
dissemination in the bloodstream and invasion of internal organs (Shapiro et al., 2011; Bandara et 
al., 2009). 
 
Candida albicans is known as the most common causal agent of invasive candidiasis, and a major 
fungal pathogen responsible for the majority of nosocomial infections (Ramage et al., 2001). The 
capacity of C. albicans to cause disease is closely associated with its ability to grow as biofilm 
communities by adhere both to cellular and inanimate surfaces of implanted devices such as 
catheters, prostetic cardiac valves, contact lenses, artificial joints and intraurine devices (IUDs) (Kojic 
and Darouiche, 2004; Lal et al., 2008).  
 
The majority of microorganisms grow in biofilms instead of planktonic (floating) state. They adhere 
to a wide variety of surfaces in all nutrient-sufficient aquatic ecosystems except deep ground water 
and abyssal oceans (Donlan and Costerton, 2002; Costerton et al., 1995). Candida albicans biofilm 
development occurs in three phases. The early (adherence) phase consists of budding-yeast cells 
which are adhered to the substratum. The attached cells proliferate to form microcolonies and begin 
to deposit extracellular matrix. Dimorphic switching occurred with a transition of the yeast cells 
forms to pseudo-filamentous and true hyphal forms, and microcolonies became interlinked by the 
hyphal extensions, forming a confluent monolayer. The complexity of the biofilm increased with the 
time and after 24 h, C. albicans biofilm consisted of a mixture of yeast cells, pseudohyphae and true 
hyphae (Jabra-Rizk, 2004). 
 
Microorganisms involved in biofilms are generally more resistant to anti-microbials than single cell 
planktonic microorganism and also against the defense mechanism of the host. This fact makes them 
a progressive source of infections (Donlan and Costerton, 2002). Although the mechanisms of the 
drug resistance of Candida biofilms are still poorly understood, the action of anti-fungal may be 
limited by their penetration and chemical reaction into biofilm matrix (Agarwal, 2007). Besides this, 
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biofilm heterogeneity is thought to be a contributing factor for the drug resistance phenomenon. 
Biofilm communities develop differential gradients in nutrients and metabolic waste, so that groups 
of cells in the same biofilm react variably in response to environmental cues, leading to a variety of 
phenotypes (Jin et al., 2005).  
 
The emerging resistance to anti-fungal agents encourages the exploration of new and effective 
natural product showing anti-fungal activity to significantly impact the treatment and the 
management of biofilm associated fungal infections. Secondary plant metabolites such as essential 
oils which are mixture of multiple heterogenous compounds can exhibit anticandida activity because 
many essential oils are capable to disrupt fungal cell membranes with their lipophilic compounds 
(Pires et al., 2011).  
 
The present study aimed to find a possible source of new anti-fungal for the treatment of C. albicans 
biofilms. We compared the anti-fungal activity of several Indonesian medicinal and spices plant 
essential oils against planktonic cells of C. albicans. We also investigated anti-biofilm properties of 
the essential oils that demonstrated anticandida activity against planktonic cells. The Candida 
biofilm architecture in the presence or absence of the essential oil also observed using confocal laser 
scanning microscope (CLSM) to gain better information of the essential oil effect on Candida biofilm. 
 
MATERIALS AND METHODS 
Fungal isolate and culture conditions 
Candida albicans ATCC 10231 was cultured in Sabouraud Dextrose Broth (SDB) and incubated for 24 
h at 30˚C with agitation (120 rpm). Following incubation, cells were sedimented by centrifugation 
(5000 x g for 15 min at 4˚C), washed twice with 5 mL of sterile PBS (phosphate buffered saline) 
buffer pH 7.2, and finally suspended to 107 CFU/mL by adjusting the optical density of the 
suspension to 0.38 at 520 nm. This cell concentration was selected because previous workers have 
demonstrated that optimal biofilm formation occurs at this particular density (Kuhn et al., 2002; 
Kruppa, 2009). Densities that are too high or too low result in poorly formed biofilms (Pierce et al., 
2008; Chandra et al., 2008). 
 
Medicinal plants and essential oil extraction 
A list of the plants studied, including the botanical name, voucher specimen and data related to 
traditional use are listed in Table 1, Chapter 3 this thesis. The plant samples were collected from 
Yogyakarta, Central Java and its surroundings, and the bark of Massoia aromatica Becc. was 
collected from Nabire district, West Papua, Indonesia, on the basis of ethnopharmacological 
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information. The species were identified, authenticated, and the voucher specimens were preserved 
in Department of Pharmaceutical Biology, Faculty of Pharmacy, Gadjah Mada University, Yogyakarta, 
Indonesia for further reference. From the collected plants, a total of 29 essential oils were obtained 
by water-steam distillation process. Oil samples obtained were dried over anhydrous sodium sulfate 
(Na2SO4), filtered using a Whatman filter paper no. 40, and stored in sealed dark glass vial at 4°C for 
further use.  
 
Determination of planktonic minimum inhibitory concentration (PMIC) of plant oils 
Minimum Inhibitory concentration (MIC) of plant essential oils against C. albicans planktonic cells 
(PMIC) were determined using microdilution method measured by optical density. The PMIC assays 
were performed in triplicate in microtiter plates and used an inoculum of 5 x 107 CFU/mL in SDB. The 
final volume including SDB, cells and test compound in each well was 200 µL. The assay of plant 
essential oils involved in five serial, twofold dilutions using SDB, starting at 1% v/v and ending at 
0.06% v/v in methanol. As positive control, fluconazole with concentration of 1 mg/mL in Dimethyl 
sulfoxide (DMSO) was used. Negative control wells received only SDB and C. albicans inoculum. 
Inhibition was monitored and calculated based on OD595 of treated vs control after 48 hours of 
incubation at 37°C (Faria et al., 2011). 
 
Effect of plant essential oils on C. albicans biofilm formation inhibition and breakdown 
Biofilms were formed on polystyrene flat bottom 96-well microtiter plates (Sarstedt Inc., Newton, 
NC, USA). Briefly, 100 µL of a standardized cell suspension (107 CFU/mL) on RPMI 1640 medium 
without sodium bicarbonate supplemented with L-glutamine (Sigma) was transferred into each well 
of a microtiter plate, and the plate was incubated for 90 minutes at 37 ˚C of adhesion phase. RPMI 
1640 medium was used because this medium capable to induce hyphal formation in C. albicans. For 
media control, wells should be unseeded, and in negative control, biofilms were not exposed to 
antifungal agent. Following the adhesion phase, the cell suspensions were aspirated and each wells 
was washed twice with 150 µL of PBS to remove loosely adhered cells. A total of 100 µl RPMI media 
containing concentration of plant oils ranging from 0.5 % v/v to 0.01 % v/v were added to the 
washed wells. Fluconazole concentration of 1 mg/mL was used as a positive control in this study, and 
methanol (MeOH) was used for vehicle control. The plates were then incubated at 37˚C for 8 hours 
for early phase biofilm, 24 hours for intermediate phase biofilm and 48 hours for mature phase 
biofilm. Quantification of biofilm formed was done using XTT reduction assay using microtiter plate 
reader (Bio-Rad 680 XR) at 495 nm. Testing was performed in triplicate. Plant oils found to reduce at 
least 50% biofilm formation were considered as biofilm preventive (Ramage et al., 2002). 
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To determine the effects of essential oils on C. albicans pre-formed biofilms, C. albicans biofilms 
were grown for 8, 24, and 48 h at 37˚C on the wells of microtiter plates using the protocol described 
by Ramage et al. (2002). Briefly, 100 µL of a standardized cell suspension (107 CFU/mL) on RPMI 
1640 medium without sodium bicarbonate supplemented with L-glutamine (Sigma) was transferred 
into each well of a  microtiter plate, and the plate was incubated for 8, 24 and 48 hours at 37˚C. 
Following biofilm formation, the medium was aspirated and nonadherent cells were removed by 
washing the biofilms three times in 150 µL sterile PBS per well. After each wash, residual PBS was 
removed by blotting the microtiter plates in an inverted position with paper towels. Serial double 
dilutions of plant essential oils (in RPMI 1640 medium) with concentrations ranged from 0.5 % v/v to 
0.01 % v/v were then added to the washed wells and the plates were incubated at 37˚C for another 
8, 24, and 48 h. The capability of plant essential oils to breakdown C. albicans established biofilms 
were estimated using the XTT reduction assay as describes below.  
 
XTT (2,3-bis-(2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-carboxanilide) (Sigma) solution (0.5 
g liter-1 PBS) was prepared, filter-sterilized using a 22-μm pore size filter, aliquot into 10 mL working 
volumes, and stored at -70˚C. A stock solution of 10 mM menadione (Sigma) in 100% acetone was 
prepared, filter sterilized, aliquout into smaller volume (about 50 μL) and stored at -70˚C. Prior to 
each assay, tubes containing 10 mL XTT solution were thawed and 1 µL of the stock  solution of 
menadione was ad 
 
The biofilm were first washed three times with 200 µl PBS, and then 100 µL of the XTT-menadione 
solution were added to each of the prewashed wells. The microtiter plate was then covered with 
aluminium foil and incubated in the dark for 2-3 h at 37˚C. Following incubation, 75-80 μL of the 
resulting colored supernatant from each wells was transferred to a new microtiter plate and the 
color change in the solution was measured with a microtiter plate reader at 495 nm. The absorbance 
values for the media controls were substracted from the values for the test wells to calculate the 
minimum biofilm inhibitory concentration (MBIC) and minimum biofilm eradication concentration 
(MBEC). MBIC50 and MBEC50 is the antifungal concentrations at which a 50% decrease in absorbance 
is detected in comparison with the control biofilms formed by the fungal isolate in the absence of 
antifungal drug (Pierce et al., 2008).  
 
C. albicans biofilm architecture analyses 
A Carl Zeiss LSM 5 Exciter Laser Scanning Confocal Microscope (Leica Microsystems, Germany) was 
used to observe the architecture of the C. albicans biofilms in the presence or absence of essential 
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oils tested. To obtained information about the effect of oil on Candida biofilm formation, Candida 
biofilms were formed by dispensing standardized cell suspension (3 ml of a suspension containing 
1.0 x 107 cells/mL in LB medium) onto 25 mm diameter pre-sterilized plastic coverslips (Thermanox; 
Nulge Nunc International) placed in the wells of pre-sterilized flat bottomed six-well plates (Iwaki). 
The plate was incubated at 37˚C for 90 minutes (adherent phase). Following incubation period, the 
supernatant was removed and a total of 3 mL RPMI medium containing different concentrations of 
plant oils were added to the washed wells. The plate then incubated for 8 h (early phase), 24 h 
(intermediate phase), and 48 h (mature phase) at 37˚C. To obtained information about the efficacy 
of oil on breaking down the established biofilm, C. albicans biofilm were formed for 8, 24, and 48 h 
on 25 mm diameter pre-sterilized plastic-coverslips (Thermanox; Nulge Nunc International) placed in 
the bottom of 6 wells microtiter plate. Following incubation period, the supernatant was removed 
and a total of 3 mL RPMI medium containing different concentrations of plant oils were added to the 
washed wells. The plate then incubated for 8, 24, and 48 h at 37˚C.  
 
The coverslips then were washed twice with PBS and stained using the LIVE/DEAD fluorescent stain  
(10 µL of 3.34 µM SYTO9 and 10 µL of 20 µM Propidium Iodide (PI) both in DMSO) (Molecular 
Probes, USA) before examined under CLSM. Serial sections in the xy plane were obtained at 1 μm 
intervals along the z axis. A 40× oil immersion objective were used with 488 nm Ar laser excitation 
and 500–640 nm band pass emission setting. The image were subsequently analysed using  the 
freely available image processing software ImageJ version 1.46 (Rasband, National  Institutes of 
Health (NIH),  Bethesda, Maryland, USA : http://rsb.info.nih.gov/ij/) including the LSM reader plugin 
to open LSM5 formatted image stack  created by the microscope software. The images' scale bar 
used to calibrate the ImageJ area measurement algorithm. The observations were made in 
triplicates and representative images are presented here (Ramage et al., 2001; Dusane et al., 2012; 
Jin et al., 2005). 
 
Statistical methods 
The data were initially analyzed by a normal distribution using the one-sample Kolmogorov-Smirnov 
test. Following the confirmation of normal distribution, statistical significance of the data were 
determined using one way ANOVA, followed by Dunnett’s test. Differences were considered 







Essential oil yields 
Oil yields of the plant samples is presented in Table 1. Most plants had oil yield around 0.25-2.5 % 
v/w, and largest quantity of oil was obtained from leaves part of Litsea cubeba (6 % v/w). 
 
Screening and determination of MIC plant oils for Candida planktonic growth 
The screening for anticandida activity and determination of PMIC of plant oils obtained by 
microdilution method are shown in Table 1 and Figure 1. Majority of oils tested were found to have 
anticandida activity and only three of the oils (Piper cubeba, Schleichera oleosa and Cananga 
odoratum) were found failed to inhibit C. albicans growth at the highest concentration tested which 
was 1 % v/v. From probit analysis, we calculated the PMIC50. The oil from C. burmannii, M. 
aromatica, O. basilicum and the seeds of L. cubeba at lowest concentration tested (0.06 % v/v) were 
effective at inhibiting partial (50%) growth (PMIC50) of C. albicans. C. burmanii oil has PMIC50 at oil 
concentration of 0.04 % v/v. M. aromatica oil and L. cubeba (seeds part), gave PMIC50 at 
concentration of 0.05 % v/v, whereas O. basilicum oil showed PMIC50 at concentration of 0.06 % v/v. 
 
 
Fig. 1: Comparison of anticandida activity of various essential oils: Ma = M. aromatica; Cb = C. 
burmannii;  Ob = O. basilicum;  Lc – s = L. cubeba seeds; N = Negative control;   M = Methanol 1% 
v/v; F = Fluconazole 1 mg/mL (positive control). The bars indicated the standard deviations of the 




















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Effect of plant essential oils on C. albicans biofilm formation and established biofilm 
C. albicans biofilm formation proceeds through three distinct developmental phases: early or 
adherence period (0 - 11 h), intermediate (12 – 30 h), and mature (38 – 72 h) (Jabra-Rizk, et al., 
2004). Plant essential oils at concentrations of 0.5% - 0.01% v/v were tested against C. albicans 
adherent cells populations at different stages of biofilm development. XTT assay was performed to 
determine the metabolic activity of C. albicans biofilms in the presence or absence of the oils tested. 
 
The result of this experiment is shown in Table 2, demonstrated that partial (50%) inhibition of C. 
albicans early, intermediate and mature biofilms occurred in the presence of oils tested except for Z. 
aromaticum, E. cardamomum, C. domestica, C. heyneana, M. fragrans, P. retrofractum and P. 
nigrum oil which were failed to prevent C. albicans biofilm formation at the highest concentration 
tested (0.5 % v/v). 
 
Only 4 from 29 essential oils tested showed capability in both inhibiting and breaking down C. 
albicans biofilms, i,e. C. burmannii oil, M. aromatica oil, O. basilicum oil and the oil from seeds part 
of L. cubeba. The oils from the bark of C. burmannii and M. aromatica exhibited the MBIC50 at 
concentration below 0.01 % v/v in order to inhibit early and intermediate phase of C. albicans 
biofilm, however higher concentration of these oils (0.03% v/v) needed to give 50% inhibition of the 
C. albicans mature biofilm (Figure 2). At concentration 0.01 % v/v, the metabolic activity of 
intermediate phase (24 hours) C. albicans biofilm in the presence of C. burmannii was 41.2 ± 0.5 % 
(P<0.001), while M. aromatica oil addition to the media for C. albicans biofilm formation capable to 
reduce metabolic activity of C. albicans intermediate biofilm up to 35.6 ± 0.5 % (P<0.001).  
 
Compare to C. burmani and M. aromatica oils, the oil obtained from O. basilicum and the seeds of L. 
cubeba showed less potent activity in inhibit intermediate and mature phase of C. albicans biofilm. 
Higher concentration (0.03 and 0.06% v/v) was needed by these oils to inhibit intermediate and 
mature phase of C. albicans biofilm (Figure 2). The metabolic activity of a 24 hours C. albicans biofilm 
in the presence of O. basilicum oil at concentration of 0.03 % v/v was 43.1±0.4 % (P<0.001), whereas 
in the presence of L. cubeba oil concentration of 0.03 % v/v, the metabolic activity of C. albicans 
intermediate biofilm was 47.9±0.4 % (P<0.001) accordingly. Higher concentration (0.03 and 0.06% 
v/v) were needed by C. burmani and  M. aromatica oils (0.03 % v/v), and by O. basilicum and L. 




In order to eradicate the established biofilm, higher concentrations of essential oils were needed. As 
shown in figure 2, the oils from the bark of C. burmannii and M. aromatica showed capability in 
partial disrupting (50%)  the early and  intermediate phase of established Candida biofilm at 
concentration of 0.03, meanwhile against mature phase of C. albicans established biofilm, those oils 
were shown activity in partially reducing biofilm at higher concentration (0.06%). In the presence of 
C. burmannii oil at a concentration of 0.06 % v/v, the metabolic activity of mature phase preformed 
biofilm of C. albicans was 48.4±0.7 % (P<0.01), while in the presence of Massoia oil at the same 
concentration, metabolic activity of  48 hours C. albicans biofilm was 43.7±0.5 % (P<0.01), 
respectively (Figure 2). 
 
Higher concentration (0.12 % v/v) was also needed by the oil from O. basilicum and L. cubeba to be 
able to breakdown C. albicans mature biofilm. In the presence of concentration of 0.12 % v/v  L. 
cubeba oil, mature phase preformed biofilm of C. albicans metaboilic activity was 35.6±0.4% 
(P<0.001), while metabolic activity of  mature phase C. albicans biofilm in the presence of O. 
basilicum oil at concentration 0f 0.12 % v/v was 34.4±0.7 % (P<0.001), respectively (Figure 3).  
 
 
Biofilm architecture analyses 
The antibiofilm activity of plant essential oils tested in microtiter plate using XTT method was 
confirmed by CLSM analysis of C. albicans biofilm. The biofilms were grown on the surface of 
coverslips and stained with SYTO9 and PI for the monitoring of live/dead cells. We observed a 
preventive activity on biofilm formation, when we inoculated C. albicans with different 
concentration of C. burmannii, M. aromatica, O. basilicum and L. cubeba oil tested. Growth 
suppression of C. albicans biofilm by essential oils was clearly seen by CLSM with the Live/Dead 
stain, compared with the dense biofilm growth of the control (Figure 4).   
 
The architecture of C. albicans biofilm in the presence of tested oils in biofilm formation inhibition 
and biofilm breakdown assays were showed in Figure 5-8.  The estimated three-dimensional view of 
the biofilm refers to the total area in the x-y-z dimension, where x and y are the coordinates of the 
pixel positioning and z is the intensity collected using ImageJ. Live cells are labeled in green (SYT09), 























































































































































































































































































































































































































































































Propidium iodide (PI) is a non-permeant fluorescent nucleic acid stain that enters dead/nonviable 
cells by binding to double-stranded nucleic acids through intercalation between base pairs with no 
preference to purine or pyrimidine base pairs. Figure 4 shows intense green fluorescence resulting 
from membrane permeant Syto9 binding to DNA of C. albicans intact cells while PI stains the cells 
red. Thus, areas of red fluorescence represent dead cells, and green fluorescent indicates healthy 
cells. The yellow color (formed as a result of overlapping of red and green images which were 
representative of SYTO9 and PI colocalization due to the presence of dead cells or eDNA, a DNA 
which is present in all environments as a source of organic nutrients and provide structural support 
for biofilm matrix.  
 
The result of this experiment, as assessed by colorimetric assay and microscopy, demonstrated that 
negative control (biofilm formed in the absence of essential oil) exhibited typical biofilm 
architecture. At early phase of biofilm development, C. albicans biofilm was found to be mainly 
composed of yeast cells. Elongated pseudohyphae and hyphae were found at intermediate phase of 
C. albicans biofilm, and at mature phase biofilms composed mainly of intertwining mycelial 
structures, and a basal layer of blastospores (Figure 4).  
 
Pretreatment of C. albicans biofilm with various essential oil concentrations showed that there was a 
dose-dependent effect on biofilm formation. CLSM study shows that the number of viable cells 
(green) decreased when the concentration of extract exposed increased. Figure 5-8 showed that in 
the presence of essential oils tested (concentration of 0.03% v/v), a significant decrease of C. 
albicans biofilm biomass compare to negative control was evident. Preincubation of biofilm with the 
concentration of essential oil equal to PMIC90 prevented successful germination of the adherent 
yeast cell, resulting in nonexistent biofilm (data not shown). When the concentration was decreased, 
pseudohyphae and mycelia were observed. The antibiofilm activity thus may be due to the 
antifungal activity of the essential oils. 
 
An interesting antibiofilm effect was determined against 2 h and 24 h old biofilm by using C. 
burmannii, M. aromatica, O. basilicum and L. cubeba (seeds part) essential oils, which are found to 
be the most potential source to inhibit C. albicans biofilm. Our results clearly demonstrate that 
essential oil of  C. burmannii, M. aromatica, O. basilicum and L. cubeba (seeds part)  not only able to 
kill C. albicans cells efficiently (PMIC50 ≤ 0.06% v/v), but also inhibit biofilm formation at sub-PMIC 
concentration. At the lowest concentration tested (0.01% v/v), essential oil of C. burmannii, M. 
aromatica and O. basilicum were still capable to inhibit 50% the formation of early phase C. albicans 
 
 123 
biofilm. However, as shown in Figure 5 and 7, the same concentration of oils was found failed to 
exhibit 50% inhibition of C. albicans mature (48 h) biofilm formation as the treated biofilms 
displayed minor defects in the overall biofilm architecture compare to the control biofilm.  
 
As can be seen in figure 6 and 8, CLSM images revealed that exposure of C. burmannii, M. aromatica, 
O. basilicum and L. cubeba (seeds part) essential oil could eradicate the established C. albicans 
biofilm, however higher concentration needed to breakdown the established biofilm compare to the 
concentration needed to disturb the biofilm formation. The concentration of oils tested required to 
remove 50% mature phase of C. albicans established biofilm mass were two-four times higher than 
those needed for breaking down intermediate phase established biofilm. 
 
 
Fig. 4: Representative confocal scanning micrograph images of negative control Candida albicans 
biofilm obtained from biofilm formation inhibition assay and biofilm breakdown assay. A: 









Fig. 5:  Representative confocal scanning micrograph images of biofilm inhibition activity of 
Massoia aromatica and Cinnamomum burmannii essential oil at concentration of 0.03 and 0.01 % 
v/v against Candida albicans. A: projected upper view of the biofilm, B: estimated three-




Fig. 6: Representative confocal scanning micrograph images of biofilm breakdown activity of 
Massoia aromatica and Cinnamomum burmannii essential oil at concentration of 0.03 and 0.01 % 
v/v against Candida albicans established biofilm. A: projected upper view of the biofilm, B: 




Fig 7. Representative confocal scanning micrograph images of biofilm inhibition activity of Ocimum 
basilicum and Litsea cubeba (seeds) essential oil at concentration of 0.03 and 0.01 % v/v against 
Candida albicans established biofilm. A: projected upper view of the biofilm, B: estimated three-




Fig. 8: Representative confocal scanning micrograph images of biofilm breakdown activity of 
Ocimum basilicum and Litsea cubeba (seeds) essential oil at concentration of 0.03 and 0.01 % v/v 
against Candida albicans established biofilm. A: projected upper view of the biofilm, B: estimated 




The chemical compositions of C. burmannii and M. aromatica bark, O. basilicum leaves and L. cubeba 
seeds essential oils determined using GC-MS are shown in Table 2. A total of three major compounds 
were identified in C. burmannii oil, 2 major compounds were identified in M. aromatica oil, 6 major 
compounds were identified from L. cubeba seed oil and five major compounds were identified from 
O. basilicum oil. Cinnamaldehyde (92.0%) was found to be main compound of C. burmannii oil and 
massoia lactone (92.1 %) was found to be the major consituent of M. aromatica oil. Among six major 
identified compounds found in oil of L. cubeba seed, citronella (41.3%) was found to be the most 
abundant compound followed by limonene (23.5%), whereas 2,6-Octadienal, 3,7-dimethyl-, (E)-(CAS) 
Geranial (36.3 %) and Z-citral (29.2 %) were found to be major compounds in O. basilicum oil.  
 
DISCUSSION 
C. albicans is a major human fungal pathogen, since its capable of invading deep tissue and organs, 
superficial sites such as skin, nails and mucosa. Like many other microbial organisms, C. albicans is 
capable to adhere to and colonize surfaces of medical devices, resulting in the development of a 
biofilm. The increasing incidence of C. albicans biofilm infections raises the urgent need for new 
antibiofilm agent, as the number of therapeutic options for Candida biofilm-related disease is very 
small. The discovery of antiinfective agents, which are not only against planktonic microorganisms 
but also against microbial biofilms, represents an important goal. Plant materials are 
important sources of starting materials for bioactive compounds in drug discovery, and many of 
them exhibit potent activity against fungal pathogen (Tsang et al., 2012).  
 
In this study we evaluated the effect of essential oils on various stages of in vitro C. albicans biofilm 
development. Our result indicated that essential oil of C. burmannii, M. aromatica, O. basilicum and 
L. cubeba (seeds part) have significant effect on the adhesion of C. albicans to polystyrene surfaces. 
Established C. albicans biofilms formed in polystyrene surface were effectively disturbed by the 
exposure of essential oils tested, athough higher concentration of oils needed to breakdown the 
already established biofilm. The reduced antibiofilm activity towards the established biofilm proved 
that cells within the biofilm are more resistant to antimicrobial agents compare to planktonic cells 





































































































































































CLSM was employed as a qualitative analytical tool to refeal the architecture of C. albicans biofilm in the 
presence or absence of essential oils tested. CLSM images confirmed the inhibition of biofilm formation 
and breakdown of biofilm biomass in the presence of essential oils. Microbial cells within the biofilm are 
protected by extracellular polymeric substances (EPS) composed mainly by proteins, glycoconjugates, 
and polysaccharides. EPS is secreted by microorganisms to their environment, and provide a barrier to 
the diffusion of antimicrobials and thus, limit the access of drugs to the cells deep in the biofilm (Baillie 
and Douglas, 2000). Since many antimicrobial agents fail to penetrate extracellular polymeric substances 
(EPS) biofilm which protect the microbial cells within, the use of compounds which capable to degrade 
the EPS biofilm become  a worthwhile alternative to consider (Walker et al., 2007). Deprivation of 
microbial adherence and biofilm formation without disturbing bacterial growth is a characteristic of 
antipathogenic therapies which become an alternative to combat microbial resistance to known 
antimicrobial agents (Escaich, 2008). 
C. burmannii, M. aromatica, O. basilicum and L. cubeba are ones among Indonesian plants which are 
used in food not only to enhance flavor and fragrance qualities and appetizing effects but also for their 
preservation.  We determined the compositions of C. burmannii, M. aromatica, O. basilicum and L. 
cubeba seeds essential oils using GCMS. It has been shown that C. burmannii oil contains 
cynnamaldehyde as major compounds, whereas massoialactone was found to be the major compound 
of M. aromatica oil. Citronella and limonene is reportedly detected as main constituent of L. cubeba 
seed oil geranial and z-citral were found to be major compounds in O. basilicum oil.  
According to Khan and Ahmad (2012), cynnamaldehyde possesses antifungal and antibiofilm activity 
against C. albicans. Study taken by Kim and Park (2012) and Mesa-Arango et al. (2009) showed that 
geranial and citral have antifungal activity against Candida and Aspergillus. Previous studies also 
reported that limonene and citronelal possess antifungal activity (Agarwal et al., 2008; Chee et al., 2009; 
Li et al., 2013).  
The possible mechanism of an active compound(s) to attenuate the development of a biofilm, or to 
breakdown a mature biofilm, may be due to the the compound(s) capability to disturb microorganism’s 
quorum sensing (Manefield et al., 1999), disrupt the permeability or to modify the hydrophobicity of 
microbial membrane structures (Cox et al., 2000), or to break the extracellular polymeric matrix in the 
biofilm to release biofilm from the surface of the solid substratum (Traba and Liang, 2011).  
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Although Khan and Ahmad (2012) already reported that cynnamaldehyde, the major components of C. 
burmannii essential oil posesses antibiofilm activity against C. albicans biofilm, in our knowledge the 
essential oil of M. aromatica, O. basilicum and L. cubeba (seeds part) have not previously been tested as 
C. albicans antibiofilm agents. The efficacy of these essential oils should be considered as an important 
factor in evaluating them as an interesting source of innovative plant derived antifungal agents that can 
be used in the development of new strategies to treat biofilms of medical relevance. Further studies 
would be required to isolate, identify and characterize the active compounds responsible for the 
observed antibiofilm activity.  
 
CONCLUSION 
In conclusion, the finding from this study conclusively demonstrated the in vitro antifungal and 
antibiofilm activity of C. burmannii, M. aromatica, O. basilicum and L. cubeba (seeds part) essential oil 
against C. albicans. This study highlights the significance of essential oils in producing novel antibiofilm 
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Targeting the quorum sensing system and interrupting bacterial communication, is an example of an 
anti-pathogenic effect and may provide a solution to increasing antibiotic resistance. The use of plants 
as medicine in Indonesia has always been a tradition. Previous anti-infective studies on Indonesian 
medicinal plants have focused mainly on anti-microbial drug discovery perspectives. However, no 
systemic effort has been made to explore the anti-quorum sensing activity of these plants. Our objective 
is to investigate several Indonesian medicinal plants’ ethanol extracts and essential oils on anti-quorum 
sensing activity using a quorum sensing violacein biosensor, Chromobacterium violaceum CV026. Also 
the effect of extracts and essential oils on the motility of Pseudomonas aeruginosa PAO1 is of interest, 
since bacterial motility has been shown to be associated with its virulence. Of the 54 plant ethanol 
extracts and 30 essential oils screened, Nymphaea nouchali ethanol extract, Syzygium aromaticum 
essential oil and Massoia aromatica essential oil demonstrated violacein production inhibition in the 
reporter strain. A significant reduction in quorum sensing related motility of P. aeruginosa PAO1 was 
also observed. This screening system forms an interesting potential for the selection of active principles 
from plant ethanol extracts and essential oils.  
 
Keywords : Quorum sensing, Chromobacterium violaceum CV026, motility, Pseudomonas aeruginosa 












Quorum sensing is a process of cell to cell communication in bacteria mediated by a small diffusible 
molecule called autoinducers (oligopeptides in Gram positive and N-acyl homoserine lactone (AHL) in 
Gram negative bacteria). These autoinducers diffuse freely from the bacterial cell and accumulate in the 
surrounding environment. When a threshold concentration (quorum) has been reached they diffuse 
back into the cell and regulate transcription of specific genes as in a response to their changing 
environmental conditions (Waters and Bassler, 2005). Fungi, like bacteria, also use quorum sensing to 
affect population-level behaviors such as biofilm formation and pathogenesis (Hogan, 2006; Nickerson 
et al., 2006; Albuquerque and Casadevall, 2012). In the human commensal and pathogenic fungus 
Candida albicans, two quorum sensing molecules have been described: farnesol and tyrosol (Chen et al., 
2004; Hornby et al., 2001). In Candida albicans, accumulated farnesol and tyrosol affect both 
dimorphism and biofilm formation. As well as in C. albicans, another QS molecules in fungi, 
phenylalanine and tryptophan, were found in Saccharomyces cerevisiae (Albuquerque and Casadevall, 
2012). 
 
Examples of cellular processes modulated by quorum sensing are biofilm formation (McClean et al., 
1997), bioluminescence (Nealson and Hasstings, 2006) and motility (Eberl et al., 1999). These traits have 
also shown to be involved in the pathogenicity of bacteria (Choo et al., 2006). It has been suggested that 
targeting the quorum sensing system by interruption of bacterial communication, instead of killing 
bacteria, is an example of an antipathogenic effect and may give a solution to antibiotics resistance 
(Hentzer and Givskov, 2003). Therefore, anti-quorum sensing (anti-QS) compounds can be of great 
interest in the treatment of bacterial infections (Fuqua et al., 2001; Rice et al., 2005). 
Anti-QS compounds like halogenated furanones produced by the marine alga Delisea pulchra (Manefield 
et al., 1999 have limited or no therapeutic application due to their toxicity and high reactivity on the 
host. Other anti-QS molecules have been found from garlic extract and Penicillium species. During 
screening of 100 extracts from 50 Penicillium species, Rasmussen et al. (2005) found patulin and 
penicillic acid as biologically active QS inhibitor (QSI) compounds. However, patulin is found to be toxic 
and today it is belongs to a list of mycotoxins that level in food is regulated. The US Food and Drug 
Administration (FDA) limits patulin to 50 µg/L (Puel et al., 2010). As well as patulin, penicillin acid also 
belongs to mycotoxin group. It found in many fruits and vegetables, and toxic effects may result from 
the accidental ingestion of the material. Animal experiments indicate that ingestion of less than 40 gram 
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may be fatal or may produce serious damage to the health of the individual (Anonym, 2010). By 
bioassay-guided fractionation of garlic extracts, Jakobsen et al. (2012) determined the primary QS 
inhibitor present in garlic to be ajoene, and the toxicity investigation revealed that ajoene has a very low 
cytotoxicity effects on human epithelium cells. Therefore, the discovery of non-toxic, broad spectrum 
quorum sensing inhibitors is still needed for successful exploitation in inhibiting bacterial 
communication (Choo et al., 2006). 
 
Plants have long been a source of medicines and continues to contribute significantly to the 
development of today’s pharmaceuticals for therapeutics and source of new bioactive compounds 
(Cragg et al., 1997). Indonesia harbors a very high flora of diverse species used in traditional ways as 
medicine (Damayanti et al., 2001). Previous anti-infective studies on Indonesian medicinal plants have 
focused mainly on antimicrobial drug discovery perspectives. However, no systemic effort has been 
made to explore its anti-QS activity. Furthermore, shifting the focus from antibacterial activity to anti-QS 
properties may disclose new quorum quenching compounds (Adonizio et al., 2006). For this reason, 
research in determining anti-QS activity of a compound is generating potential for development of a 
new therapeutic. 
 
Motility of P. aeruginosa in aqueous and dry environments has been shown to be associated with its 
virulence. In the presence of a quorum sensing inhibitory compound, the motility and therefore the 
virulence will be limited (Drake and Montie, 1988; Häse, 2001; Rasmussen et al., 2011; Majik et al., 
2013). Six different forms of bacterial movement have been described including swimming, swarming, 
twitching, gliding, sliding and darting (Henrichsen, 1972). These various forms of surface motility enable 
bacteria to increase their efficiency of nutrient uptake, avoid toxic substances, move to preferred hosts 
and provide access to optimal colonization sites within, and spread themselves into the environment 
(Rashid and Kornberg, 2000). Bacterial motility plays a different role in biofilms. They can promote 
adhesion of the cell to the surface for biofilm maturation process and/or in be involved in the dispersal 
process (Marchal et al., 2010). However, motility is not critical to biofilm formation, which was shown 
for biofilms produced by P. aeruginosa PAO1 mutant strain which is lack flagella and type IV pili (Chow 
et al., 2011). 
 
In this study, we provide the screening result of some commonly used Indonesian medicinal plants for 
anti-QS activity using the quorum sensing violacein biosensor, Chromobacterium violaceum 31532 wild 
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type (WT) strain, C. violaceum CV026 mutant strain, and P. aeruginosa PAO1. The wild type strain C. 
violaceum ATCC 31532 produces a purple pigment, violacein, when AHL molecules reach a threshold 
level, whereas the mutant strain CV026 lacks the ability to produce violacein unless exogenous AHLs are 
detected. We also investigated the correlation of the quorum sensing inhibition in reducing quorum 
sensing related motility of P. aeruginosa PAO1. Swimming, swarming and twitching motility have been 
studied in this research. We have found anti-QS activity in 10 out of 54 plant ethanol extracts and 12 out 
of 29 plant essential oils, with 1 extract and 2 essential oils demonstrating a high anti-quorum sensing 
activity. 
 
MATERIALS AND METHODS 
Bacterial strains and culture conditions 
The bacterial strains used in this study were Chromobacterium violaceum ATCC 31532 wild type (WT) 
strain, C. volaceum CV026 mutant strain and P. aeruginosa PAO1 strain. The C6-homoserine lactone 
(HHL) (Sigma Aldrich, Germany) was dissolved in dimethylsulfoxide (DMSO) and used as autoinducer for 
violacein pigment production in C. violaceum CV026. The bacterial strains were grown on Luria-Bertani 
(LB) Agar and incubated for 24 hours at 30⁰C. Following the incubation on agar plate, the colonies were 
transferred to LB broth and incubated for another 24 hours at 30⁰C with shaking (250 rpm). Cell density 
was adjusted to 108 CFU/mL by altering the optical density of the suspension to 0.1 at 600 nm. 
 
Indonesian medicinal plants  
Fifty four commonly used medicinal plants were collected from Yogyakarta, and its surroundings, and 
the bark of Massoia aromatica Becc. was collected from Nabire district, West Papua, Indonesia,  on the 
basis of ethnopharmacological information. Crude ethanol extracts were prepared by washing and 
cutting the plant samples into small pieces followed by oven drying (40⁰C) for 48-72 hours. The dried 
plant materials were grind into a fine powder. The pulverized materials were soaked in Petroleum Ether 
(PE) in a ratio of 1 g (plant material) : 10 ml PE to remove the lipids. Secondly, plant materials were also 
extracted with 70% ethanol (EtOH) using a ratio of 1 g (plant material) : 10 mL (EtOH) to obtain crude 
ethanol extract. Extracts were dried and concentrated under reduced pressure using a rotary evaporator 
(Ika RV 10 Basic, Ika HB 10, Heidolph). Stock solutions (100 mg/mL) of crude ethanol extracts in the 
excipient DMSO were prepared, filter-sterilized (0.2 µm) and stored at 4oC. A total of 29 essential oils 
were obtained from water-steam distillation process. The oils obtained were dried over anhydrous 
sodium sulphate (Na2SO4), filtered using a Whatman filter paper no. 40, and stored in sealed dark glass 
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vial at 4°C. Stock solutions of 50 % (v/v) essential oils were prepared in methanol (MeOH), for the 
following dilution to obtain essential oil concentration ranging from 1 to 0.01 % v/v. 
 
Screening for anti-quorum sensing assay using disc diffusion method 
Standard disc diffusion assay was used to detect anti-quorum sensing activity of the plant ethanol 
extracts and essential oils. 100 µL of C. violaceum WT strain adjusted to OD600 nm = 0.1 (approximately 1 x 
108 CFU/mL) was spread on LB agar plates. A cork-borer (6 mm in diameter) was used to make wells on 
the agar plates. Each plant ethanol extract (1 mg/mL) in DMSO and essential oil 1% v/v in MeOH was 
loaded in the wells. DMSO concentrations of 1 % v/v and methanol concentration of 1 % v/v were used 
as the background control.  Streptomycin at a concentration of 100 µg/mL was used as positive (growth 
inhibition) control. Bacterial growth inhibition by the plant extracts and essential oils was measured the 
radius (r1) in mm from the obtained halo, while plant extracts and essential oils showing both growth 
and pigment inhibition was measured as radius (r2) in mm. The pigment inhibition was determined by 
substracting bacterial growth inhibition radius (r1) from the total radius (r2) thereby, quorum sensing 
inhibition is r2-r1 in mm, as illustrated in Figure 1 (Zahin et al., 2010). 
 
Fig. 1: Illustration of quorum sensing inhibition diameter measurement on C. violaceum growth on a 
petridish. 
 
Planktonic Minimal Inhibitory Concentration (PMIC) 
Planktonic minimal inhibitory concentrations (PMIC) of plant ethanol extracts and essential oils which 
showed anti-QS activity against C. violaceum WT strain were determined by the broth microdilution test. 
Briefly, LB broth containing two-fold increments of plant extracts and essential oils was added to a 96-
wells plate micro dilution tray. The bacterial suspension equal to a 0.5 McFarland standard was further 
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diluted and added to the tray to achieve a final inoculum of 5×105 CFU/mL per well. Inoculated 96-well 
plates were incubated for 18–24 h at 30 °C. The PMIC50 concentration, i.e.  the extract or oil 
concentration showing 50% growth inhibition on the bacterial tested, was calculated using probit 
analysis. 
 
Quantification of violacein production 
Properly labeled tubes containing: (i) LB broth and HHL; (ii)LB broth, HHL and methanol; (iii) LB broth,  
HHL and different dilutions of essential oils; were used to measure the amount of violacein production. 
100 µL of a bacterial suspension (108 CFU/mL) was added to each tube. Tubes were incubated for 24 
hours at 30⁰C (Table 1).  
 
Table 1: Composition of the tubes for determining cell growth inhibition and antiquorum sensing 
activity. 
 A B C Final 
Concentration 
LB 895 µL 895 µL 895 µL  
CV026 50 µL 50 µL 50 µL 1 x 108 CFU/mL 
HHL 5 µL 5 µL 5 µl 15 µmol/mL 
Ethanol extracts/Essential oils - - 50 µl ½ PMIC 
DMSO/Methanol 50 µL 50 µL - ≤ 1% (v/v) 
Total Volume  1000 µL 1000 µL 1000 µL  
 
After incubation, tubes were centrifuged at 13.000 rpm for 10 minutes to precipitate the insoluble 
violacein. The culture supernatant was discarded and 1 mL of DMSO or MeOH was added to the pellet. 
The solution was vortexed vigorously for 30 seconds to completely solubilize violacein and centrifuged 
at 13.000 rpm for 10 minutes to remove the residue of cells. 200 µL of the violacein containing 
supernatant was added to a 96-well flat bottomed microplate, four wells per each sample and the 
absorbance was measured at 595 nm with a microplate reader (Perkin Elmer’s Enspire® 2300 







Pseudomonas aeruginosa PAO1 motility test 
The plant ethanol extract and essential oils which inhibited violacein production were further tested to 
explore their effects on quorum sensing related swarming, swimming and twitching motility of P. 
aeruginosa PAO1. Swimming, swarming and twitching motility assays were performed by the method of 
Rashid and Kornberg (2000). Briefly,  LB agar (0.3%) plates (for swimming motility), and LB agar (0.5%) 
plates (for swarming motility) containing sub-inhibitory concentrations of ethanol extract or essential 
oils were prepared and allowed to dry for 3-4 h at 30⁰C. Plates were point inoculated with freshly grown 
culture cells using a blunt ended sterile toothpick. For twitching motility, LB agar (1%) plates were used 
bacterial cells were inoculated by using a sharp end toothpick and stabbing through the agar to the 
bottom of the petridish.  After 24 hours of incubation in upright position at 30⁰C, the extent of motility 
was determined by measuring the diameter of the bacterial colony.  
 
Statistical analysis 
All data were initially analyzed by a normal distribution using the one-sample Kolmogorov-Smirnov test. 
Following the confirmation of normal distribution, differences for individual parameters between 
treated groups and control were tested by one way ANOVA, followed by Dunnett’s test. Differences 




A list of the plant extracts studied, including the botanical name, voucher specimen and data related to 
traditional use is listed in Table 1 Chapter 2, whereas the list of essential oils is indicated in Table 1 
Chapter 3. Fifty four plants ethanol extracts and 29 essential oils were obtained as described in Material 
and Methods of Chapter 2 and 3, this thesis.  The yields of plant oils are presented in Table 2 Chapter 3, 
this thesis. 
 
Anti-quorum sensing activity 
The inhibition in quorum sensing activity of the evaluated plant ethanol extract and essential oils are 
shown in figure 2 and 3. The disappearance of the violet colored (violacein) pigment in C. violaceum is an 
indication of anti-QS activity by the added plant ethanol extracts and essential oils. From out of 54 plant 
ethanolis extracts screened for anti-quorum sensing activity, 10 plants (Cinnamomum burmannii, 
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Zingiber officinale, Terminalia catappa, Sesbania grandiflora, C. sintoc, Piper bettle, Caesalpinia sappan, 
Kaempferia rotunda, Nymphaea nouchali and Syzygium aromaticum) showed anti-QS activity, 12 out of 
29 plants essential oil extracts (Massoia aromatica, Ocimum basilicum, Z. purpureum, Litsea cubeba 
(leaves and bark part), C. sintoc, S. polyanthum, S. aromaticum, Myristica fragrans, Z. officinale var 
rubrum, Coriandrum sativum, K.rotunda, and K.galanga) proved to be effective. Strong anti-QS activity 
was observed in essential oils from M. aromatica (Table 2).  
 
 
Fig. 2: Inhibition in violacein production and cell growth in Chromobacterium violaceum ATCC 31532 
(wild type strain) by ethanol extracts. Anti-QS activity and growth inhibition was demonstrated for  (a) 
Cinnamomum burmannii , (e) Zingiber officinale, (f), Syzigium aromaticum,  (i) Sesbania grandiflora,(l)  
Cinnamomum sintoc, (m) Piper bettle, (n) Caesalpinia sappan, (o) Kaempferia rotunda, (p) Nymphaea 
nauchalli, and (v) Terminalia catappa ethanol extracts. As a positive control (t), Streptomycin 50 




Fig. 3: Inhibition in violacein production and cell growth in Chromobacterium violaceum ATCC 31532 
(wild type strain) by  essential oils : (1) Massoia aromatica, (2) Ocimum basilicum, (3) Cinnamomum 
burmannii, (4) Zingiber purpureum, (5) Litsea cubeba (leaves), (6) L. cubeba (seeds), (7) L. cubeba 
(bark), (8) Cinnamomum sintoc, (9) Elettaria cardamomum, (10) Citrus aurantifolia, (12) Z. officinale 
var rubrum, (13) Syzigium aromaticum, (14) S. polyanthum, (15) Coriandrum sativum, (16) Piper 
nigrum, (17) Caesalpinia sappan, (20) Myristica fragrans, (21) Kaempferia rotunda, (27) K. galanga. As 




Fig. 4: Anti-QS activity versus antibacterial activity. (a) no anti-QS nor antibacterial activity, (b) anti-QS 







Table 2: Antiquorum sensing activity of Indonesian medicinal plants ethanol extracts by agar well 
diffusion method (Values are mean ±SD of 3 experiments). 
No Plants Sample 
form 









1 C. burmannii Extract Bark 13.0±0.0 11.5±0.0 1.5±0.0 
2 Z. officinale Extract Rhizome 13.0±0.0 9.5±0.0 3.5±0.0 
3 S. aromaticum Extract Flower 21.5±0.0 9.5±0.0 12.0±0.0 
4 Sesbania grandiflora Extract Leaves 13.0±0.0 8.0±0.0 5.0±0.0 
5 C. sintoc Extract Bark 13.5±0.0 9.0±0.0 4.5±0.0 
6 P. betle Extract Leaves 12.0±0.0 9.5±0.0 2.5±0.0 
7 C. sappan Extract Bark 12.5±0.0 8.0±0.0 5.5±0.0 
8 K. rotunda Extract Rhizome 11.5±0.0 8.0±0.0 3.5±0.0 
9 Nymphaea nouchali Extract Flower 24.5±0.0 11.5±0.0 13.0±0.0 
10 Terminalia catappa Extract Leaves 16.0±0.0 9.2±0.0 6.8±0.0 
11 Massoia aromatica Oil Bark 24.2±0.3 - 24.2±0.3 
12 Syzygium aromaticum Oil Flower 23.7±0.6 8.3±0.56 15.3±0.6 
13 Ocimum basilicum Oil Leaves 9.7±0.6 - 9.7±0.6 
14 Zingiber purpureum Oil Rhizome 12.2±0.3 - 12.2±0.3 
15 Z. officinale var rubrum Oil Rhizome 10.0±0.00 8.0±0.0 2.0±0.0 
16 Litsea cubeba  Oil Leaves 12.2±0.3 - 12.2±0.3 
 Bark 12.0±0.0 9.3±0.6 2.7±0.6 
 Seeds 8.0±0.0 8.0±0.0 - 
17 S. polyanthum Oil Leaves 12.0±0.0 - 12.0±0.0 
18 Myristica fragrans Oil Seeds 10.2±0.3 - 10.2±0.3 
19 Kaempferia rotunda Oil Rhizome 10.0±0.0 - 10.0±0.0 
20 K. galanga Oil Rhizome 10.0±0.0 - 10.0±0.0 
21 Coriadrum sativum Oil Seeds 9.5±0.5 - 9.5±0.5 
22 Cinnamomum burmannii Oil Bark 18.0±0.0 18.0±0.0 - 
23 C. sintoc Oil Bark 8.2±0.3 - 8.2±0.3 
24 Elettaria cardamomum Oil Bark 12.0±0.0 12.0±0.0 - 
25 Piper nigrum Oil Fruit 9.2±0.3 9.2±0.3 - 
26 Caesalpinia sappan Oil Bark 9.2±0.2 9.2±0.3 - 
27 Citrus aurantifolia Oil Leaves 9.3±0.6 9.3±0.6 - 
28 Control (Streptomycin 50 µg/mL) 24.8±0.0 24.8±0.0 - 
29 Control (Streptomycin 100 µg/mL) 36.2±0.3 36.2±0.3 - 
r1= radius of growth + pigment inhibition (mm); r2= radius of growth inhibition (mm); (r1-r2)= radius of 
pigment inhibition (mm). 




The antibacterial activity of plant ethanol extracts and essential oils against C. violaceum CV026 was 
determined using the microbroth dilution method. The results obtained from this assay are presented in 
Table 3.  
 
S. aromaticum and N. nouchali ethanol extracts showed the capability to inhibit 50% of C. violaceum 
CV026 growth (PMIC50) at a concentration of 0.12 mg/mL and 0.25 mg/mL. Higher concentrations to 
inhibit CV026 growth were needed for the other ethanol extracts. A total of four essential oils (M. 
aromatica, O. basilicum, K. rotunda, and C. sativum) had a PMIC50 at a concentration of 0.06% (v/v). 
Essential oils from C. burmannii showed a PMIC50 at 0.03% (v/v).  
 
Violacein quantification 
Quantification of violacein production by C. violaceum CV026 was used to measure the inhibition 
quantity in quorum sensing activity. N. nouchali ethanol extract, S. aromaticum essential oil and M. 
aromatica essential oil showed the highest quorum sensing inhibition activity by using the agar well 
diffusion method. Figure 5 shows the result of reduction in violacein production by N. nouchali ethanol 
extracts, S. aromaticum essential oil and M. aromatica essential oil.  
 
Nymphaea nouchali ethanol extracts, S. aromaticum essential oil and M. aromatica essential oil showed 
a concentration dependent anti-quorum sensing activity derived from the amount of violacein 
produced. At elevated concentrations, both the ethanol extract and essential oils tested demonstrated 
antibacterial activity besides the anti-QS activity (Figure 5).  
 
At the lowest concentration tested (0.06% v/v) of M. aromatica oil, the amount of violacein pigment 
produced by C. violaceum was 38.9±0.6% (**P<0.01), whereas the percentage of cell growth on that 
concentration was 72.0±0.5% (*P<0.05). In the presence of concentration of 0.06% v/v of S. aromaticum 
oil, violacein production of C. violaceum was 43.7±0.4% (**P<0.01), and the percentage of total cell 
growth was around 64.4±0.6% (**P<0.05), respectively. This result indicates that the anti-quorum 
sensing activity of M. aromatica and S. aromaticum oil is independent of cell growth (Figure 5).  
 
The violacein production of C. violaceum CV026 impregnated with HHL was respectively decreased by 
the ethanol extract of N. nouchali at a concentration of 0.25 mg/mL, with total amount of violacein 
 
 147 
produced as much as 49.2±0.9% (**P<0.01) . However, at the same concentration the percentage of cell 
growth was found to be 51.2±0.8% (**P<0.01) indicates that for N. nouchali extract, the violacein 
production inhibition is basically dependent on the cell growth of bacterial reporter strain (Figure 5). 
The ethanol extracts and essential oils which showed anti-QS activity by inhibition of violacein 
production were further tested to explore their effect on quorum sensing related swimming, swarming 
and twitching motility for P. aeruginosa PAO1.  
 
Table 3: Antiquorum sensing activity of Indonesian medicinal plants essential oils by microdillution 
method. 
No Plants Materials PMIC50
a 
1 N. nouchali Extract 0.25 mg/mL 
2 Syzygium aromaticum Extract 0.12 mg/mL 
3 Massoia aromatica Oil 0.06% (v/v) 
4 Syzygium aromaticum Oil >1.00% (v/v) 
5 Ocimum basilicum Oil 0.06% (v/v) 
6 Zingiber purpureum Oil 0.12% (v/v) 
7 Z. officinale var rubrum Oil 0.25% (v/v) 
8 Litsea cubeba (bark) Oil 0.25% (v/v) 
L. cubeba (leaves) Oil 0.25% v/v 
L. cubeba (seeds) Oil 0.12% (v/v) 
9 S. polyanthum Oil 0.25% (v/v) 
10 Myristica fragrans Oil 0.12% (v/v) 
11 Kaempferia rotunda Oil 0.06% (v/v) 
12 K. galanga Oil 0.12% (v/v) 
13 Coriadrum sativum Oil 0.06% (v/v) 
14 Cinnamomum burmannii Oil 0.03% (v/v) 
15 C. sintoc Oil 0.12% (v/v) 
16 Elettaria cardamomum Oil 0.50% (v/v) 
17 Piper nigrum Oil 0.25% (v/v) 
18 Caesalpinia sappan Oil 0.12% (v/v) 
19 Citrus aurantifolia Oil 0.50% (v/v) 
a PMIC50 : plant ethanol extract concentration (mg/mL) or essential oil concentration (% v/v) at which 
































































































































































































































Inhibition of bacterial motility  
We investigated if the extracts and essential oils which inhibited quorum sensing had any effect on 
quorum sensing related motility in the human opportunistic pathogen P. aeruginosa PAO1. Our 
result, shown in figure 6, indicated that ethanol extracts of N. nouchali at a concentration of 1 and 
0.5 mg/mL significantly reduced the swimming motility of P. aeruginosa PAO1 by 74.7±0.9 % 
(***P<0.001) and 54.4±0.6 % (**P<0.01), respectively.  The swarming motility of P. aeruginosa PAO1 
was also reduced as much as 67.8±0.3 % (***P<0.001) and 53.4±0.3 % (**P<0.01) when 
concentrations of 1 mg/mL 0.5 mg/mL were applied. The same concentrations of the extract also 
showed a decrease in twitching motility namely, 75.8±0.0 % (***P<0.001) and 62.1±0.3 % 
(**P<0.001) respectively.  
These results are in accordance with our previous study (chapter 2 this thesis) which showed that 
ethanol extracts from N. nouchali have inhibitory effects on the biofilm of P. aeruginosa PAO1 at the 
concentrations of 0.06 mg/mL. According to O’Toole and Kolter (2002), twitching motility of the type 
IV pili has been shown to be important for the adherence adhesion to eukaryotic cell surfaces and is 
necessary for biofilm development. At the microscopic level, the edge of the colonies in twitching 
motility is highly irregular and this is thought to be a consequence of the surface movement 
associated with type IV pili (Figure 7). 
Both concentrations of essential oils from M. aromatica (1% (v/v) and 0.5% (v/v)) that were tested 
significantly decreased the swarming motility of P. aeruginosa PAO1 by 29.57 ± 0.57 % (***P≤0.001),  
and 51.4 ± 0.0 % (**P<0.01) respectively. As much as 100±0.0 % and 50.9 ± 0.6 % inhibition in 
twitching motility for P. aeruginosa PAO1 was demonstrated by these essential oils with 
concentrations ranging from 1 to 0.06 % (v/v) (Figure 8). The capability of essential oils from M. 
aromatica in reducing P. aeruginosa PAO1 twitching motility correlated siginificantly with a decrease 
in P. aeruginosa PAO1 biofilm formation when these cells were incubated with the same essential oil 
concentration of 0.06 % (v/v) and higher (data chapter 3 this thesis). However, at concentrations 
lower than 0.5 % (v/v) essential oils from M. aromatica failed to reduce more than 50% of the 




Fig. 6: Effect of Nymphaea nouchali ethanol extracts on swimming, swarming and twitching 
motility of Pseudomonas aeruginosa PAO1. The bars indicated the standard deviations of the 
means. Asterisks indicate a significant difference between treatment and negative control. 
 
 
Fig. 7: Pseudomonas aeruginosa PAO1 twitching motility. (a) Arrow shows twitching motility of P. 
aeruginosa PAO1 on 1% LB agar, (b) Twitching motility of P. aeruginosa PAO1 on 1% LB agar 
stained with crystal violet, (c) Direct visual inspection of the colony edges by microscopy and (d) 
colony edges stained with crystal violet. The edge is highly irregular. Micrographs were taken at 





Fig. 8: Effect of Massoia aromatica essential oils on swimming, swarming and twitching motility of 
Pseudomonas aeruginosa PAO1. The bars indicated the standard deviations of the means. 




Fig. 9: Effect of Syzigium aromaticum essential oils on swimming, swarming and twitching motility 
of Pseudomonas aeruginosa PAO1. The bars indicated the standard deviations of the means. 
Asterisks indicate a significant difference between treatment and negative control. 
 
At concentrations ranging from 1 – 0.25 % (v/v), essential oils from Syzygium aromaticum 
significantly (**P<0.01) decreased the swimming motility of P. aeruginosa PAO1 from 60.5±0.3 % to 
50.5±0.6 %, respectively. However this essential oil failed to reduce the swarming motility of P. 
aeruginosa PAO1 at concentrations lower than 1 % (v/v) (Figure 9). As much as 53.2±0.8 to 50.0 ± 0.6 
% (**P<0.01) inhibition in twitching motility of P. aeruginosa PAO1 was shown by this essential oil 
with a concentration range from 1 to 0.5 % (v/v). The capability of the essential oil from S. 
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aromaticum in reducing P. aeruginosa PAO1 twitching motility correlated with a siginificant decrease 
in P. aeruginosa PAO1 biofilm formation when incubated with the same essential oil concentration 
of 0.5 and 1 % (v/v) (chapter 3, this thesis).  
 
DISCUSSION 
The aim of this study was to determine the anti-QS potential of ethanol extracts and essential oils 
from Indonesian medicinal plants with a potential to a possible use in controlling detrimental 
infections. Quorum sensing in P. aeruginosa has been well studied. This organism has two QS 
systems, LasR/I and RhlR/I systems. The lasI produces diffusible extracellular signal, N-(3-
oxododecanoyl)-L-homoserine lactone (3-oxo-C12-HSL) which binds with LasR to activate a number 
of virulence genes and biofilm maturation, and to regulate the expression of LasI.  In the Rhl system, 
the RhlI synthase produces N-butyryl-L-homoserine lactone (C4-HSL), which interacts with RhlR 
protein and activated C4-HSL-RhlR complex, further stimulates the expression of RhlI, virulence 
genes and biofilm associated genes and biofilm associated genes (Whiteley et al., 1999; De Kievit, 
2009; Desai and Gala, 2014).  
P. aeruginosa produces a third signaling molecule, 2-heptyl-3-hydroxy-4(1H)-quinoline, called 
Pseudomonas quinolone signal (PQS). It is produced by the pqs (pqsABCDE) operon and pqsH gene, 
wherein the pqsABCDE operon products synthesize 2-heptyl-4-hydroxyquinoline (HHQ), and the 
PqsH converts HHQ into PQS. PQS diffuses in and out of the cell, accumulates in the environment, 
and when a threshold concentration reached, it binds to the regulator protein, PqsR, which 
modulates genes encoding virulence factors and the synthesis of PQS itself, resulting in 
autoinduction (Whiteley et al., 1999; Desai et al., 2014).  
There are several reports in literature that propose different mechanisms of quorum sensing 
inhibition by natural products, either by inhibition of the signal molecule biosynthesis (Vattem et al., 
2007), preventing the binding of the AHL molecules to its receptors (Hentzer and Givskov, 2003), or 
enzymatic inactivation and biodegradation of the quorum sensing signaling molecules (Defoirdt et 
al., 2004). 
Plants are the sources of varied bioactive metabolites which useful for the development of 
successful and effective drugs. Various plants have demonstrated the ability to interfere with 
microbial QS systems that further and control its virulence. Vanilla (Vanilla planifolia), garlic (Allium 
sativum), weeping bottlebrush (Callistemon viminalis), Zaragoza mangrove (Conocarpus erectus), 
graceful sandmat (Chamaesyce hypericifolia), black olive (Bucida buceras), Florida clover ash 
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(Tetrazygia bicolor), and southern live oak (Quercus virginiana), showed quorum sensing inhibitory 
properties against C. violaceum and Agrobacterium tumefaciens (Choo et al., 2006; Adonizio et al., 
2006). Study from Zahin et al., (2010), Chong et al., (2011) and Priya et al., (2013) also revealed 
quorum sensing property of Mangifera indica, Punica granatum, Myristica cinnamomea and 
Phyllanthus amarus, which showed efficacy in regulating violacein production of C. violaceum and 
inhibiting motility of P. aeruginosa. The result in our study have revealed that the ethanol extract of 
N. nouchali, M. aromatica and the essential oils from S. aromaticum significantly inhibit the quorum 
sensing mechanism of P. aeruginosa PAO1 as indicated by a reduction in violacein production of the 
reporter strain C. violaceum. They are also able to inhibit the motility of P. aeruginosa PAO1 which is 
an important trait for its pathogenicity. 
To interfere with signal reception, plants produce molecules that structurally mimic the AHLs, and 
the competitive binding is effective to block activation of AHL-mediated QS (Koh et al., 2013). 
Halogenated furanones isolated from D. pulchra were found to inhibit QS regulated behaviors by 
competitively bind to the LuxR type proteins, thus, promote their rate of proteolytic degradation 
without killing the bacteria (Manefield et al., 1999). Chong et al., (2011) extracted malabaricone C 
from nutmeg Myristica cinnamomea, whose structure is not similar to AHL but possesses anti-QS 
activity by inhibits both lasR and rhlR systems in P. aeruginosa, CviR system in C. violaceum. 
However, that compound does not inhibit AHL production in P. aeruginosa. ,  
S. aromaticum essential oil also known as clove oil has a long history of use in traditional medicine, 
and is a proven antimicrobial (Indonesian National Health Department, INHD, 1985). The oil contains 
majority of eugenol, which comprises around 72-90% of the oil. Other important consituents of the 
oil include tannins, flavonoids, and several sesquiterpenes (Joseph and Sujatha, 2011). Eugenol 
found to be toxic in relatively small quantities, as low as 5 mL (Jirovetz et al., 2006).  Krishnan et al., 
(2012) discovered that hexane and methanol extract of S. aromaticum bud inhibited QS-controlled 
virulence production in P. aeruginosa, including reducing the bioluminescence of P. aeruginosa 
PAO1 lecA::lux (by hexane extract), swarming (maximum inhibition by methanol extract), pyocyanin 
(maximum inhibition by hexane extract). Inhibition of P. aeruginosa lecA::lux fusion suggests that S. 
aromatica extracts might interfere with lux, rhl and las QS-regulated system. Flavonoids contains in 
S. aromaticum is thought to be the compound responsible for the anti-QS mechanism. Flavonoids 
such as catechin, naringenin and taxifolin were found to have capability to reduce the expression of 
QS genes: lasI, lasR, rhlI and rhlR, and attenuate virulence factors such as pyocyanin, elastase and 
biofilm formation in P. aeruginosa (Vandeputte et al., 2010; Sarabhai et al., 2013). 
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Beside used as spices, massoia oil from M. aromatica bark traditionally used in Indonesia to cure 
diarrhea, sore throat and stomach ache. Balinese people use this oil in the massage therapy 
(Hartnoll et al., 1993). From GC-MS analysis we found out that massoia oil contains massoia lactone 
(77.06%) (Chapter 4, this thesis). Amaya et al., (2012) discovered anti-QS activity of six 
sesquiterpenes lactones isolated from Centratherum punctatum. At low concentration, those 
lactones showed capability to prevent biofilm formation, elastase activity controlled by AHL, and 
production of AHLs.  Similar to Amaya et al., Cartagena et al., (2007) studies acetogenin and 
squamocin, a plant sesquiterpene lactones isolated from Asteraceae and Hepaticae, which found to 
be able to inhibit P. aeruginosa QS-regulated biofilm formation. 
Similar to study from Krishnan et al., (2012), the result from this study showed that S. aromaticum 
oil possess antibacterial as well as anti-quorum sensing activity. The fact that at elevated 
concentrations, N. nouchali extract, M. aromatica and S. aromaticum essential oils also 
demonstrated antibacterial activity along with anti-QS activity raised a question on whether the 
antibacterial and anti-QS effect in the ethanol extract and essential oils are from the same or distinct 
chemical compounds.  
Bacterial motility plays a pivotal role in microbial surface colonization and the spreading of bacteria 
across the surface. These motilities contribute to the formation of structured surface-associated 
communities of bacteria called biofilms. The gram-negative bacterium, P. aeruginosa, can undergo 
the flagellum-mediated swimming motility and the surface-associated swarming and twitching 
motilities (Chow et al., 2011].  
Swimming and swarming motility are dependent on flagella, whereas twitching has been shown to 
require type IV pili (Harshey, 2003). Swimming motility of bacteria formed on the plates with a low 
concentration of agar (0.3%) is not a social event unlike swarming, swimming motility. This motility 
represents individual cell movement and bacteria are fully immersed within the semisolid medium. 
The cells move separately in an unorganized manner resulting in an unorganized pattern, and this 
does not involve differentiation into polar hyperflagellated cells (Rashid and Kornberg, 2000; Inoue 
et al., 2008). Flagellum-mediated swimming motility is not required for P. aeruginosa biofilm 
structure development (Wu et al., 2011) however, this type of motility increases initial attachment 
to surfaces during initial biofilm development (O’Toole and Kolter, 2002). 
Swarming is a cell density dependent way of movement and is considered as a model of bacterial 
social behavior. This motility is assessed on more solidified media (0.5% agar). This multicellular 
migration, generally dependent on flagella, takes place when the fluid layer on a surface is relatively 
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thin  and involves a complex process of cell differentiation (elongated and hyperflagellated) leading 
to co-ordinated movement (Soto et al., 2002). In addition to flagella, swarmer cells require an 
increased production of certain extracellular components known as wetting agents that reduce 
surface frictions and enable the smooth migration of a group of cells on viscous surfaces (Rashid and 
Kornberg, 2000; Inoue et al., 2008). 
Type IV pili extend and retract from the poles of the cell to mediate a form of surface translocation 
termed twitching motility, which is critical for host infection. The cells move in short, intermittent 
jerk of up to several micrometers and movement only appears when cells are within several 
micrometers of each other. The morphological pattern of twitching is less organized than in 
swarming motility (Rashid and Kornberg, 2000).  
According to Shrout et al., (2006), swarming motility promotes cell movement on the surface and 
results in the formation of a flat, uniform biofilm. Limitations in swarming motility resulted in 
biofilms containing cell aggregates, whereas twitching motility has been shown to be important in 
later steps in the formation of a structured biofilm. Klausen et al., (2003) demonstrated that the 
bacterial migration which forms biofilm cap is mediated by type-IV pili. Cap formation is a process 
during biofilm maturation, by which a motile subpopulation in older biofilms moves across the 
surface and accumulates on an immobile subpopulation of cells. This immobile subpopulation is an 
aggregate of cells and has been termed “the stalk”. 
The capability of ethanol extract from N. nouchali to inhibit swarming and twitching motility more 
severe than swimming motility of P. aeruginosa suggest that these extracts probably contain 
compound(s) that are capable to reduce the amount of quorum sensing signal in P. aeruginosa 
PAO1. Subsequently they also showed a reduction in violacein production by C. violaceum CV026 
impregnated with HHL (Figure 3).  
It is also still not clear why essential oils from M. aromatica at a low concentration (0.06% v/v) show 
a larger inhibition on swarming than swimming motility of P. aeruginosa. A possible explanation can 
be that essential oils from M. aromatica contain compounds capable to reduce the amount of 
quorum sensing signal in P. aeruginosa, as again demonstrated by the reduction in violacein 
production, Such low concentrations showed less activity in inhibition of single cell swimming 
motility, followed by no planktonic growth inhibition at a concentration of 0.06 % (v/v) of M. 
aromatica oil (chapter 3 this thesis).  
The inhibition of quorum sensing signals could block cell-to-cell communication but fail to interfere 
with surface colonization by swimming motility. The blocking of cell-to-cell communication reduced 
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the production of several virulence factors and cytotoxic compounds such as elastase, rhamnolipids, 
cyanide and pycocyanine, which  in turn strongly reduced the swarming motility (which also requires 
rhamnolipids (RLs) and 3-(3-hydoxylalkanoyloxy) alkanoic acids (HAAs) (Reimmann et al., 2002; 
Tremblay and Déziel ,2010). 
The capability of S. aromaticum in reducing the swimming motility to a larger extend than reducing 
the swarming and twitching motility of P. aeruginosa PAO1 could be due to the antibacterial 
compounds present in the essential oil. These antibacterial compounds might disturb the single cell 
movement as in swimming instead of groups of cells movement in swarming motility. 
In order to have a better insight whether the antibacterial and anti-QS effect from essential oils from 
M. aromatica are from the same or distinct chemical compounds, the bioautography test using C. 
violaceum WT strain should be performed. Further work will focus on chemical identification of the 
anti-quorum sensing compounds using chromatographic methods and mass spectrometry. 
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Massoia lactone (C10H16O2), also known as (R)-5,6-dihydro-6-penthyl-2H-Pyrane-2-one was isolated 
from Massoia aromatica bark essential oil. Preparative Thin Layer Chromatography (TLC), followed 
by Gas Chromatography-Mass Spectrometry (GC-MS) and 1D- 1H-Nuclear Magnetic Resonance 
(NMR) analysis were used to isolate and elucidate this compound. The effect of massoia lactone on 
microbial biofilm was evaluated. The result showed that this compound exhibit anti-biofilm activity 
against Candida albicans ATCC 10231, Pseudomonas aeruginosa PAO1 and Staphylococcus aureus 
Cowan I (MBIC50 at concentration of 25, 50 and 100 µg/mL). The anti-biofilm activity of massoia 
lactone also found to be three times greater when in combinations with anti-fungal/anti-bacterial. 
These result indicated that massoia lactone displayed potent activity against microbial biofilms in 
vitro and therefore has potential therapeutic implication for biofilm-associated microbial infections.  
 
 


















Massoia aromatica (synonym : Cryptocarya massoy (Oken) Kosterm) is an evergreen tree belongs to 
the family of Lauraceae. It is a medium-sized tree, growing up to 15 m tall, with optimal growth in 
rainforests between 400 m and 1000 m altitude. This plant is a rare plant species that grow in 
Indonesia, distributed mostly in Maluku and West Papua (Gunawan, 1999).  
Local people common used massoia woods as building materials, and the bark is used as a mixture of 
red dye in batik making. In the islands of Seram, Maluku Indonesia, fishermen are commonly utilize 
masoyi leaves to fill pillows, and used to warm their heads when they go to sea (Guenther, 1972). 
Javanese and Balinese women are commonly use massoia bark powder to prepare a warming 
ointment, called bobory, which is used to lubricate the body, especially on days cold and rainy. The 
result makes the body feels warm, and it is believed to help alleviate complaints to various diseases. 
Massoia tree bark has a pleasant, sweet coconut-like aroma and is steam distilled to yield massoia 
bark oil that is used as the fragrance materials in incense manufacture (Hapsari and Simanjuntak, 
2010).  
The pleasant smell of massoia oil is believed to be capable of stimulating the emergence of sexual 
desire. In some areas in Indonesia, this plant is used as a medicinal plant to treat asthma, for a 
carminative (a herb or preparation that either prevents formation of gas in the gastrointestinal tract 
or facilitates the expulsion of said gas, thereby combatting flatulence), diaphoretic (herbs that 
induce prespiration, sweating and in return it will help to reduce fever, cool the body and speed the 
elimination of toxins from the system) (Heyne, 1987). 
Previous studies mentioned that massoia oil was traditionally used to treat diarrhea, abdominal 
cramps, fever, tuberculosis, muscle pain, headache and chronic constipation, vaginal discharge, 
fever, anti-inflammatory agent, and as herbal postpartum. It is also believed that massoia oil has 
antiinsect and antifungal activity, since canoe or boat made of wood masoyi known to be able to 
resist insects and fungi (Lily, 1980; Gunawan, 1999; Bustanussalam et al, 2012). 
Up to now, not much scientific research on the efficacy of massoia oil for health treatment that has 
been done. Thus, the mechanism underlying the efficacy of oil masoyi in modern medicine has not 
been widely known. From several studies it is known that massoia wood could act as a counter 
irritant (moisten capillaries) and aromaticum (fragrance materials, used as a mixture of fragrant 
incense). A study by Widowati and Pudjiastuti (1999) noted that infuse (water decoction) of massoia 
bark has properties of analgesics (pain relievers). A research by Sa'roni and Adjirni (1999) revealed 
that massoia bark also has activity as an anti-inflammatory.  
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Our previous study showed that beside the capability of inhibition of planktonic growth and biofilm 
formation, M. aromatica essential oil also showed activity in breaking the biofilm of Pseudomonas 
aeruginosa PAO1, Staphylococcus aureus Cowan I and Candida albicans ATCC 10231. The oil also 
showed activity in inhibit quorum sensing (QS) using QS reporter strain Chromobacterium violaceum 
CV026 and P. aeruginosa PAO1. In the experiments reported here, the active compound found in M. 
aromatica oil was isolated and screened for antibiofilm activity against P. aeruginosa PAO1, S. 
aureus Cowan I and C. albicans ATCC 10231. 
 
MATERIALS AND METHODS 
Plant Material 
As much as five kilograms of M. aromatica bark were obtained from Nabire district, West Papua, 
Indonesia. A voucer specimen was identified and deposited at Department of Pharmaceutical 
Biology, Faculty of Pharmacy, Gadjah Mada University, Indonesia. The essential oil was obtained by 
steam-hydrodistillation process. The oil sample was dried over anhydrous sodium sulphate (Na2SO4), 
stored in sealed dark glass vial, and kept at 4°C.  
Planar chromatographic separation and analysis 
Chromatography was performed on 10 × 20 cm silica gel 60 F254 aluminium sheet Thin Layer 
Chromatography (TLC) plates (Merck, Germany). Before use, the plates were preconditioned by 
heating at 120°C for 3 h. Without this procedure adsorbent layers became partly detached when 
soaked. Pure samples of eugenol, cynamaldehyde, and 1,8-cineole used as standards were obtained 
from Sigma Aldrich, dissolved in toluene to give solutions containing 1 µL/30 µL, and 3 µL was 
applied to the 10 x 20 cm TLC silica gel F254 type plates, using Minicaps capillary pipettes (West 
Germany). For the solution of the essential oils 100 µL was dissolved in 1 mL ethanol, and 5 µL of it 
was applied to the 10 x 20 cm TLC silica gel F254 type plates with Minicaps capillary pipettes. The 
position of the starting line was 1.0 cm from the bottom and 1.0 cm from the left side. The standards 
of the main components of the essential oils were applied to the TLC plates next to the spots of the 
oils. After the sample application, the TLC plates were developed with the previously optimized 
mobile phase. For the separation of essential oils, toluene:ethyl acetate, 93:7, as a mobile phase is 
recommended (Wagner and Bladt, 1996). The development mode was ascendant chromatography in 
a saturated twin-trough chamber (Camag, Switzerland). All TLC separations were performed at room 




After chromatographic separation, the absorbent layers were dried in an oven at 90°C for 5  min to 
remove the solvent completely. An alcoholic vanillin–sulphuric acid reagent was used to visualize the 
separated compounds. The developed layers were dipped into this reagent and heated for 5 min at 
100°C. Detection of the separated compounds was performed according to Rf (retardation factor) 
value:  the ratio of the distance traveled by the center of a spot to the distance traveled by the 
solvent front; and colour of the standards. The TLC plate for bioautography was processed in parallel 
without final development with reagent (Wagner and Bladt, 1996; Horváth et. al., 2010). 
 
Bioautography analysis 
Agar diffusion or contact bioautography was used for the bioautography analysis. P. aeruginosa 
PAO1, S. aureus Cowan I and C. violaceum ATCC 31532 (wild type strain) were grown overnight in 
100 mL Luria Bertani (LB) broth, at 37°C for S. aureus and 28°C for P. aeruginosa and C. violaceum in 
a shaker incubator for 24 h to an optical density (600 nm) of 1.0 or greater. The bacterial suspension 
was diluted with fresh LB to OD600 = 0.1, which corresponds to approximately 1 × 10
8 colony-forming 
units (CFU)/mL. C. albicans ATCC 10231 was cultured in Sabouraud Dextrose Broth (SDB) and 
incubated for 24 h at 30⁰C with agitation (250 rpm). Following incubation, cells were finally 
resuspended to a concentration of 107 CFU/mL by adjusting the optical density of the suspension to 
0.38 at 520 nm.  
A 100 μL sample of the microbial culture was spreaded onto 15 mL of LB Agar for bacteria and 
Sabouraud Dextrose Agar (SDA) for yeast in petri dishes. After the agar solidified, the chromatogram 
plate developed was placed face down onto the inoculated agar layer and left for 24 hour at 4⁰C to 
enable diffusion. Following the incubation, the chromatogram plate was removed and the agar layer 
was incubated at 37°C for 24 hours. The inhibition zone was observed on the agar surface in the 
places where the spots of compounds are diffuses into the agar. The presence of anti-bacterial 
activity within a sample was indicated by a clear halo on the agar surface were the separated 
compounds are present. The Rf value of the inhibition zone was measured by the distance of the 
substance over the distance moved by the solvent (Horváth et. al., 2010). 
 
 
Isolation of M. aromatica Oil Active Compound   
A Preparative TLC separation of M. aromatica oil was performed on 10 × 20 cm silica gel 60 F254 
aluminium sheet TLC plates (Merck, Germany) as described above by spotting the essential oil over 
the whole width of the starting line (streaking the plate). UV254 instead of stain reagent was used for 
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the visualization. The area (band) which is showed the same Rf value as the Rf of the inhibition zone 
was marked, and carefully rubbed out off using a spatula. The loosened silica then transferred onto a 
glass funnel where glass wool is present and ethylacetate as mobile phase is poured over them as a 
solvent. The eluted fraction that has been collected, dried using SpeedVac, and dissolved in ethanol 
was further analysed by TLC and visualized under UV254. GC-MS analysis also performed to obtain 
information about the chemical composition of the eluted fraction.  
 
Gas Chromatography-Mass Spectometry (GC-MS) analysis 
The isolated fraction of M. aromatica essential oil was analysed by GC-MS according to the method 
of Wu et al. (2008) on a GC-2010 gas chromatography (Shimadzu, Japan) equipped with a GC-MS-
QP2010 Plus mass spectrometer (Shimadzu, Japan). An Agilent J&W DB-1 column (30 m length, 0.25 
mm diameter, 0.25 µm film thickness, Agilent) was used for separation and also a s split injector. 
Diluted samples (1/100 in ethyl acetate, v/v) of 1.0 mL were injected by an autosampler in the split 
mode (1/153). The oven temperature was programmed from 70C to 230C at a rate of 5⁰C ml-1. 
Helium was used as the carrier gas. Identification of compounds was based on comparisons of their 
mass spectra with those recorded in the MS library database NIST (National Institute of Standards 
and Technology) 12, NIST62 and WILEY229. Quantitative analysis of each essential oil component 
(expressed as area percentage) was carried out by peak area normalization measurement. For dead-
time and Kovats Retention Index determination were conducted under isothermal condition (70⁰C). 
 
NMR analysis 
In order to obtain information about the structure of the isolated active compound, 1H-NMR 
(Nuclear Magnetic Resonance) spectroscopy analysis was performed. NMR spectra was recorded 
using Bruker DRX 500 (1H: 500 MHz, 13C: 125.77 MHz). The isolated fraction (20 mg/1.0mL) was 
dissolved in CDCl3 into a 5mm NMR tube, and the solvent signal was used for the spectra calibration 
(1H at 7.26 ppm).  
 
Effect of essential oil isolated compound on bacterial biofilm formation and fungal preformed 
biofilms  
Biofilms of C. albicans were formed on polystyrene flat bottom 96-well microtiter plates (Sarstedt 
Inc., Newton, NC, USA). Briefly, 100 µL of a standardized cell suspension (107 CFU/mL) grown on 
RPMI 1640 medium without sodium bicarbonate supplemented with L-glutamine (Sigma) was 
transferred into each well of a microtiter plate, and the plate was incubated for 24 h at 37⁰C to yield 
a intermediate biofilm phase. RPMI 1640 medium was used because in this medium C. albicans is 
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capable to induce hyphal formation in C. albicans. Following incubation, the cell suspension was 
aspirated and each wells was washed twice with 150 µL of PBS to remove loosely adhered cells. A 
total of 100 µL concentrated compound ranging from 100 to 6.25 µg/mL in methanol (MeOH) were 
added to the washed wells. For vehicle control we used ethanol at concentration 1% v/v, and for the 
negative control the biofilm was not exposed to anti-fungal agent. The plates were then incubated at 
37⁰C for 24 h. Quantification of the biofilm formed was done using the MTT (3-(4,5-dimethylthiazol-
2-yl)-2,5-diphenyltetrazolium bromide) assay describes below with a microtiter plates reader (Bio-
Rad 680 XR) at 550 nm. Testing was performed in triplicate. Fluconazole concentration ranging from 
1,024 – 128 µg/mL was used as a positive control in this study. When a compound was found to 
reduce at least 50% of biofilm formation (Minimum biofilm inhibition concentration, MBIC50), it was 
considered as biofilm preventive (Ramage et al., 2002). 
 
To test for the inhibition of active compounds on P. aeruginosa PAO1 and S. aureus Cowan I biofilm 
formation inhibition, a PVC (polyvinyl chloride) flexible U bottom 96 wells plates was used (Falcon 
3911, Becton Dickinson, Franklin Lakes, NY). Compound concentrations ranging from 100-6.25 
µg/mL in MeOH were used. Negative control (cells + media : TSB for S. aureus Cowan I and M63 
supplemented with 20% casamino acid, 20% glucose and 1mM MgSO4 for P. aeruginosa PAO1), 
positive control (cells + media + streptomycin), vehicle controls (cells + media +methanol 
concentration 1% v/v), and media controls were included. For the positive controls of the 
streptomycin concentration of 1000-100 µg/mL were used. Blanks undergo the same treatment as 
test samples, but without incubation. All tests were performed in triplicate. The MTT assay was used 
to estimate and validate the effects of plant essential oils on the biofilms formation. Inhibition of 
biofilm formation was calculated as % of inhibition on the basis of color absorbance by using the 
formula mentioned below to determine the final MBIC50 values:  
 
[(ODgrowth control – Odsample) / ODgrowth control] x 100 
ODt= optical density (595 nm) of the test well; ODmc24: optical density (595 nm) of the media 
control well; ODvc: optical density (595 nm) of the vehicle control well (Sandasi et al., 2009). The 
concentration at which the extract depleted the bacterial biofilm by at least 50% was labeled as the 
MBIC50. 
 
Essential oils isolated compound in combination with anti-microbial against microbial biofilm 
The anti-microbial activity of isolated plant essential oils isolated in combination with fluconazole or 
streptomycin was assessed by the chequerboard method in triplicate (Karpanen et al., 2008). 
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Microtiter plates containing C. albicans biofilms were washed three times with 200 µL sterile PBS per 
well to remove any unbound cells. The isolated compounds used at concentration that inhibit 50% 
planktonic cells and fluconazole at various concentration were prepared in RPMI 1640 medium. 
Next, 50 µL of the compound was added to the wells of the microtiter plates in diminishing 
concentrations, and 50 µL of fluconazole was added to the columns. The isolated compound alone at 
various concentration, fluconazole alone and saline were used as controls. The microtiter plates 
were incubated at 37⁰C for 24 h (intermediate phase Candida biofilm). 
 
The compound isolated from essential oil at concentration that inhibited 50% of planktonic cells and 
streptomycin were prepared in LB medium. Next, 50 µL of the essential oil’s isolated compound 
solution was added to the rows of 96 well microtiter plates in diminishing concentrations, and 50 µL 
of streptomycin was added to the columns in diminishing concentrations. The compounds isolated 
from essential oil alone at various concentrations, streptomycin alone and saline were used as 
controls. The microtiter plates were incubated at 37⁰C for 24 h (P. aeruginosa biofilm) and 48 h (S. 
aureus biofilm). Following the incubation time, the effects of plant essential oil’s isolated compound 
on the fungal and bacterial biofilms were estimated using the MTT assay as describes below. The 
test compound found to reduce at least 50% of the biofilm formation was considered as biofilm 
preventive (Ramage et al., 2002).  
 
The analysis of the combination of massoia lactone and streptomycin or fluconazole was obtained by 
calculating the Fractional Inhibitory Concentration Index (FICI) as follows: FICI = (MIC of the 
combination of massoia lactone and streptomycin or fluconazole /MICa alone) + (MIC of the 
combination of massoia lactone and streptomycin or fluconazole /MICb alone), where MICa is the 
Minimal Inhibitory Concentration of massoia lactone from M. aromatica oil, and MICb is the Minimal 
Inhibitory Concentration of streptomycin or fluconazole. The FICI was interpreted as follows: (1) a 
synergistic effect when FICI ≤ 0.5; (2) an additive or indifferent effect when FICI >0.5 and <1 and (3) 
an antagonistic effect when FICI >1 (konate et al., 2012). 
MTT assay 
The activity of the active compound in inhibit fungal and bacterial biofilm was quantified by 
determining biofilm cell viability using the MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium 
bromide) assay. MTT (Sigma) solution (5 mg/mL in PBS) was prepared, filter-sterilized using a 0.22-
µm pore size filter. The preformed biofilms were first washed three times with 200 µL PBS, and then 
100 µL of PBS buffer and 20 µL of the MTT solution were added to each of the prewashed wells. The 
microtiter plate was then incubated for 2 h at 37⁰C. Following incubation, the PBS-MTT solutions 
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were removed from the wells and replaced with 100 µL of DMSO in each well to dissolve the water 
soluble purple formazan crystal. The color intensity of the soluble formazan was determined using 
microplate reader (Bio-Rad 680 XR) at 550 nm. Percentage of cell survival is expressed as the 
formula below:  
 
                                
                           
                           
 
 
Qualitative analysis on C. albicans biofilm 
A Carl Zeiss LSM 5 Exciter Laser Scanning Confocal Microscope (Leica Microsystems, Germany) was 
used to observe the architecture of the C. albicans biofilms in the presence of massoia lactone. 
Candida biofilms were formed by dispensing standardized cell suspension (500 µL of a suspension 
containing 1.0 x 107 cells/mL in LB medium) onto 13 mm diameter pre-sterilized plastic coverslips 
(Thermanox; Nulge Nunc International) placed in the wells of pre-sterilized flat bottomed twelve-
well plates (Iwaki). The plate was incubated at 37⁰C for 90 minutes (adhesion phase). Following 
incubation period, the supernatant was removed and a total of 500 µL RPMI medium containing 
different concentrations of massoia lactone (100 – 6.25 µg/mL) were added to the washed wells. The 
plate then incubated for 8 h (adherence phase), 24 h (intermediate phase) and 48 h (maturation 
phase) at 37 ⁰C.  
The coverslips then were washed twice with PBS and stained using the LIVE/DEAD fluorescent stains  
(10 µL of 3.34 µM SYTO9 and 10 µL of 20 µM Propidium Iodide (PI) both in DMSO) (Molecular 
Probes, USA) before examined under CLSM. Serial sections in the xy plane were obtained at 1 μm 
intervals along the z axis. A 20× and 40x oil immersion objective were used with 488 nm Ar laser 
excitation and 500–640 nm band pass emission setting. The image were subsequently analysed using  
the freely available image processing software imageJ version 1.46 (Rasband, National  Institutes of 
Health (NIH),  Bethesda, Maryland, USA : http://rsb.info.nih.gov/ij/) including the LSM reader plugin 
to open LSM5 formatted image stack  created by the microscope software. The images' scale bar 
used to calibrate the ImageJ area measurement algorithm. The observations were made in 
triplicates and representative images are presented here (Ramage et al., 2002; Jin et al., 2005; 






Measurement of Hemolytic Activity  
The hemolytic activity was investigated by incubating 100 µL of serially diluted massoia lactone (100-
6.25 µg/mL) in phosphate-buffered saline (PBS) with 100µL of a suspension of 1% red blood cells in 
96-wells V-bottom plate (Greiner). Fresh human red blood cells (RBCs, 30 mL) were suspended in 10 
mL of PBS and washed 3 times by centrifugation (5 minutes at 1500 rpm) until the supernatant was 
clear and resuspended in PBS. Erythrocyte suspensions (5 × 106 cells/mL) were incubated with 
different concentrations of massoia lactone (100 – 6.25 µg/mL) at 37°C for 1 hour and then 
centrifuged at 2000 rpm for 10 minutes to precipitate intact erythrocytes and debris. The 
supernatant in each well was transferred to a new plate and were assayed for absorbance at 450 nm 
to determine the percentage of hemoglobin released from the lysed erythrocytes. 100% hemolysis 
data was obtained by adding 10 mL of TRITON-X solution (5 % v/v in DMSO), a strong surfactant, to 
the above-prepared RBC suspension. The hemolytic activity of the massoia lactone was expressed as 
the percentage of absorbance compared with that observed after 100% lysis induced by Triton X-




Statistical analysis was conducted with one way ANOVA followed by Dunnett’s tests. Differences 
were considered significant with P-values of 0.05 or less. 
 
RESULT AND DISCUSSION 
TLC profile and Bioautography assay of M. aromatica oil 
The essential oil obtained had a yield of 0.5 % (w/w).The TLC profile of the M. aromatica essential oil 
separation using Toluene:ethylacetate 93:7, and anysaldehyde sulphuric acid as stain solution 
showed three spots (Table 1). Using GC-MS analysis, the majority of the oil constituents were 
identified using the data sources available (Table 2). Among the identified compounds, Massoia 









Table 1: TLC profiling of M. aromatica Essential Oil 
 
 
Table 2: Chemical composition of the essential oil from the bark of M. aromatica 
No Compound Retention Time 
(min) 
Peak Area (%) 
1 L-Linalool $$ 10.491 1.95 
2 Alpha Copaene  15.243 2.94 
3 Beta Elemene $$ 15.467 1.24 
4 Alloaromadendrene $$ 16.411 3.17 
5 5-Hydroxy-2-Decenoic Acid Lactone $$ 2H-Pyrane-2-one, 
5,6-dihydro-6-penthyl-, (R)-(CAS) (-)-Massoia lactone 
17.242 77.06 
6 Cyclopentane, 1,1’-ethylidinebis-$$ Ethane, 1,1-
dicyclopenthyl-$$  1,1-Dicyclopenthylethane 
19.591 8.54 




Fig. 1: Isolation of M. aromatica oil’s active compound. (A) Bioautography analysis of (a) M. 
aromatica oil on C. violaceum WT plate, (b) M. aromatica oil, isolated M. aromatica oil active 
compound (Mlact), cynamaldehyde and eugenol on C .albicans 10231 plate, on P. aeruginosa 
PAO1 plate, and (d) on S. aureus Cowan I plate. (B) Scheme of isolation procedure for M. 
aromatica active compound using preparative TLC. 
 
Figure 1 shows a bioautography profile applied for M. aromatica essential oil using P. aeruginosa 
PAO1. The method resembles a disk assay, and combined with TLC separation provide a valuable 
screening method that quickly detection of components of an essential oil with anti-microbial 
activity. In this experiment we used contact bioautography, where the microbials diffuse from a TLC 
plate to an inoculated agar plate. The bioautography against P. aeruginosa showed that the 
component at Rf value 0.25 appear to be the main one responsible for the biological properties of 





Isolation of M. aromatica oil active compound, GC-MS and NMR analysis 
A preparative thin layer chromatography method was used to isolate the active compound of the M. 
aromatica essential oil. The result gave 3 isolated compound (24, 22, and 32 mg/mL). TLC profiling of 
the isolated compound showed one single dark blue spots at Rf value of 0.25.   
 
In order to obtain information about the chemical compounds contain in the M. aromatica essential 
oil, GC-MS analysis was performed. Table 2 and Figure 2 show the chemical composition of M. 
aromatica essential oil and the GC-MS spectra. Massoia lactone was shown to be the major 
compound (77%).  
 
Fig. 2: GC-MS profile of M. aromatica essential oil. The indicated compounds in the 
chromatograms are shown in Table 3. 
 
 
GC-MS analysis was also performed to check the chemical composition of the isolate compound. 
Table 3 and figure 3 showed that the isolated compound from M. aromatica oil obtained by 
preparative chromatography method followed by GC-MS analysis is 5-Hydroxy-2-Decenoic Acid 
Lactone $$ 2H-Pyrane-2-one, 5,6-dihydro-6-penthyl-, (R)-(CAS) (-)-Massoia lactone C10H16O2 (94%). In 
our previous study, we determined the amount of massoia lactone in massoia oil using TLC-
densitometry at 211 nm maximum wavelength. The content of massoia lactone in 1% v/v massoia oil 
was 0.55 % w/v respectively (Hertiani et al., manuscript in preparation). 
 
1D 1H-NMR elucidation was performed to ensure the structure of the massoia lactone obtained. H-
NMR  profile obtained (Figure 4) convinced the proposed structure recommended by the GC-MS i.e. 
C10H16O2 which was supported further by comparison to the data reported by Siminiatt (2007) and 
Harbindu and Kumar (2011) reccorded on CDCl3 as well (Table 4). The present of an aliphatic chain 
was confirmed by resonance peaks at the upfield region integrated as 11H which support a propyl 
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substituent.  A shift to more down field area was observed at  4.40-4.46 (1H, m) which represent an 
H-containing chiral carbon next to the lactone moiety (H-6).  A cis-vicinal H-H coupling of an alkene 
was observed between resonances at  6.87-6.92 and  6.03-6.06 having a coupling constant of 9.75 
Hz. These finding support the present of an , unsaturated lactone. Further splitting of the 
resonance peak is resulted from the present of an adjacent methylene (H-5). Considering that the 
only the R isomer is available in nature, the isolate is elucidated as Figure 4. 
 
We also assessed the anti-biofilm activity of massoia lactone in combination with antibiotic and anti-
fungal drug. The result showed that the median MBIC of individual fluconazole for C. albicans biofilm 
was 512 µg/mL, and the median MBIC of individual streptomycin for P. aeruginosa PAO1 and S. 
aureus Cowan I biofilm was 500 µg/mL.  The MBIC of fluconazole in combination with massoia 
lactone decreased four fold for C. albicans biofilm. The MBIC of streptomycin, in combination with 
massoia lactone decreased from 500 µg/mL to 125 µg/mL (Table 5, Figure 7). Therefore, the 
combination of streptomycin/massoia lactone yielded synergism activity against the biofilm of P. 
aeruginosa and S. aureus (FICI 0.5), whereas the combination of fluconazole/massoia lactone also 
gave a synergistic effect where the effect of the combination is greater than the sum of the 
individual effects, with FICI value of 0.375. The use of anti-microbial combinations may improve the 
management of microbial biofilm-associated infection, disrupt the biofilm and prevent the 
emergence of microbial resistance. Although the result showed that there is a synergistic activity of 
massioa lactone with streptomycin and fluconazole, the exact mechanism are still unknown and has 






































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Fig. 4: Massoia lactone chemical structure 
 
Effect of massoia lactone on microbial biofilms 
Biofilm infections are a major medical problem since they are difficult to eradicate and the source of 
many chronic infections. The discovery of anti-infective agents, which are active not only against 
cells but also against microbial biofilms, represents an important goal (Schillaci et al., 2008). 
Essential oils are mixtures of numerous organic chemicals, and some individual components are 
known to exhibit anti-microbial properties.  
 
The MTT assay was used to measure the efficacy of massoia lactone against microbial biofilm. In this 
assay, microorganisms with active electron transport system metabolically reduce the yellow 
tetrazolium salt (MTT) to water soluble purple formazan product. The color intensity of the soluble 
formazan was determined using a microplate reader at A550 (Mossmann, 1983). The colorimetric 
assay using MTT is quicker, more sensitive compare to the traditional anti-bacterial assay that use 
colony counting of bacteria on nutrient agar plates, and less expensive compare to XTT (Stevens and 
Olsen, 1993; Roehm et al., 1991). The disadvantage of MTT is that the formazan forms a crystalline 
presipitate needs to be solubilized first prior to absorbance measurements. 
 
In our study, we found the anti-biofilm potential of the massoia lactone. As the main compound 
isolated from M. aromatica bark essential oil, massoia lactone showed anti-biofilm activity against all 
the test organisms. A reduced level of biofilm formation was clearly observed against control 
(biofilm without the presence of the test compound). At concentration of 100 µg/mL, showed 
capability in inhibit  the formation of C. albicans intermediate biofilm as much as 82.25 ± 0.54% 
(***P<0.001), whereas at lower concentration (25 µg/mL)  massoia lactone capable to inhibit C. 
albicans intermediate biofilm formation as much as 49.98 ± 0.32% (**P<0.01).  The median biofilm 
inhibition concentration (MBIC50) for massoia lactone was at concentration of 50 µg/mL for P. 
aeruginosa biofilm (50.14 ± 0.08) (**P<0.01), and 100 µg/mL  for S. aureus biofilm (67.28 ± 0.28) 




Efficacy massoia lactone in inhibit microbial biofilm tested in microtiter plate using MTT method was 
confirmed by CLSM analysis. Intermediate phase (24h) of C. albicans biofilms were grown on the 
surface of coverslips and stained with SYTO9 and PI for the monitoring of live/dead cells. We 
observed a preventive activity on biofilm formation, when we inoculated C. albicans with different 
concentration of massoia lactone. Growth suppression of C. albicans biofilm by massoia oil was 
clearly seen by CLSM with the Live/Dead stain, compared with the dense biofilm growth of the 
control (Figure 6).   
 
Pretreatment of C. albicans biofilm with various concentrations of massoia lactone showed that 
there was a dose-dependent effect of massoia lactone on C. albicans biofilm formation. CLSM study 
showed that in the presence of massoia lactone (concentration of 100 µg/mL), a significant decrease 
of C. albicans biofilm biomass compare to negative control was evident (figure 6). When the 
concentration was decreased, we observed the increase amount of blastopores, pseudohyphae and 
mycelia in C. albicans biofilm biomass. The anti-biofilm activity thus may be due to the anti-fungal 
activity of the massoia lactone. 
 
The  effect  of  massoia  lactone  to microbial biofilms has  yet been scrutinized. Massoia lactone 
possess a characteristic α,β-unsaturated δ-lactone, which is also a common feature in a number of 
biologically active natural products such as (+)-geniothalamin, (-)-callystatin A, canolide A and the 
kava lactones, either different in the substituents at the C6 position or have a molecular structure 
architecture that maintains the α,β-unsaturated δ-lactone skeleton (Rali et al., 2007).  The 
mechanism of action of lactone against microorganims is not fully understood but it is speculated to 
be involved in membrane disruption, resulting in alterations in membrane permeability and leakage 
of intracellular materials. This compound could be able to penetrate through the polysaccharide 
matrix of a biofilm and dissolve lipids in the biofilm matrix (Cowan, 1999; Trombetta et al., 2005). In 
the presence of lactone, Yarrowia lipolytica lossed its cultivability and membrane integrity and 
addition of lactone in the medium provoked a decrease in the concentration of ergosterol (Ngoc Ta 
et al., 2010). However, a study by Kishimoto et al. (2005) suggested that the anti-fungal activity of 
massoia lactone is possibly due to its capability in inhibit respiratory system of C. albicans,  because 
it arrests oxygen consumption by C. albicans. Since the exact mechanism of anti-biofilm activity of 
massoia lactone remains unclear, study on a gene expression of C. albicans cells in response to 















































































































































































































































































































































































































































































































































































































































































































































































Table 5: MBICs of Massoia lactone and antibiotics alone and in combination, and fractional 
inhibitory concentration index (FICI) values against P. aeruginosa, S. aureus and C. albicans biofilm 
formation 
















50 12.5 0.25 0.5 synergy 
streptomycin 500 125 0.25 




100 25 0.25 0.5 synergy 





50 12.5 0.25 0.375 synergy 
fluconazole 512 64 0.125 
 
Massoia lactone has been synthesized from various methods (Ramachandran et al., 2000, Sabitha et 
al., 2007; Sato et al., 2001), however no investigation about its anti-biofilm activity has ever been 
conducted. In future research, the effect on P. aeruginosa and S. aureus biofilm architecture in the 
presence of massoia lactone could be examined.  
 
Hemolysis assay 
In order to measure the cytotoxicity of the massoia lactone, hemolytic activity test was performed 
using human red blood cells. Result demonstrated that massoia lactone showed a dose dependent 
increase in destroying red blood cell and release hemoglobin (Figure 8). At to the highest 
concentration tested (100 µg/mL), exerted as much as 12.4 ± 0.9 % human red blood cells hemolysis 
compare to Triton X-100 which gave 100% hemolysis. This result indicates that at the range 
concentration tested, massoia lactone is less toxic to the human erythrocytes.  
In nature massoia lactone is a rare essential oil component that was first characterized by Abe in 
1937 (Abe, 1937).  It is also present in Hierochloe odorata and H. australis that are commonly used in 
vodka production (Bernreuther et al., 1990), and has been isolated from mandibular glands 
formicine ants of the genus Camponotus as an alarm pheromone (Cavill et al., 1968). The pleasant 
and sweet light coconut odor of massoia lactone make this compound very useful as a flavor for milk 
and butter, in the manufacturing of alcoholic drinks and as aromatizer in perfumes  (Mineeva, 2012).  
IFRA (International Fragrance Association) prohibited the use of Massoia aromatica oil and massoia 
lactone because it was shown to be skin irritant and cause sensitization when it is applied in 
aromatheraphy. According to the study by Benoni and Hardebeck (1964), the oral toxicity (LD50) for 
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massoia lactone is 1890 mg/kg, however the recommended safety dosage for massoia lactone to be 
use as a fragrance ingredient is not yet available (Anonim, 2009).  
 
 
Fig. 8: Hemolytic activity of massoia lactone. Triton X-100 used as positive control. 
 
In the future, massoia lactone could be used for therapeutical  formulations to treat diseases caused 
by microorganisms. However, to be used as a drug for human and animal illness in pharmaceutical 
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Instead of the occurrence of freely swimming single (planktonic) cells, microorganisms in nature 
have the tendency to interact with surfaces or each other, initially in a reversible association and 
eventually in an irreversible adhesion, resulting in the development of adherent microbial biofilm. 
The formation of a biofilm is a universal microbial strategy for survival under unfavorable conditions 
such as desiccation, nutrient starvation, and anti-microbial treatments. The multicellular structure of 
the biofilm makes it possible for the microbes to differentiate (e.g. going into dormancy or 
hibernation), enabling them to survive the harsh conditions (Bordi and de Bentzmann, 2011). The 
microbials within a biofilm are generally much more resistance to biocides and antibiotics, and less 
well recognized by phagocytic cells or antibodies compared to their planktonic counterparts, which 
makes them a source of many uncontrollable infections, and extremely difficult to eradicate 
(Schahter, 2003).  
Pseudomonas aeruginosa, Staphylococcus aureus, and Candida albicans are opportunistic pathogens 
capable of causing biofilm infections on both natural body surfaces as well as medical devices such 
as contact lenses, central venous catheters and needleless connectors, endotracheal tubes, 
intrauterine devices (IUDs), mechanical heart valves, pacemakers, peritoneal dialysis catheters, 
prosthetic joints, ear tubes, urinary catheters, and voice prostheses. They are major contributors to 
diseases that are characterised by an underlying microbial infection and chronic inflammation, e.g. 
periodontal disease, cystic fibrosis, chronic acne and osteomyelitis (Costerton et al., 1999). Chronic 
biofilm infections cause inflammation, which is linked to carcinogenesis (Coussens and Werb, 2002). 
Biofilm related chronic mucocutaneous candidiosis (CMC) has been associated with a significant risk 
for oral cancer in vivo (Marttila et al., 2013). Biofilms are also found in wounds and are suspected to 
delay healing. Electron microscopy of biopsies from chronic wounds found that 60% of the 
specimens contained biofilm structures in comparison with only 6% of biopsies from acute wounds 
(James et al., 2008). According to a recent public announcement from the National Institutes of 
Health (NIH), approximately 65% of microbial infections in humans are biofilm-related (Soto, 2014). 
 This makes the discovery of anti-infective agents which are active against planktonic and biofilm 
microbial represents an important goal (Veeh et al., 2003; Soto, 2014; Mathé and Van Dijck, 2013; 
Tran et al., 2009).  
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Medicinal plants have been a source of wide variety of biologically active compounds for many 
centuries and used extensively as crude material or as pure compounds for applied for the 
treatment of inflammations, wounds, certain forms of cancer, infections due to bacteria, virus or 
fungi, and many more  (Arif et al., 2009). It is estimated that there are 250.000 to 500.000 species of 
plants on earth and 1 to 10% of these plants are used by humans (Cowan, 1999). The beneficial 
medicinal effects of plant materials typically result from the combinations of secondary metabolites 
present in the plant (Saranraj and Sivasakhti, 2014). In many cases, these substances serve as plant 
defense mechanism against microorganisms, insect, and herbivores. Some substances are 
responsible for plant odor, flavor and pigment (Cowan, 1999).  
The plant’s role is twofold in the development of new drugs. They may become the natural template 
for the development of a new medicine, and they may become a phytomedicine to be used to treat 
various disease conditions. The use of anti-microbials and other drugs derived from plants is widely 
accepted by modern (conventional) medicine, as traditional antibiotics become ineffective (Arif et 
al., 2009). Clinical microbiologists have two reasons to be interested in the topic of anti-microbial 
plant extracts. Firstly because there is a need to develop alternative anti-microbial drugs as the 
increasing resistance against many microbial infections due to the misuse of commonly used anti-
microbial drugs. Secondly, because the scientists realize that the effective life span of any antibiotic 
is limited and new sources of antibiotics, including from plant sources, are required. In addition, the 
increasing interest in natural product as an alternative form of medical treatments contributes the 
developing of anti-microbial from plant extract into medicines (Cowan, 1999). Many commercially 
exploited drugs in modern medicine were initially used in crude form in traditional medicine 
indicating potentially useful biological activity. The primary benefits of using plant derived medicines 
are the perception that they are relatively safer, and have a long history of use in folk medicine for 
the cure and prevention of infections and diseases, offering profound therapeutic benefits and more 
affordable treatment (Sandasi et al., 2009; Ciocan and Bara, 2007). Application of phytochemical 
methods in medical treatments has led to the isolation of a wide range of natural compounds from 
the various plant species and include quinones, numerous flavonoids, tannins, comarins, terpenoids 
and essential oils, alkaloids, and other compounds of plant extracts (Samy and Gopalakrishnakone, 
2010; Doughari 2012).  
Indonesia is an archipelago country of more than 17000 islands straddling the equator in Southeast 
Asia. Indonesia considered to be rich in biodiversity, the second richest after Brazil, with at least 47 
distinct natural ecosystems which are rich in plant and animal resources and large number of islands 
endemics, with the total known species about 1.46 million. Indonesia also plays a key role in the 
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herbal medicine industry in regards to its rich biological heritage, cultural background and 
population (Nitis, 1999).  Indonesia has more than 38.000 plants species, about 9.600 are listed as 
medicinal plants and according to Indonesian National Agency of Drug and Food Control, NADFC 
(Badan Pengawas Obat dan Makanan Republik Indonesia, BPOM RI), only around 300 plant species 
have been studied scientifically for their medicinal properties and are officially registered and used 
commercially as traditional medicine. The larger remaining part still requires research and screening 
for their potential medicinal properties. The use of plants to treat common ailments to fertility aid 
(BPOM RI, 2008; Schonhardt, 2010; Neubauer, 2002) is common and important among Indonesian 
people from generations to generations, but much of the information regarding medicinal plants is 
empirical and lacking logical validation (Diba et al., 2013). Most of the Indonesian people have ever 
used traditional herbal medicines which are popularly known as jamu. Jamu is a word in Javanese 
tribe language, meaning the traditional medicine from plants. Today, jamu has been adopted into 
Bahasa Indonesia with the similar meaning (Limyati and Juniar, 1998; Elfahmi et al., 2014). Many 
institutions in Indonesia, especially governmental institutions such as the Ministry of Health, and the 
NADFC (BPOM RI) as well as the universities are actively involved in plant research in the area of 
medicine, pharmacy, chemistry, biology, agriculture, forestry, marine, environment and engineering. 
Lots of study have been conducted on the biological activities of the most common plants used 
in Indonesian traditional medicine, e.g. Piper betle, Caesalpinia sappan, Cinnamomum  burmannii, C. 
sintoc, Syzigium aromaticum, Nymphaea nouchali, Kaempferia rotunda and Massoia aromatica, as 
reported in the literatures (Nawawi et al., 1999; Sangat and Larashati, 2002;  Batugal et al., 2004; 
Atmadja et al., 2009; Elfahmi et al., 2014, Wijaya et al., 2014), however, very few studies have 
investigated Indonesian medicinal plants for their anti-quorum sensing and anti-biofilm activities, 
including in P. aeruginosa, S. aureus and C. albicans.  
From our study, we found biofilm formation inhibition and biofilm breakdown activities from 
ethanol extracts of K. rotunda, C. burmannii, C. sintoc, C. sappan, and N. nouchali as well as essential 
oils of C. burmannii, M. aromatica, O. basilicum and L. cubeba against P. aeruginosa and S. aureus 
biofilm (Chapter 2 and 3, this thesis). Biofilm formation of C. albicans was suppressed by C. 
burmannii and M. aromatica essential oils. Both oils also showed capability in disturbing established 
C. albicans biofilm (Chapter 4, this thesis). Further research involving C. burmannii and M. aromatica 
oils revealed that both oils also have capacity to impede violacein pigment production related 
quorum sensing activity of Chromobacterium violaceum, a reporter strain in quorum sensing 
(Chapter 5, this thesis). 
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According to Shan et al., (2007), the extract of C. burmannii showed significant anti-bacterial activity 
against five common food-borne pathogenic bacteria such as Bacillus cereus, Listeria 
monocytogenes, S. aureus, Escherichia coli, and Salmonella anatum. Among the strains, the highest 
activity observed was against S. aureus and the least activity was observed against E. coli. Highly 
positive relationships were observed between anti-bacterial activities and phenolic content of the 
tested extracts against each bacterium. The study suggested that the anti-bacterial activity of the 
tested extracts were closely associated with their phenolic constituents. Nuryastuti et al., (2009) 
showed the potency of C. burmannii oil to combat both planktonic and biofilm cultures of clinical 
Streptococcus epidermidis strains, with MICs, ranging from 0.5 to 1% and 1 to 2%, respectively. CLSM 
images indicated that cinnamon oil is able to detach and kill existing biofilms. 
Trans-cinnamaldehyde (TCA) has been identified as one of the bioactive compounds in C. burmannii 
(Lv et al., 2010). Jia et al., (2011) found that cinnamaldehyde, a major constituent of cinnamon 
essential oils, occurs naturally in the bark and leaves of cinnamon trees of the genus Cinnamomum 
could inhibit the biofilm formation of S. aureus ATCC 25923 in a dose-dependent manner, with MICs 
and MBCs were in the range of 0.06–0.5% (v ⁄ v).   
Cinnamaldehyde is also known to possess anti-fungal properties. MIC of cinnamaldehyde against 
clinical isolate of C. albicans and C. tropicalis was 400 μg/mL and 500 μg/mL (Shreaz et al., 2010). 
Study from Khan and Ahmad (2011) revealed that cinnamaldehyde alone or in combination with 
fluconazole and amphotericin B exhibit strong anti-biofilm activity against C. albicans biofilm, with 
the SMICs of 200–400 mg/L for C. albicans 04 and 100–360 mg/L for C. albicans SC5314. Further 
studies to mechanism of action suggested that cinnamaldehyde has an anti-fungal activity by 
targeting cell membrane integrity of yeast cells (Bennis et al., 2004), decreased ergosterol content 
(Mukherjee et al., 2003) and diminished level of ergosterol biosynthesis gene expression (Garcia-
Sanchez et al., 2004). Inhibition of H (+) (-) ATPase leads to intracellular acidification and cell death 
(Shreaz et al., 2010).  The defects in the cell wall are coupled with altered morphology and the 
inability of Candida cells to form hyphae and generate a biofilm. These defect in cell membrane 
integrity was notably translate into reduced pathogenicity of the Candida strain (Tan et al., 2014). 
In chapter 6 of this thesis, we isolated the major compound of M. aromatica oil using preparative 
thin layer chromatography (TLC). 1H-NMR analysis confirmed that the compound obtained is massoia 
lactone (C10H16O2). Massoia lactone is a rare essential oil component and has only been found in a 
few other plants such as in cane sugar, tobacco and Osmanthus fragrans. Massoia lactone has an 
odour that is described as sweet, coconut-like and slightly fruity (Rali et al., 2007). We discovered 
that massoia lactone exhibit anti-biofilm activity against P. aeruginosa, S. aureus, and C. albicans.  
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However, we found no activity of massoia lactone toward established biofilms of the 
microorganisms tested.  
 
Various studies reported in vitro biological activity of massoia lactone related compounds against 
bacteria or fungi. Simionatto et al. (2007) reported that massoia lactone isolated from Aeolanthus 
suaveolens Mart. ex Spreng has anti-bacterial activity against P. aeruginosa. Anti-fungal activity of 
massoia lactone has been reported by Walter et al. (2000), and Kishimoto et al. (2005). It was 
suggested that the anti-fungal activity of massoia lactone is possibly due to its capability to inhibit 
the respiratory system of C. albicans because it arrested oxygen consumption by C. albicans. Efficacy 
of several lactone compounds against bacterial and fungal biofilm has also been reported. Plant 
sesquiterpene lactones are known as an inhibitory agent of P. aeruginosa biofilm formation 
(Cartagena et al., 2007). A 3-oxo-C12 homoserine lactone is also reported to hinderithe 
filamentation of C. albicans by blocking the yeast-to-hyphal shift, an essential step for the adherence 
of Candida cells to a substrate to form a biofilm (Hall et al., 2011). Little is known about effects of 
massoia lactone on Candida biofilm formation or breakdown on the molecular level. A gene 
expression study of C. albicans biofilm cells in response to massoia lactone will be interesting to shed 
some further light on the molecular mechanism by which massoia lactone affects biofilm formation 
or breakdown. 
 
Some selected natural products have already been found exhibit efficacy in influencing microbial 
biofilm formation. For example, halogenated furanone isolated from red algae Delisea pulchra, are 
thought to have evolved to interfere bacterial quorum sensing (Mannefield et al., 1999). Other 
compounds disturb microbial biofilm by inhibit peptidoglycan synthesis (Ogunlana et al., 1987), 
damage microbial membrane structure (Cox et al., 2000), change bacterial membrane surface 
hydrophobicity (Turi et al., 1997), and inhibit quorum sensing (Gao et al., 2003; Shayan and Saeidi, 
2013).  
It remains an important challenge to develop massoia lactone that has been isolated from this study 
into a new anti-biofilm drug. The process of drug discovery and development is a long-term, 
competitive, expensive and complicated (Mandal et al., 2009). The hit compound obtained from a 
screening process still has to be evaluated and undergo limited optimization to identify promising 
lead compound. The hit compound which shows biological activity has to be evaluated to determine 
its drug-like properties.  Christopher A. Lipinski in 1997 formulated 5 rules, known as Lipinski’s rule-
of-five or Pfizer’s rule-of-five, based on the observation that most orally administered drugs are 
relatively small and moderately lipophilic molecules. The rule requires that a hit molecule must have 
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no more than 5 hydrogen bond donors, not more than 10 hydrogen bond acceptors, a molecular 
mass less than 500 dalton, a partition coefficient (logP – a measure of hydrophobicity) less than 5 
(Lipinski, 2004; Hefti, 2008). Massoia lactone is found to have 1 hydrogen bond donor, 2 hydrogen 
bond acceptors, a molecular mass of 168.24 dalton, and a partition coefficient of 2.419 (NCBI, 2014; 
ChemAxon, 2014), thus it fits Pfizer’s rule-of-five requirements.  
 
The lead compound has to undergo extensive optimization and trial programs before it can be 
considered as a successful drug. For this purpose, the lead compound is tested in cells (in vitro) and 
in animals (in vivo) to study its pharmacokinetics which include absorption, distribution, metabolism, 
excretion (ADME) and toxicology. The successful lead candidate, now called drug candidate, must be 
non-toxic, have a good bioavailability, can be distributed to the drug target in the body, can be 
metabolized efficiently and effectively as well as successfully excreted from the body. This part of 
the development process is referred to as the ‘preclinical phase’ and drug candidate is prepared for 
testing in humans. This phase is followed by the ‘clinical phase’ of development, in which the 
efficacy and safety of a drug candidate is scrutinized in patients (Saha, 2014). Although the road is 
well mapped out, it is certainly not easy or guaranteed to end in success (Hefti, 2008). 
  
Therefore, further studies need to be conducted to examine the potency of massoia lactone as 
biofilm related drug, especially in immunosuppressed patient. The effect of massoia lactone to 
immune response has yet been investigated. However, other lactone subtances, such as homoserine 
lactone (Khajanci et al., 2011), macrolides lactone (Nau and Tauber, 2008), and sesquiterpene 
lactone (Niphade et al., 2009), do have immunomodulatory properties.  Due to its potential adverse 
side effects, massoia lactone also has to be tested for its selective toxicity towards normal cell. 
Cytotoxicity on host cells is a very important standard for assessing the selectivity of the observed 
pharmacological activities (Cos et al., 2006). Many drug development process are discontinued due 
to safety problems such as unfavorable toxic side effects, cardiac toxicity, etc (Mandal et al., 2009). 
The toxicity of massoia lactone towards normal cells needs to be determined. 
 
REFERENCES  
Arif, T., Bhosale, J.D., Kumar, N., Mandal, T.K., Bendre, S., Lavekar G.S., Dabur R., 2009, Natural 
Products-Anti-fungal Agents Derived From Plants, J Asian Nat Prod Res., 11(7): 621-638. 
 
 195 
Atmadja, W.R, Ma’mun, Suriati S., 2009, Efektifitas Minyak Masoyi (Massoia aromatica) Terhadap 
Helopeltis antonii Sign. Pada Jambu Mete dan Chrysocoris javanus Pada Jarak Pagar, Bull Littro.,  20 
(2): 141 – 147. 
Batugal, P.A., Kanniah J., Young, L.S., Oliver, J.T. (Eds)., 2004. Medicinal Plants Research in Asia, 
Volume 1: The Framework and Project Workplans. International Plant Genetic Resources Institute – 
Regional Office for Asia, the Pacific and Oceania (IPGRI-APO), Serdang, Selangor 
DE, Malaysia. Available online: 
http://www.bioversityinternational.org/uploads/tx_news/Medicinal_plants_research_in_Asia_944.p
df , Access date: 11 August 2013. 
 
Bennis, S., Chami, F., Chami, N., Bouchiki, T., Remmal, A., 2004, Surface Alteration of Saccharomyces 
cerevisiae Induced By Thymol and Eugenol, Lett Appl Microbiol., 38(6): 454-8.  
 
Bordi, C.,  de Bentzmann, S., 2011, Hacking Into Bacterial Biofilms : A New Therapeutics Challenge, 
Ann  Intensive Care.,  1: 19. Available online: 
http://www.annalsofintensivecare.com/content/pdf/2110-5820-1-19.pdf.  
 
BPOM RI. Badan POM RI. Direktorat obat asli Indonesia BPOM.  2008. Taksonomi Koleksi Tanaman 
Obat Kebun Tanaman Obat Citerreup. Available online : 
http://perpustakaan.pom.go.id/ebook/Taksonomi%20Koleksi%20Tanaman%20Obat%20Kebun%20T
anaman%20Obat%20Citeureup/Cinnamomum%20burmani%20(Ness%20&%20T.%20Nees)%20Blum
e.pdf, Access date: 8 May 2011. 
 
Cartagena, E., Colom, O.A., Neske, A., Valdez, J.C., Bardón., 2007, Effects of Plant Lactones on The 
Production of Biofilm of Pseudomonas aeruginosa, Chem Pharm Bull., 55: 22-25. 
 
Chao, L.K., Hua, K.F., Hsu, H.Y., Cheng, S.S., Liu ,J.Y., Chang, S.T., 2005, Study on the  
Antiinflammatory  Activity  Of  Essential  Oil  From  Leaves  of  Cinnamomum osmophloeum, J Agri 
Food Chem., 53: 7274–7278. 
ChemAxon, 2014, Chemical Structure of massoia lactone, Available online: 
http://www.chemicalize.org/structure/#!mol=O%3DC%5C1OC%28CCCCC%29C%2FC%3DC%2F1, 
Access date: 16 December 2014. 
Ciocan, I.D., Bara, I.I., 2007, Plant Products as Anti-microbial Agents, Analele Stiintifice ale 
Universitatii “Alexandru Ioan Cuza”, Sectiinea Genetica si Biologie Moleculara, TOM VIII, 151-156.  
Cos, P., Vlietinck, A.J., Berghe, D.V., Maes, L., 2006, Anti-infective Potential of Natural Products: How 
to Develop A Stronger In Vitro Proof-of-Concept, J Ethnopharmacol., 106: 290-302. 
Costerton, J.W., Stewart, P.S., Greenberg, E.P., 1999, Bacterial Biofilms: A Common Cause of 
Persistent Infections, Science, 284(5418): 1318-22. 
Coussens, L.M., Werb, Z., 2002, Inflammation and Cancer, Nature, 420(6917): 860-867. 
Cowan, M.M., 1999, Plant Products as Anti-microbial Agents, Clin Microbiol Rev., 12(4): 564-582. 
Cox, S., Mann, C., Markham, L., Bell, H., Gustafson, J., 2000, The Mode of Action of The Essential Oil 




Diba, F., Yusro, F., Mariani, Y., Ohtani, K., 2013, Inventory and Biodiversity of Medicinal Plants from 
Tropical Rain Forest Based on Traditional Knowledge by Ethnic Dayaknese Communities in West 
Kalimantan Indonesia, Kurushio Sci., 7(1): 75-80. 
 
Doughari, J.H., 2012, Phytochemicals: Extraction Methods, Basic Structures and Mode of Action as 
Potential Chemotherapeutic Agents, In:  Rao, V. (Ed.), Phytochemicals - A Global Perspective of Their 
Role in Nutrition and Health, InTech, ISBN: 978-953-51-0296-0, Available from: 
http://cdn.intechopen.com/pdfs-wm/32936.pdf. 
Elfahmi, Woerdenbag, H.J., Kayser, O.,  2014,  Jamu: Indonesian Traditional Herbal Medicine 
Towards Rational Phytopharmacological Use, J Herb Med., 4(2): 51-73. 
Gao, M., Teplitski, J., Robinson, W., 2003, Production of Substances by Medica gotruncatula that 
Affect Bacterial Quorum Sensing, Mol Plant-Microb Interact., 16: 827-834.  
 
Garcia-Sanchez, S., Aubert, S., Iraqui, I., Janbon, G., Ghigo, J.M., D’Enfert, 2004, C.  Candida 
albicans Biofilms: A Developmental State Associated With Specific and Stable Gene Expression 
Patterns, Eukaryot Cell., 3(2): 536-45. 
 
Hall, R.A., Turner, K.J., Chaloupka, J., Cotteir, F., De Sordi, L., Sanglard, D., Levin, L.R., Buck, J., 
Mühlschlegel, F.A., 2011, The Quorum Sensing Molecules Farnesol/Homoserine Lactone and 
Dodecanol Operate Via Distinct Modes of Action in Candida albicans, Eukaryot Cell., 10: 1034-1042. 
 
Hefti, F.F., 2008, Requirements for A Lead Compound to Become A Clinical Candidate, BMC 
Neurosci., 9(3): S7. 
 
James, G.A., Swogger, E., Wolcott, R., Pulcini, E.D., Seco, P., Sestrich, J., Costerton, J.W., Stewart, P.S., 
2008, Biofilms in Chronic Wounds, Wound Repair Regen., 16(1): 37-44. 
Jia, P., Xue, Y.J., Duan, X.J., Shao, S.H., 2011, Effect of Cinnamaldehyde on Biofilm Formation and 
sarA Expression by Methicillin-Resistant Staphylococcus aureus, Lett Appl Microbiol., 53(4): 409-416. 
 
Khajanchi, B.K., Kirtley, M.L., Brackman, S.M., Chopra, A.K., 2011, Immunomodulatory and Protective 
Roles of Quorum-Sensing Signaling Molecules N-Acyl Homoserine Lactones During Infection of Mice 
with Aeromonas hydrophila, Infect Immun.,  79:  2646–2657. 
 
Khan, M.S.A., Ahmad, I., 2011, Anti-biofilm Activity of Certain Phytocompounds and Their Synergy 
With Fluconazole Against Candida albicans Biofilms, J Antimicrob Chemother.,  67(3): 618-621. 
 
Kishimoto, N., Sugihara, S., Mochida, K., Fujita, T., 2005, In Vitro Anti-fungal and Antiviral Activities of 
γ-and δ-Lactone Analogs Utilized as Food Flavoring, Biocontrol Sci., 10 (1-2): 31-36. 
 
Limyati, D.A., Juniar, B.L.L., 1998, Jamu Gendong, A Kind of Traditional Medicine in Indonesia: The 
Microbial Contamination of Its Raw Materials and Endproduct, J Ethnopharmacol., 63(3): 201-208. 
 
Lipinski, C.A., 2004, Lead- and Drug-Like Compounds: The Rule-of-Five Revolution, Drug Dis Today: 




Lv, G., Huang, W., Yang, F., Li, J., Li, S., 2010, Pressurized Liquid Extraction and GC-MS Analysis for 
Simultaneous Determination of Seven Components in Cinnamomum cassia and Effect of Sample 
Preparation,  J Sep Sci., 33: 2341–2348. 
 
Mandal, S., Moudgil, M., Mandal, S.K., 2009, Rational Drug Design, Eur J Pharm., 625: 90-100.  
 
Manefield, M., de Nys, R., Kumar, N., Read, R., Givskov, M., Steinberg, P., Kjelleberg, S., 1999, 
Evidence That Halogenated Furanones from Delisea pulchra Inhibit Acylated Homoserine Lactone 
(AHL)-Mediated Gene Expression by Displacing The AHL Signal From Its Receptor Protein. 
Microbiology, 145(2): 283-91. 
 
Marttila, E., Uittamo, J., Rusanen, P., Lindqvist, C., Salaspuro, M., Rautemaa, R., 2013, Acetaldehyde 
Production and Microbial Colonization in Oral Squamous Cell Carcinoma and Oral Lichenoid Disease, 
Oral Surg Oral Med Oral Pathol Oral Radiol., 116: 61–68. 
Mathé, L., Van Dijck, P., 2013, Recent Insights into Candida albicans Biofilm Resistance Mechanisms, 
Curr Genet., 59(4):251-64. 
 
Mukherjee, P.K., Chandra, J., Kuhn, D.M., Ghannoum, M.A., 2003, Mechanism of Fluconazole 
Resistance in Candida albicans Biofilms: Phase-Specific Role of Efflux Pumps and Membrane 
Sterols, Infect Immun., 71(8): 4333-40. 
 
NCBI (National Center for Biotechnology Information), 2014, PubChem Compound Database: 
CID=22788906, Available online: https://pubchem.ncbi.nlm.nih.gov/compound/22788906, Access 
date: 16 December 2014. 
 
Nau, R., Tauber, S.C., 2008, Immunomodulatory Properties of Antibiotics, Curr Mol Pharmacol., 1: 
68–79.  
 
Nawawi, A., Nakamura, N., Hattori, M., Kurokawa, M., Shiraki, K., 1999, Inhibitory Effects of 
Indonesian Medicinal Plants on the Infection of Herpes Simplex Virus Type 1, Phytother Res.,  13 : 
37–41. 
Neubauer, L. , 2012,  Jamu : Why Isn't Indonesia's Ancient System of Herbal Healing Better Known?, Time 
Magazine, Available online : http://content.time.com/time/world/article/0,8599,2107489,00.html, 
Access  date : 11 August 2013. 
 
Niphade, S.R., Asad, M., Chandrakala, G.K., Toppo, E., Deshmukh, P., 2009, Immunomodulatory 
Activity of Cinnamomum zeylanicum Bark. Pharm Biol., 47: 1168–1173.  
 
Nitis, I.M., 1999, Country Pasture/Forage Resources Profiles Indonesia, In: Reynolds, S.G. (Ed.), Food 
and Agriculture Orgaization of the United Nations Report Indonesia: Agriculture Sector 2006, 
Available online : www.fao.org/ag/AGP/AGPC/doc/Counprof/Indonesia/Indones.htm, Access date: 
10 October 2014. 
 
Nuryastuti, T., Mei, H.V.D., Busscher, H.J., Iravati, S., Aman, A.T., Krom, B.P., 2009, Effect of 
Cinnamon Oil on icaA Expression and Biofilm Formation by Staphylococcus epidermidis, Appl Environ 
Microbiol., 75(21): 6850-6855.  
 
Ogunlana, E., Hoeglund, G., Onawunmi, O., 1987, Effects of Lemongrass Oil on The Morphological 




Rali T, Wossa SW, leach DN., 2007, Comparative Chemical Analysis of the Essential Oil Constituents 
in The Bark, Heartwood and Fruits of Cryptocarya massoy (Oken) Kosterm. (Lauraceae) From Papua 
New Guinea, Molecules, 12: 149-154.  
 
Saha, L., 2014, Role of Pharmacovigilance in drug development, Enliven : Pharmacovigil Drug Saf., 
1(1): e002, Available online: http://www.enlivenarchive.org/pharmacovigilance-drug-safety-
e002.pdf, Access date 14 November 2014. 
 
Samy, R.P., Gopalakrishnakone, P., 2010, Therapeutic Potential of Medicinal Plants as Anti-microbials 
for Drug Discovery, eCAM, 7(3): 283-294. 
Sandasi, M., Leonard, C.M., Viljoen, A.M., 2010, The In Vitro Anti-biofilm Activity of Selected Culinary 
Herbs and Medicinal Plants Against Listeria monocytogenes, Lett Appl Microbiol., 50(1): 30-35. 
Sangat, H.M., Larashati, I., 2002, Some Ethnophytomedical Aspects and Conservation Strategy of 
Several Medicinal Plants in Java Indonesia, Biodiversitas., 3(2): 231-235.  
 
Saranraj, P., Sivasakthi, S., 2014, Medicinal Plants and Its Anti-microbial Properties : A Review, Global 
J Pharmacol., 8(3): 316-327.  
 
Schahter, B., 2003, Slimmy Business – The Biotechnology of Biofilms, Nature Biotech., 21: 361-365. 
 
Schonhardt, S., 2010, Jamu Power: Indonesia's Cure-All Elixir, CNN Travel, Available online: 
http://travel.cnn.com/explorations/drink/power-jamu-gods-350690, Access  date: 11 August 2013. 
 
Shan, B., Cai, Y.Z., Brooks, J.D., Corke, H., 2007, Anti-bacterial Properties and Major Bioactive 
Components of Cinnamon Stick (Cinnamomum burmannii): Activity Against Foodborne Pathogenic 
Bacteria, J Agric Food Chem., 55: 5484–90.  
 
Shayan, S., Saeidi, S., 2013, Anti-bacterial and Anti-biofilm Activities of Extract Capsicum annuum L 
on The Growth and Biofilm Formation of Common Pathogenic Strain, Int Res J Appl Basis Sci., 5(4): 
513-518. 
 
Shreaz, S., Sheikh, R.A., Bhatia, R., Hashmi, A.A., Nikhat, M., Khan, L.A., 2010, Anticandidal Activity of 
Cinnamaldehyde, Its Ligand and Ni(II) Complex: Effect of Increase in Ring and Side Chain, Microb 
Pathog., 49(3): 75-82.  
 
Simionatto, E., 2007, Chemical Composition and Anti-microbial Activity of The Essential Oil From 
Aeolanthus suaveolens MART. ex Spreng., Quim Nova,  30(8): 1923-1925.  
 
Soto, S., 2014, Importance of Biofilms in Urinary Tract Infections: New Therapeutic Approaches. Adv 
Biol, Article ID 543974, 13 pages.  
 
Tan, X., Fuchs, B.B., Wang, Y., Chen, W., J. Yuen, G., Chen, R.B., Jayamani, E., Anastassapoulou, C., 
Pukkila-Worley, R., Coleman, J.J., Mylonakis, E., 2014, The Role of Candida albicans SPT20 in 
Filamentation, Biofilm Formation and Pathogenesis, PLoS ONE, 9(4): e94468. 
doi:10.1371/journal.pone.0094468.  
Tran, P.L., Hammond, A.A., Mosley, T., Cortez, J., Gray, T., Colmer-Hamood, J.A., Shashtri, M., 
Spallholz, J.E., Hamood, A.N., Reid, T.W., 2009,  Organoselenium Coating on Cellulose Inhibits the 
Formation of Biofilms by Pseudomonas aeruginosa and Staphylococcus aureus, Appl Environ 




Turi, M., Turi, S., Koljalg, R., 1997, Influence of Aqueous Extracts of Medicinal Plants on Surface 
Hydrophobicity of Escherichia Coli Strains of Different Origin, APMIS, 105: 956-962. 
 
Walter, M., Boyd-Wilson, K.S.H., Perry, J.H., Hill, R.A., 2000, Botrytis Tolerance to 6-Pentyl-Alpha-
Pyrone and Massoialactone, New Zealand Plant Protec., 53: 375-381. 
 
Wijaya, S.H., Husnawati, H., Afendi, F.M., Batubara, I., Darusman, L.K., Altaf-Ul-Amin, M., Sato, T., 
Ono, N., Sugiura, T., Kanaya, S., 2014, Supervised Clustering Based on DPClusO : Prediction of Plant-
Disease Relations Using Jamu Formulas of KNApSAcK Database. BioMed Res Intl., Article ID 831751, 
15 pages, Available online: http://dx.doi.org/10.1155/2014/831751, Access date: 14 November 
2014. 
Veeh, R.H., Shirtliff, M.E., Petik, J.R., Flood, J.A., Davis, C.C., Seymour, J.L., Hansmann, M.A., Kerr, 
K.M., Pasmore, M.E., Costerton, J.W., 2003, Detection of Staphylococcus aureus Biofilm on Tampons 
and Menses Components, J Infect Dis., 188: 519–530. 
Zhang, J., Liu, L., He, Y., Kong, W., Huang, S., 2010, Cytotoxic Effect of Trans-Cinnamaldehyde on 


































































Microbial resistance to most commonly antibiotics is increasing and therefore requiring continuous 
development of new anti-microbial agents. Moreover, recent research has revealed that microbial 
biofilms causing elevated resistance to both most anti-microbial drugs and the host defense systems, 
which often results in persistent and difficult-to-treat infections. The discovery of anti-infective 
agents which are active against planktonic and biofilm microorganisms are therefore urgently 
required to deal with these biofilm-mediated infections. 
Recently, scientists have focused on the anti-pathogenic potential of natural products. Plants are an 
interesting and important source for finding novel anti-biofilm compounds. They are a rich source of 
new molecules with pharmacological properties for the development of new drugs. Indonesia is one 
of the countries which has a very diverse flora and a rich tradition in the use of medicinal plants. 
Since several Indonesian medicinal plants contain anti-microbial compounds it was considered 
conceivable that they might also be a source of new anti-biofilm compounds. Therefore the research 
present in this thesis has been focused on the screening and identification of mixtures with anti-
microbial and anti-biofilm activity, which may contain candidate compounds for developing new 
anti-biofilm drugs.  
 
In Chapter 1 a description is given about microbial biofilms which colonize polymer surfaces and 
forms a multilayered cell cluster. The biofilms are difficult to control due to their recurrence and high 
inherent resistance to anti-microbial agents and host immune responses. Quorum sensing, a cell-to-
cell communication between microorganisms, is responsible for biofilm formation by 
microorganisms and plays an important key in microbial pathogenicity and antibiotic resistance. 
Infections due to the presence of microbial biofilms are major clinical concerns since they have the 
ability to adhere to and colonize surfaces of medical devices like e.g. implants. In many cases, this 
device has to be removed in order to cure the infections. These medical issues can be prevented if 
novel anti-microbials with high activity against microbial biofilms are discovered and identified. 
Medicinal plants are considered as an interesting source for novel anti-biofilm compounds. Plant-
derived compounds have gained widespread interest in the search of drugs from natural sources. 
The compounds are widely accepted because of the perception that they are safe and have a long 
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history of use in folk medicine or treatment and prevention of the diseases and infections. In this 
chapter, we also discussed Pseudomonas aeruginosa, Staphylococcus aureus and Candida albicans as 
model microorganisms which are capable to form biofilm, and their pathogenicity. 
 
Chapter 2 describes the screening of 54 ethanol extracts of different Indonesian medicinal plants for 
the presence of anti-microbial and anti-biofilm compounds against P. aeruginosa PAO1 and 
Staphylococcus aureus Cowan I. The extracts showed an inhibitory effect on planktonic grown 
bacteria but even more interestingly also on the formation of biofilm structures. At a concentration 
as low as 0.12 mg/mL, biofilm formation of P. aeruginosa PAO1 and S. aureus Cowan I is inhibited by 
5 plant ethanol extracts : Kaempferia rotunda L., Caesalpinia sappan L., Cinnamomum burmanii Nees 
ex Bl., C. sintoc L., and Nymphaea nouchali Burm.f. The same extracts showed activity in degradation 
of the established biofilm of bacterial strains tested with higher concentration. Limited bacteriostatic 
activity was evident. This study demonstrated the effectiveness of Kaempferia rotunda L., C. sappan 
L., C. burmanii Nees ex Bl., C. sintoc L., and N.a nouchali Burm.f extract towards P. aeruginosa PAO1 
and S. aureus Cowan I biofilm. This property can be applied clinically to treat infectious biofilm along 
with conventional antibiotics, or applied industrially e.g. to remove biofilms from water pipes (Kim 
and Park, 2013). 
 
In Chapter 3 and 4 we report screening for anti-biofilm compounds in 29 essential oils from  
Indonesian medicinal plants against P. aeruginosa PAO1, S. aureus Cowan I, and towards C. albicans 
ATCC 10231 biofilms. Candida cells, like many other microorganisms, are able to adhere to and 
colonize surfaces of medical devices, resulting in development of a biofilm. The anti-biofilm activity 
of essential oils was confirmed by confocal laser scanning microscope analysis, along with LIVE/DEAD 
staining for the monitoring of live/dead cells. Essential oil from C. burmanii and M. aromatica 
showed a 50% inhibition of P. aeruginosa PAO1 and S. aureus Cowan I planktonic growth (PMIC50) at 
concentration of 0.25 % v/v. Essential oil from C. burmanii and M.  aromatica have been 
demonstrated to exhibit 50% (MBIC50) of P. aeruginosa PAO1 and S. aureus Cowan I biofilm 
formation at concentration of 0.03 % v/v, whereas higher concentration (0.12 % v/v) was needed by 
both oils to disrupt 50% of P. aeruginosa PAO1 and S. aureus Cowan I established biofilms.  
 
The essential oil of C. burmanii, M. aromatica, O. basillicum and L. cubeba (seeds part) showed an 
evident antifungal activity against planktonic growth of C. albicans and inhibited the formation of C. 
albicans biofilm at three different stages of development at a sub-PMIC concentration. The initial 
biofilm formation inhibition by plant essential oils was found to be concentration dependent. In the 
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presence of the essential oils, a significant decrease of biofilm biomass compared to negative control 
(biofilm cells without addition of plant essential oil) was evident. We also analyzed major 
components contained in Cinnamomum oil and Massoia oil by GC-MS. Cinnamic aldehyde (92.02 %) 
was found to be the major component of C. burmanii essential oil, and massoia lactone (92.05 %) is 
the main constituent of M. aromatica essential oil. The results obtained in this study indicate that 
the oil of C. burmanii and M. aromatica is an interesting source for anti-biofilm agents in the 
development of new strategies to treat infections caused by P. aeruginosa, S. aureus and C. albicans 
biofilm. 
 
Chapter 5 reported the screening of the 54 ethanol extracts of Indonesian medicinal plants and 29 
essential oils for their capability in inhibiting microbial quorum sensing mechanism using quorum 
sensing biosensor Chromobacterium violaceum ATCC 31532 (wild-type strain) and C. violaceum 
CV026 mutants strain. We also investigated the effect of the extracts and essential oils on the 
motility of pathogen Pseudomonas aeruginosa PAO1 strain, since bacterial motility has been shown 
to be associated with its virulence. Of the 54 plant extracts and 29 plants essential oils screened, 
Nymphaea nouchali ethanol extract, Syzygium aromaticum essential oil and Massoia aromatica 
essential oils demonstrated varying level of inhibition in violacein production of the reporter strains. 
A significant reduction in quorum sensing related motility of P. aeruginosa PAO1 has also been 
observed compare to the control. These plants extracts and essential oils may be selected for activity 
guided fractionation to identify and characterize the active principle. 
 
Based on research described in Chapter 3, 4 and 5 which showed the activity of M. aromatica 
essential oil to inhibit biofilm formation of P. aeruginosa, S. aureus and C. albicans, and also 
violacein production of C. violaceum and P. aeruginosa motility related quorum sensing activity, the 
isolation of the active compound from this plant sample has been described in Chapter 6. 
Preparative thin layer chromatography along with GC-MS and 1H-NMR elucidation were used to 
isolate and identify the active compound.  Result from bioautography analysis revealed that massoia 
lactone (synonym: 5-Hydroxy-2-Decenoic Acid Lactone; 2H-Pyrane-2-one, 5,6-dihydro-6-penthyl-) is 
the active compound of massoia oil. The microtiter broth method was performed to detect the 
antifungal and antibacterial activity, as well as anti-biofilm activity of massoia lactone, alone and in 
combinations with antibacterial and antifungal agents. Massoia lactone found to exhibit anti-biofilm 
activity against C. albicans ATCC 10231 at concentration of 25 µg/mL. Biofilm formation of P. 
aeruginosa PAO1 and S. aureus Cowan I are also partially hindered by massoia lactone at 
concentration of 50 and 100 µg/mL. The anti-biofilm activity of massoia lactone also found to be 
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three to four times greater in combinations with antifungal/antibacterial drug. We performed initial 
toxicity study of massoia lactone by hemolysis assay using human red blood cells. At the highest 
concentration tested (100 µg/mL), massoia lactone showed 12.4±0.9 % human red blood cells 
hemolysis compare to Triton X-100 which gave 100% hemolysis. This result indicates that at the 
range concentration tested, massoia lactone is less toxic to the human erythrocytes. The result 
obtained in this thesis indicated that massoia lactone displayed potent activity against microbial 
biofilms in vitro and therefore has potential therapeutic implication for biofilm-associated microbial 
infections.  
 


















































Microbiële resistentie tegen de meeste gebruikte antibiotica neemt steeds meer toe en daarom is 
het noodzakelijk om nieuwe anti-microbiële medicijnen te ontwikkelen. Daarnaast heeft recent 
onderzoek laten zien dat biofilms van micro-organismen een verhoogde resistentie bezitten tegen 
bijna alle antibiotica en het menselijke afweersysteem, wat vaak resulteert in blijvende of moeilijk te 
bestrijden infecties. De identificatie van nieuwe anti-microbiële middelen, die zowel actief zijn tegen 
vrij bewegende (planktonische) micro-organismen als micro-organismen aanwezig in biofilms, is 
daarom erg urgent om infecties beter te kunnen behandelen. 
 
Recent onderzoek wijst uit dat er natuurlijke producten de potentie hebben om pathogene micro-
organismen te bestrijden. Daarbij is gebleken dat planten een belangrijke en interessant bron zijn 
van verbindingen die een anti-biofilm werking kunnen hebben en dus een rijke bron zijn voor nieuwe 
moleculen met farmacologische eigenschappen, waarmee nieuwe geneesmiddelen kunnen worden 
ontwikkeld. Indonesië is een van de landen met een enorme diverse flora en een rijke traditie in het 
gebruik van medicinale planten. Omdat verschillende Indonesische medicinale planten anti-
microbiële verbindingen bevatten  leek het waarschijnlijk dat ze ook een bron konden zijn voor anti-
biofilm verbindingen. Daarom heeft het onderzoek beschreven in dit proefschrift zich gericht op het 
screenen en identificeren van mengsels met anti-microbiële en anti-biofim activiteit, welke mogelijk 
kandidaat verbindingen kunnen bevatten  voor de ontwikkeling van nieuwe therapeutica. 
 
In Hoofdstuk 1 wordt  een uitleg gegeven over biofilms, een cluster van meerdere lagen van cellen, 
die oppervlakten koloniseren.  De bestrijding van een biofilm is moeilijk door het steeds maar weer 
vormen van nieuwe lagen van cellen en de hoge inherente resistentie tegen anti-microbiële 
verbindingen en  immuun response van de gastheer. Quorum sensing , een cel tot cel communicatie 
systeem tussen micro-organismen, is onder andere verantwoordelijk voor de vorming van biofilms 
en speelt dan ook een belangrijke rol bij microbiële pathogeniciteit en antibiotica resistentie. 
Infecties veroorzaakt door de aanwezigheid van micro-organismen die biofilms vormen zijn van 
grote zorg in de medische wereld omdat ze in staat zijn oppervlakte van  medische hulpmiddelen 




In vele gevallen moeten die implantaten worden verwijderd om de infectie te genezen. Nieuwe 
antimicrobiële middelen die een hoge anti-biofim activiteit hebben kunnen hier een oplossing 
bieden.  Zoals eerder genoemd, een interessante bron voor nieuwe anti-biofilm verbindingen zijn 
met name medicinale planten. Dit komt mede omdat extracten van planten al decennia lang  een 
brede belangstelling hebben gekregen voor het zoeken naar medicijnen van natuurlijke oorsprong. 
Deze verbindingen worden breed geaccepteerd vanwege de perceptie dat ze veilig zijn en een lange 
geschiedenis hebben als volksmedicijn ter behandeling en preventie van ziektes en infecties. In dit 
hoofdstuk worden Pseudomonas aeruginosa, Staphylococcus aureus en Candida albicans besproken 
als model micro-organismen voor infecties via biofilm formatie.  
 
De screening van 54 ethanol extracten van verschillende Indonesische medicinale planten op de 
aanwezigheid van antimicrobiële en antibiofim activiteit tegen P. aeruginosa PAO1 en  S. aureus 
Cowan I is beschreven in hoofdstuk 2. De extracten vertoonden een remmend effect op 
planktonische groei maar, nog interessanter, op de vorming van biofilm-achtige structuren. Bij een 
minimale concentratie van 0.12 mg/mL, wordt biofilm vorming van P. aeruginosa PAO1 geremd 
evenals die van S. aureus Cowan I. De volgende  5 plant ethanol extracten vertonen deze remmende 
activiteit: Kaempferia rotunda L., Caesalpinia sappan L., Cinnamomum burmanii Nees ex Bl., C. sintoc 
L., en Nymphaea nouchali Burm.f.  Dezelfde extracten  lieten ook een verstoring van reeds gevormde 
biofilms door eerder genoemde bacteriën zien maar wel bij hogere concentraties. Ook beperkte 
bacteriostatische activiteit werd waargenomen. Deze eigenschappen kunnen mogelijk klinisch 
toegepast worden om infectieve biofilms te behandelen in combinatie met bestaande antibiotica. 
Daarnaast zou een toepassing ookindustrieel kunnen zijn zoals bijvoorbeeld het verwijderen van 
gevormde biofilms uit waterpijpleidingen (Kim en Park, 2013). 
 
In hoofdstuk 3 en 4 is de screening voor anti-biofilm verbindingen in 29 essentiële oliën  van   
Indonesische  medicinale planten  tegen P. aeruginosa PAO1, S. aureus Cowan I, en C. albicans ATCC 
10231 biofilms beschreven . Candida cellen, zoals vele andere micro-organismen, zijn in staat zich 
aan oppervlakten van medische hulpmiddelen  te hechten, te koloniseren en biofilms te vormen. De 
anti-biofilm activiteit van essentiële oliën werd bevestigd door confocale laser scanning microscopie 
analyse, samen met een dood/levende kleuring om dode en levende cellen te monitoren. Essentiele 
olie van C. burmanii en M. aromatica lieten 50% remming bij een concentratie van 0.25% v/v zien 
van P. aeruginosa PAO1 en S. aureus Cowan I planktonische groei (PMIC50). Tevens werd aangetoond 
dat essentiële olie van  C. burmanii en  M.  aromatica 50% inhibitie laat zien op de (MBIC50) biofilm-
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vorming van P. aeruginosa PAO1 en S. aureus Cowan bij een  concentratie 0.03 % v/v, terwijl een 
hogere concentratie (0.12 % v/v) nodig was van  beide oliën om 50%  van de reeds gevormde 
biofilms van  P. aeruginosa PAO1 en S. aureus Cowan I af te breken. 
 
De essentiele olie van C. burmanii, M. aromatica, Ocimum basillicum en Litsea cubeba (zaden) lieten  
een duidelijke anti-schimmel activiteit zien tegen de planktonische groei van C. albicans. Deze zelfde 
olie veroorzaakt ook remming van de vorming van C. albicans biofilm gedurende de drie 
verschillende stadia van biofilm ontwikkeling (sub-PMIC concentratie). Gevonden werd dat de 
remming van initiële biofilm vorming door deze essentiële oliën concentratie afhankelijk is. In de 
aanwezigheid van de geteste oliën , wordt  een significante afname van  biofilm biomassa gevonden 
vergeleken met de negatieve controle (biofilm cellen zonder toevoeging van  essentiële oliën die 
duidelijk dicht op elkaar gelegen lagen van cellen lieten zien). Door GC-MS zijn ook de belangrijkste 
componenten die aanwezig zijn in cinnamomum oil en massoia olie geïdentificeerd. Cinnamic 
aldehyde (92.0 %) is de meest aanwezige component in C. burmanii essentiële olie, en 
Massoialactone (92.1 %) is de  hoofdcomponent van  M. aromatica essentiële olie. De resultaten 
verkregen in deze studie laten duidelijk zien dat de olie van C. burmanii en M. aromatica een 
interessante bron zijn voor mogelijke anti-biofilm verbindingen waarmee strategieën kunnen 
worden ontwikkeld om infecties veroorzaakt door P. aeruginosa, S. aureus end C. albicans biofilms 
te bestrijden. 
 
In hoofstuk 5 is de screening van de 54 ethanol extract en 29 essentiële oliën van  Indonesische 
medicinale planten beschreven op mogelijke remming van het microbiële quorum sensing 
mechanisme met behulp van de quorum sensing biosensor Chromobacterium violaceum ATCC 31532 
(wild type stam) en  C. violaceum CV026 mutant stam (maakt geen signaal moleculen). Ook is het 
effect van de extracten en essentiële oliën op de beweeglijkheid  van de pathogene P. aeruginosa 
PAO1 stam geanalyseerd, omdat is aangetoond dat beweeglijkheid geassocieerd is met de virulentie 
van deze stam en dat bewegelijkheid nodig is voor biofilm vorming.  Van de 54 gescreende  planten  
ethanol extracten en 29 planten essentiële oliën vertoonde N. nouchali ethanol extract, Syzygium 
aromaticum essentiële olie en M. aromatica essentiële olie een variërend remmend niveau van 
violacein-productie. Een significante reductie in quorum sensing, gerelateerd aan beweeglijkheid van 
P. aeruginosa PAO1 ten opzichte van de controle, werd ook gevonden. Deze planten extracten en 





Gebaseerd op het onderzoek beschreven in hoofdstuk 3, 4 en 5 waarin de activiteit van M. 
aromatica essentiële olie om zowel  biofilm vorming van P. aeruginosa, S. aureus en C. albicans, te 
remmen als de violacein productie van C. violaceum en ook de beweeglijkheid- gerelateerde quorum 
sensing activiteit van P. aeruginosa te verminderen, is de actieve verbinding uit dit planten preparaat 
geïsoleerd en dit staat beschreven in hoofdstuk 6. Preparatie van dunne laag chromatografie 
tezamen met GC-MS en 1H-NMR werden gebruikt om de actieve verbinding te isoleren en te 
identificeren. De resultaten van bioautografie analyse lieten zien dat massoia lactone (synonym: 5-
Hydroxy-2-Decenoic Acid Lactone; 2H-Pyrane-2-one, 5,6-dihydro-6-penthyl-) de actieve component 
is in massoia oil. De microtiter broth methode werd uitgevoerd om zowel  de  anti-schimmel, anti-
bacteriële activiteit en de anti-biofilm activiteit van massoia lactone te bepalen. Ook werden deze 
activiteiten in combinatie met standaard anti-bacteriële en anti-schimmel verbindingen (antibiotica) 
bepaald. Massoia lactone vertoont anti-biofilm activiteit tegen C. albicans ATCC 10231 bij een 
concentratie of 25 µg/mL. Biofilm vorming van  P. aeruginosa PAO1 en S. aureus Cowan I wordt ook 
gedeeltelijk geremd door massoia lactone bij concentraties van  50 en 100 µg/mL. De anti-biofilm 
activiteit van massoia lactone is drie tot vier keer groter in combinatie met antibiotica. Ook werd een 
initiële toxiciteit studie met massoia lactone d.m.v. een hemolysis assay met humane rode 
bloedcellen uitgevoerd. Bij de hoogste concentratie (100 µg/mL), veroorzaakt massoia lactone bij 
12.4±0.9 % menselijke bloedcellen, hemolyse t.o.v. Triton X-100 dat 100% hemolyse gaf. Dit 
resultaat laat zien dat in de range concentraties die getest zijn, massoia lactone minder toxisch is 
voor human erythrocyten. De resultaten die in dit proefschrift beschreven zijn laten zien dat massoia 
lactone een duidelijke activiteit heeft tegen microbiële biofilms in vitro en daarom een duidelijke 
potentie heeft  als  therapeuticum voor  biofilm-geassocieerde microbiële infecties. 
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List of abbreviations 
 
AHL N-acylhomoserine lactone 
AIDS Acquired Immune Deficiency Syndrome 
ANOVA Analysis of variance 
ATCC American type culture collection 
C4-HSL N-butyryl-L-homoserine lactone 
CDCl3 Deuterated chloroform 
CDR Candida drug resistance 
CF Cystic Fibrosis 
CFU Colony forming unit 
CLSI Clinical and laboratory standard institute 
CLSM Confocal laser scanning microscope 
CMC chronic mucocutaneous candidiosis 
CoNS Coagulase negative staphylococci 
CP capsular polysaccharide 
DMSO Dimethyl sulfoxide 
eDNA Extracellular DNA 
ECM Extracellular matrix 
EOs Essential oils 
EPS Extracelullar polymeric substances, Exopolysaccharide 
ETs exfoliative toxins 
EtOH Ethanol 
FDA Food and Drug Administration 
FICI Fractional inhibitory concentration index 
GC-MS Gas chromatography-mass spectrometry 
HHL C6-Homoserine lactone 
HULIS Humic-like substances 
ICSBD Indonesian Country Study on Biodiversity 
IUD Intrauterine device 
LB Luria bertani 
MCSRAMMS Microbial surface components recognizing adhesive matrix molecules 
MDR Multi-drug resistance 
Mm Milimeter 
MIC Minimum inhibitory concentration 
MBIC Minimum biofilm inhibitory concentration 
MBEC Minimum biofilm eradication concentration 
MTT 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide 
µm Micrometer 
NIH National Institutes of Health 
NIST National institute of standards and technology 
nm Nanometer 
NMR Nuclear magnetic resonance 
OD Optical density 
PBS Phosphate buffer saline 
PE Petroleum ether 
PI Propidium iodide 
PIA The polysaccharide intercellular adhesion 





PTSAgs Pyrogenic toxin superantigens 
PVC Polyvinyl chloride 
QS Quorum sensing 
QSI Quorum sensing inhibition 
QSM Quorum sensing molecule 
RI Retention index 
RT Retention time 
SDB Sabouraud dextrose broth 
SEs Staphylococcal enterotoxins 
SI Similarity index 
SOD superoxide dismutase 
SSSS Staphylococcal scalded skin syndrome 
TLC Thin layer chromatography 
TM Traditional medicine 
TSS Toxic shock syndrome 
TTSS Type III secretion system 
v/v Volume/volume 
WT Wild type 
XTT 2-3-bis-(2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-carboxanilide 
 
 
